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This thesis describes the investigations towards developing facile protocols for the 
determination of the enantiomeric excesses of three classes of compounds - chiral diols, 
diamines and amino alcohols - employing tandem imine and boronate ester 
condensation of pairs of enantiomers to afford corresponding pairs of diastereoisomeric 
iminoboronate esters or imidazolidine boronate esters from which the enantiomeric 
excess of the parent compound may be determined using 1H NMR analysis. 
 
The first chapter begins with a brief overview of boron chemistry before considering 
some examples of intermolecular N→B coordinate bonding. We then go on to focus on 
the nature and use of the intramolecular N→B interaction in a variety of synthetic 
methodologies. 
 
The second chapter introduces our previous work toward the development of a novel 
protocol for the determination of the enantiopurity of chiral primary amines. We then 
consider different spectroscopic approaches for determination of ee before detailing 
individual studies to expand this methodology for the determination of the 
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Figure 1 Three-component protocol for determination of the enantiomeric excess of a chiral diol. 
 
For chiral diols, the approach involved a 3-component coupling of 2-
formylphenylboronic acid with enantiopure (S)-α-methylbenzylamine and the diol 
     Abstract 
 
vii 
under investigation to afford a pair of iminoboronate esters which show baseline 
resolution of pairs of proton resonances by 1H NMR spectroscopy (Figure 1). 
 
For chiral diamines, two approaches were conceived. Three-component coupling of 
1,2-diphenylethane-1,2-diamine with 2-formylphenylboronic acid and the enantiopure 
diol hydrobenzoin afforded pairs of imidazolidine boronate esters whose resonances 
were again distinct by 1H NMR analysis. However, the general applicability of this 
protocol has not been established, in which case an alternative mono-Boc protection 
strategy was developed followed by iminoboronate ester formation with an enantiopure 
diol as before. 
 
Attempted 3-component oxazolidine boronate ester formation for the determination of 
the enantiopurity of chiral amino alcohols proved unsuccessful. We therefore employed 
an O-protection approach before forming diastereomeric iminoboronate esters to 
determine their ee. The synthesis of a range novel chiral oxygen-bridged di-boron 
species, initially formed as in situ products in our early investigations with amino 
alcohols is then described (Figure 2). 
 
 
Figure 2 Synthesis of oxygen-bridged di-boron species. 
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1 
1.1  General Introduction 
 
In this short review, we will first consider some of the characteristic chemistry 
involving boron-containing compounds. We will then follow this with a brief overview 
of literature reporting intermolecular boron-nitrogen coordinate bonding before 
focusing in greater depth on the employment of intramolecular N→B bonding in a wide 
range of methodologies. 
 
 
1.2 Boron-Nitrogen Bonds and Their Applications in Synthesis  
 
There has been a significant amount of interest in the field of asymmetric synthesis in 
recent years, due in part to the increasing demand for enantiomerically pure compounds 
from the pharmaceutical industry.1 Synthesising such compounds has been achieved 
using a variety of methodologies. These range from using ‘chiral pool’ substrates as 
enantioselective reagents,2-4 chiral auxiliaries5 and chiral reagents,6, 7 through to kinetic 
resolution8-10 and asymmetric catalysis.5, 11, 12  
 
 
1.2.1 Hydroboration and the Origins of Boron in Asymmetric 
Synthesis 
 
There has been growing interest in the application of electron-deficient boron species 
for asymmetric synthesis.13-15 The proliferation of boron-based synthesis dates back to 
1956 with seminal work published by Herbert C. Brown et al. for which he later 
received the Nobel Prize.16† In this paper, a novel technique for the conversion of 






† The 1979 Nobel Prize was awarded jointly to H. C. Brown and G. Wittig for their development of Boron and 
Phosphorous-containing compounds respectively into significant reagents for organic synthesis. 























Scheme 1 The first reported hydroboration reaction of 1,1-diphenylethene 1 to 2,2-diphenylethanol 2 by 
H. C. Brown et al. 
 
Of particular note was the apparent anti-Markovnikov regioselectivity of the B-H bond 
across the alkene.17 This can be reasoned due to steric and electronic factors. Boron has 
an electronegativity (2.0) comparable, but importantly more electropositive than carbon 
(2.5) and hydrogen (2.2). As a consequence of this, the more electronegative hydrogen 
adds to the more substituted carbon atom (Scheme 2). 
 
 
Scheme 2 Concerted addition of the B-H bond across an alkene. 
 
The hydroboration step is considered to be concerted, although C-B bond formation 
occurs slightly more rapidly than the C-H bond, giving a more substituted carbocation. 
Hence, the mechanism proceeds via a 4-membered transition state with an anionic sp3 
boron species. It is this Lewis-acidic nature - due to the vacant 2p orbital - which 
characterises the chemistry of boron.18,19 
 
H. C. Brown et al. expanded on this work with the synthesis of chiral organoborane 
reagents which can be used in asymmetric hydroboration reactions to afford chiral 
compounds.20-23 Some of the most widely used chiral boranes are derived from 
inexpensive terpenes, such as monoisopinocampheylborane 3 and 
diisopinocampheylborane 4 (represented as IpcBH2 and Ipc2BH respectively) (Figure 
1).23-26 
 





Figure 1 Commonly used chiral boranes in asymmetric hydroboration. 
 
One such example, shown below, was reported by Brown et al. in 1984 (Scheme 3). 
They used (+)-diisopinocampheylborane (+)-4 to effect a highly stereoselective 
asymmetric allylation reaction of 3-methylbuten-2-al 7 to (+)-artemisia alcohol 8 in 
96% ee, 85% isolated yield.7 
 
 
Scheme 3 Asymmetric allylation using chiral borane reagent (+)-4. 
 
Following the pioneering work by H. C. Brown, organoboranes have been shown to 
undergo a wide range of chemical transformations utilising the electron deficient nature 
of the boron atom.21, 23, 27-30 One such example is the work reported by Imai et al. in 
1986.6, 31 They employed a stoichiometric quantity of C2-symmetric dimethylborolane 
reagent 10 to asymmetrically reduce prochiral ketones to their corresponding secondary 
alcohols with very high enantioselectivity (up to 98%). Chirality is induced into the 
alcohol in the diastereomeric transition state which directs the asymmetric reduction to 






























Scheme 4 Asymmetric reduction of prochiral ketones using a C2-symmetric chiral boron reagent. 




A general feature which characterises the mechanism of many reactions of 
organoboranes (boron species which contain alkyl substituents) is that when the 
nucleophile bears a good leaving group (or a group capable of accepting electrons) adds 
to an sp2 boron, affording an sp3 tetrahedral conformation, 1,2-migration of an alkyl 
group can occur from the boron to the atom bearing the leaving group.  
 
 
Figure 2 Addition-migration pathway which characterises much of the chemistry of boron. 
 
Importantly, these migrations are stereoselective, with the migrating alkyl group and 
the leaving group aligning antiperiplanar to one another prior to the migration and with 
any stereocentres in the migrating group being conserved.32, 33 
 
The full scope of organoborane reactions are beyond this review. More relevant is the 
use of boron-complexes as chiral Lewis acids in mediating reactions and generating 
high levels of enantioselectivity which we will now go on to consider. 
 
 
1.2.2  Covalent Interactions between Boronic Acids and Diols 
 
Phenylboronic acid was first synthesised in 1880 by Michaelis and Becker,34, 35 some 
20 years after the first reported synthesis of ethylboronic acid by Frankland in 1860.36 
The route documented by Michaelis and Becker involved treatment of boron trichloride 
and diphenyl mercury to form dichlorophenylboronate which was then hydrolysed and 
recrystallised to afford the boronic acid. This strategy was refined in 1909 when the 
classical route to boronic acids through Grignard reagents and trialkyl borates was 
established.37  
 




The first binding study between phenylboronic acid and diols was not published until 
much later, with seminal work by Kuivila et al. in 1954 reporting the solvation of 
mixtures of phenylboronic acid and several different classes of diol. This included 
polyols and saccharides with the group suggesting that cyclic boronate esters were 
formed.38, 39 
 
This was expanded in 1959 by Lorand and Edwards who reported a potentiometric 
investigation into the binding interaction between phenylboronic acid and different 
saccharides.40 They first proposed the tetrahedral geometry of the phenylboronic acid 
anion although this structure is still disputed (Figure 3).41 
 
 
Figure 3 First reported investigation into the sp2 versus sp3 nature of the boronate anion was in 1959. 
 
It is now known that boronic acids react rapidly and reversibly with diols to afford 
cyclic boronate esters in non-aqueous or basic aqueous conditions.42-44 It has also been 
widely reported that boronic acids show good binding affinity with other nucleophiles 
such as dicarboxylic acids42-47 and α-hydroxy-carboxylic acids.46-48 The most common 
interactions involve cis-1,2- or 1,3-diols which afford 5 or 6-membered boronate ester 
rings respectively (Scheme 5).49, 50 
 
 
Scheme 5 Reversible formation in basic aqueous media (A) and irreversible cyclic boronate ester 
formation in aprotic solvent (B). 
 
The formation of the cyclic boronate ring has a large impact on the hybridisation at the 
boron centre. The free boronic acid adopts a trigonal planar, sp2 hybridised, geometry 




(with a bond angle of 120°). When the boronic acid condenses with a diol the bond 
angle reduces to approximately 113° which is closer to the ideal bond angle of 109° for 
sp3 hybridised systems. The addition of the diol therefore changes the hybridisation at 
the boron centre from sp2 towards an sp3 tetrahedral geometry. 
 
Addition of a diol also changes the Lewis acidity of the boron atom. This change in 
acidity is often ascribed to the contraction of the oxygen-boron-oxygen (O-B-O) bond 
angle on complexation. Controlling the geometry around the boron centre through diol 



















Scheme 6 Lewis base addition assisted by cyclic boronate ester (B) rendering the boron centre more 
acidic. 
 
The formation of an sp3 hybridised boronic acid was reported by Wulff et al. in 1982.51 
They showed that incorporation of an adjacent amine would allow for N→B coordinate 
interaction with the boron atom adopting a tetrahedral conformation (Figure 4). This 
will be considered further, later in the chapter. 
 
 











1.2.3 Chiral and Achiral Boron Lewis Acids 
 
There has been a plethora of examples of chiral boron reagents used as Lewis acids in 
enantioselective reactions in the literature in recent years.15, 52 Boron chemistry is 
characterised by the formation of three, two-centre-two-electron bonds leaving the 
boron centre sp2 hybridised with bond angles of 120°.53 This results in an electron 
deficient boron atom with an empty 2p orbital which is available to accept electrons 
from anions or electron-rich nucleophiles. This empty p-orbital is responsible for boron 
acting as a Lewis acid and as such it readily forms complexes with Lewis basic 
compounds to afford neutral tetrahedral species. Alternatively, reaction with an anionic 
nucleophile results in the formation of an “ate” anionic species (Figure 5).29 
 
 
Figure 5 Trigonal sp2 and tetrahedral sp3 boron species. 
 
Boron trigonal species can then be considered as neutral equivalents of carbocations, 
and tetrahedral boron species as mimics of sp3 carbon compounds. The most commonly 
used boron Lewis acids contain electronegative ligands and are of the general structure 
BX3, RBX2 and R2BX where X = F, Cl, Br, I and OTf.  
 
We will now consider a couple of boron-ligand complexes employed in achiral and 
enantioselective reactions. We will then look at examples of boron-nitrogen, Lewis 
acid-base bonding in asymmetric synthesis before focusing on intramolecular boron-
nitrogen bonds and their applications. For a more extensive appraisal, particularly of 
asymmetric reductions of ketones and reactions of boron enolates, see the review by 
Deloux et  al.32   
 
In the late 1980s, Yamamoto and co-workers developed a series of chiral catalysts 
prepared from monoacyl tartaric acids and borane, called CAB (chiral(acyloxy)borane) 
catalysts (Figure 6).54, 55 
 





Figure 6 Formation of a CAB catalyst 14. 
 
Their use was reported in the asymmetric Diels-Alder reaction of an α,β-unsaturated 
aldehyde, such as methylacrylaldehyde 15, with a variety of dienes, inferring a good 
level of asymmetric induction, with ees of up to 96% and endo / exo ratios in the order 
of 9 / 1.54 
 
 
Scheme 7 Asymmetric Diels-Alder reaction catalysed by CAB catalyst 14. 
 
The use of these CAB catalysts was expanded on by the Yamamoto group, who, in 
1991, reported their use in the asymmetric Mukaiyama aldol condensation of silyl enol 
ethers and aldehydes.56 Sub-stoichiometric quantities of the CAB catalyst were used 





























93 / 7 erythro / threo
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Scheme 8 CAB catalysed Mukaiyama aldol condensation. 
 




More recently, work by Marshall et al. has demonstrated the excellent versatility of this 
class of chiral boron catalyst using the same CAB catalyst 14 (Figure 6) to catalyse 
addition of allylic stannanes such as (E)-but-2-enyltributylstannane 24 to achiral 




20 mol% CAB 11









93 / 7 syn / anti  
Scheme 9 Asymmetric addition of organotin reagents to aldehydes. 
 
 
1.2.4 Boron Lewis Acids with Inter-Molecular N→B Bonds 
 
The use of boron as a Lewis acid extends to formation of coordinate bonds with a wide 
variety of hetero-atoms including oxygen, sulfur,58 phosphorus59 and nitrogen.60 Such 
compounds have widespread use in organic synthesis (Figure 7).20 
 
 
Figure 7   Some typical boron reagents incorporating heteroatom coordination. 
 
In 1991, Itsuno et al. reported the preparation of secondary amines from nitriles such as 
benzonitrile 26 in the first example of a reaction between an N-boryl imine and an 
organometallic compound.61 Borane-tetrahydrofuran was used to form N-boryl imines 
from their respective nitrile substrates, followed by alkylation with various alkyl- or 
aryl-lithium reagents to afford their corresponding secondary amines (Scheme 14). The 
formation of the N-boryl imine occurs in situ, via a hydroboration-type pathway, 
involving borane addition across the nitrile bond. 
 





Scheme 10  Reaction mechanism for the one-pot generation of secondary carbinamines from nitriles. 
 
Nucleophilic-addition of the organometallic reagent is assisted by the presence of the 
N-boryl group, reducing the electron density around the nitrogen atom and hence 
increasing the imine carbon’s electrophilicity. This was observed as the reaction 
proceeded rapidly with good-to-excellent yields at -80 ºC. 
 
The first example of a boron complex with binaphthol ligands was reported by Kelly 
and co-workers in the mid 1980s.62 They documented the use of peri-hydroxyquinones 
as substrates in the asymmetric Diels-Alder reaction with (E)-trimethyl(3-methylbuta-
1,3-dienyloxy)silane 30 mediated by boron-BINOL complexes formed from substituted 
BINOL ligands such as (R)-3,3′-diphenyl-1,1′-binaphthyl-2,2′-diol (R)-29. Diels-Alder 
reactions carried out with these complexes afforded cycloaddition products with 
excellent enantioselectivities of up to >98% ee. The authors commented on the 
convenience of using peri-hydroxyquinones as substrates, as the phenolic hydroxyl 
group could act as a second ligand donor to the Lewis acid, thus forming a highly rigid 
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Scheme 11 Diels-Alder reaction of peri-hydroxyquinones. 
 
In 1993, Hattori et al. reported the use of N-boryl BINOL complexes for the 
transformation of imines into β-amino esters in good to excellent des of 74 - 94% 
(Scheme 12).63   
 





Scheme 12 Boron-assisted diastereoselective reaction between a Lewis-acid coordinated imine and a 
silyl ketene acetal. 
 
The diastereoselectivity arises from the intermolecular coordination of the imine with 
the chiral BINOL-boron Lewis acid (R)-35 in the N-boryl complex transition state. The 
Lewis acid blocks the si-face of the imine, promoting preferential nucleophilic attack 




Figure 8 Intermolecular N→B coordination induces facial selective addition to the imine. 
 
Lewis acid systems using a chiral biaryl backbone have since been employed in 
inducing stereoselectivity into a variety of reactions. Yamamoto et al. successfully 
applied this system to the aza-Diels-Alder reactions of an imine (S)-37 with 
Danishefsky’s diene 36, reporting a high degree of selectivity (Scheme 13).64, 65 
 
 
Scheme 13 Aza-Diels-Alder reaction mediated by a boron-BINOL Lewis acid (R)-35. 
 




1.2.5 Boron Lewis Acids with Intramolecular N→B Bonds 
 
There are few examples in the literature of compounds exploiting intramolecular boron-
nitrogen bonds in organic synthesis. The use of such compounds has so far been 
restricted to the development of boronic acid-based sensors for saccharides such as 
glucose,66 and  in studies of the trigonal vs. tetrahedral nature of the boron centre.67 
 
One of the earliest examples of a compound containing an intramolecular N→B bond 
was reported in 1968 by Dunn et al.68 They reported the synthesis of trimeric boronic 
anhydride Schiff bases 39a-d from condensation of the trimeric anhydride of 2-
formylphenylboronic acid with primary aromatic / aliphatic amines (Figure 9). This 
was confirmed by the presence of infra-red absorbances in the region 1622-1648 cm-1 
corresponding to the C=N stretch. Absence of absorptions due to OH or NH 
functionalities confirmed the trimeric anhydride structure. On addition of catechol, 
absorption was observed at 1220 cm-1 which the authors postulated to be an N-B 
stretch. This stretch was not seen in the spectra of 39a-d, and it was concluded that this 




Figure 9 Dunn et al. reported examples of Schiff bases incorporating intramolecular N→B bonding. 
 
Of particular note is the application of these Schiff bases as intermediates for the 
formation of aminoboronic acids (Scheme 14). Lithium aluminium hydride reduction of 
39a gave N-phenylboronophthalimidine 41 which was subsequently further dehydrated 
to afford dimeric anhydride 42. Importantly, the authors noted the difficulty of isolating 
the mono-aminoboronic acid. 
 





Scheme 14 Reduction of anhydride 39a to aminoboronic acid 41a which dimerised on heating. 
 
A range of chiral boron Lewis acids have been developed over the last 20 years which 
take advantage of the intramolecular N→B interaction. Perhaps the most well known 
example, the CBS (Corey-Bakshi-Shibata) catalyst, (S)-44 was first reported by Corey 
in the late 1980s for the asymmetric reduction of prochiral ketones to their 
corresponding alcohols (Scheme 15).69 
 
 
Scheme 15 CBS reduction of acetophenone. 
 
They employed an oxazaborolidine catalyst, prepared from treatment of an enantiopure 
α-amino acid (or their corresponding alcohol) with borane to induce excellent 
enantioselectivities of up to 97%. This work is particularly worthy of note since it 
advantageously uses both inter and intramolecular N→B bonding, with the nitrogen 
atom coordinating to the adjacent boron centre and an incoming BH3 molecule, which 
is then activated to act as a hydride source for the reduction of the carbonyl group 
(Scheme 16). 
 





































































Scheme 16 Inter and intramolecular N→B coordination involved in the CBS reduction mechanism. 
 
The catalytically active species forms via the rapid and reversible coordination of a BH3 
molecule to the Lewis basic nitrogen on the α-face of the oxazaborolidine bicycle, 
affording a cis-oxazaborolidine.borane complex. Donation of the N-lone pair into the 
vacant 2p orbital of the boron atom activates this centre and allows the hydride transfer 
to occur.  
 
This class of oxazaborolidine catalysts have since proven particularly versatile, with 
further published work by Corey et al. applying CBS catalysts to a variety of 
transformations, including the asymmetric Diels-Alder reaction between 2-


















-78 °C, 1 h
95% yield
99% ee
96 : 4 exo : endo  
Scheme 17 Asymmetric Diels-Alder transformation catalysed by a CBS catalyst (S)-47. 
 
They reported excellent enantiomeric excesses of up to 99% and exo / endo-selectivity 
of up to 96 / 4. N-tosyl protection of the nitrogen interrupted the N→B interaction, 
delocalising the amine lone pair onto the sulphonyl moiety. This rendered the boron 
centre more electron deficient, and thus afforded a more potent Lewis acid. 
 




This catalyst, (S)-tryptophan-derived (S)-47, has been used to prepare chiral building 
blocks for the asymmetric synthesis of natural products such as the potent antiulcer 
substance cassinol 49 and plant growth regulator gibberellic acid 50 (Figure 10).71 
 
 
Figure 10 Two natural products synthesised using CBS methodology. 
 
The CBS series has also been used in the Mukaiyama aldol reactions of silyl ketene 
acetals and aldehydes, as reported in 1991 by Kiyooka and co-workers.72 They used an 
enantiopure (S)-valine-derived oxazaborolidine catalyst (S)-52 as a stoichiometric 
Lewis acid to affect the chiral addition with ees of up to 98% (Scheme 18). 
 
 
Scheme 18 (S)-valine-derived CBS reagent used to effect chiral additions to aldehydes. 
 
They reported chiral addition to simple aldehydes, such as benzaldehyde 21, with good 
to excellent enantiomeric excesses (45 - 98% ee) and good yields (77 - 86%). 
 
Kinugasa et al. reported the first example where an arylboron CBS catalyst (S)-55 was 
used to catalyse the formal aldol reaction of a silyl enol ether with a 1,3-dioxolane 
substrate (Scheme 19).73 Initial complexation of the catalyst to the dioxolane afforded 
an in situ oxonium intermediate which was then trapped via reaction with silyl ketene 
acetal 56 to generate the O-protected ether (R)-57.  
 










































-20 °C, 5 h rt, 0.5 h
 
Scheme 19 N-protected chiral boron CBS reagent used in enantioselective ring cleavage reactions. 
 
These few examples have shown how powerful a synthetic tool the CBS 
oxazaborolidine series is in effecting stereoselective induction in a wide range of 
chemical transformations. 
 
Perhaps the field in which the N→B interaction has been most widely exploited is in 
the design of novel sugar sensors.74-78 Systems based on aniline-type nitrogens were 
reported by Sandanayake et al. in 1995,79, 80 who prepared a fluorescent ICT (Internal 
Charge Transfer) sensor 58 which coupled donor nitrogen and acceptor boronic acid 







Figure 11 An ICT sensor containing an intramolecular N→B interaction. 
 
Bosch et al. reported the synthesis of several novel aniline-based sensors including 59 
(Figure 12).81-83 They showed that following saccharide binding, the emission 
wavelength of the sensor was significantly altered. In aqueous solution, buffered at pH 
8.21, the addition of D-fructose caused a blue-shifting of the emission maximum of 59 




by 42 nm. This was ascribed to a change from TICT (or Twisted Internal Charge 
Transfer) in the boronic acid to LE (Locally Excited) fluorescence in boronate 60. 
 
 
Figure 12 Saccharide binding significantly affects emission wavelength. 
 
TICT arises in 59 due to a N→B interaction, confirmed by X-ray crystallography, 
which lies perpendicular to the π-system of the aniline. This stabilisation of the excited 
state is lost in the anionic boronate which shows no N→B interaction. No TICT 
stabilisation was observed when meta-61 and para-62 were used (Figure 13). 
 
 
Figure 13 No TICT stabilisation for meta-61 and para-62. 
 
Further to this, an investigation by Toyota and Oki suggested a mathematical 
determination of the degree of N→B interaction in a molecule (their proposed formula 
will be discussed in Chapter 2). They found that the level of coordination between the 
nitrogen and boron atoms was subtly influenced by a number of factors including 
substituent and solvent effects (Figure 14). They compared the energy barrier for 
dissociation of the intramolecular N→B bond of three examples (63a, 63b and 64) and 
suggested that the Lewis basicity of the nitrogen lone pair was inversely affected by the 
size of the N-substituents, with larger R-groups reducing the energy barrier for 
dissociation. 





Figure 14 Several factors influence the strength of the N→B interaction. 
 
The Lewis acidity of the boron atom was also found to influence the strength of the 
interaction, with electron donating oxygen atoms reducing the Lewis acidity of 
boronates compared to the corresponding alkylboranes.  
 
James et al. reported a novel design for a PET (Photoinduced Electron Transfer) sensor 
(boronic acid 65, Figure 15) incorporating the N→B motif with a more Lewis basic 
nitrogen.51,84, 85 They prepared an N-methyl-o-(aminomethyl)phenylboronic acid core 
structure modified with an additional anthracene fluorophore to facilitate PET, which 







Figure 15 Anthracene PET sensor with the N→B ‘on-off’ switch controlled by saccharide binding. 
 
PET is interrupted in the unbound sensor by a N→B coordinate interaction. Contraction 
of the O-B-O bond angle of the boronic acid on complexation with the saccharide (and 
the associated increase in the acidity at the boron centre) augments the N→B 
interaction, and hence disrupts PET. 
 
Following this initial success, a wide range of boronic acid sensors bearing the same N-
methyl-o-(aminomethyl)phenylboronic acid backbone have been reported, often 
involving more than one boronic acid moiety for multi-point binding to a saccharide, 
with a variety of linker motifs which affect the inter-boronic acid distance (Figure 
16).85-87 
 





Figure 16 Two published saccharide sensor designs incorporating the aminoboronic acid moiety. 
 
In 1982, Wulff and co-workers were considering novel techniques to improve a 
chromatographic procedure initially introduced in 1970 by Gilham et al. to separate 
diols from their impurities by binding the diols to boronic acids attached to a polymer 
chain.51 It was observed that diol binding was several orders of magnitude faster when 
the reaction was conducted in aqueous alkaline solution than when a neutral organic 
solvent was used. They rationalised this by considering that in alkaline solution the 
boron centre adopted an sp3 geometry with an extra hydroxyl group affiliated with the 
boron centre. 
 
Wulff showed that altering the boron centre, such that it adopted a tetrahedral geometry 
by means of an intramolecular N→B coordinate bond, would have the same effect on 
the efficiency of diol binding (under neutral organic conditions) as in aqueous alkaline 
solution. The intramolecular bond is formed by the incorporation of an amine adjacent 
to the boronic acid (Scheme 20). 
 
 
Scheme 20 N→B coordination improves the efficiency of diol binding. 
 
In 2001, Wiskur et al. reported a study on the pKa values of secondary and tertiary 
amines adjacent to boronic acids.67 They showed that secondary ammonium salts have 
comparable pKa values with their analogous tertiary ammonium salts (Scheme 21). 
 









































Scheme 21 Equilibria involved in potential N→B intramolecular interaction. 
 
This system was studied at a range of pHs. Initially, deprotonation of the ammonium 
ion (pKa1) affords 68b. This then allowed two deprotonation pathways (pKa2) to afford 
either free amine (68c) or coordinated amine (68d). The hybridisation at boron remains 
sp3 after either pathway, so 11B NMR spectroscopy cannot be used to differentiate these 
alternative pathways. However, further elimination of hydroxide from species 68d 
would be observable by 11B NMR since the boron centre in 68e would now be sp2 
hybridised. If this occurred, the effectiveness of this system for binding diols at high pH 
would be severely hampered. 
 
This system was studied in comparison with the analogous tertiary amine system, 
where only one deprotonation of the amine functionality is possible, which indicated 
that the second pKa2 observed was a result of coordination of the hydroxyl group to the 
boron atom (Scheme 22).  
 




















Scheme 22 Analogous system involving a tertiary amine. 
 
Potentiometric titrations of 68a and 69a showed comparable pKa1 values (5.3 and 5.2 
respectively). 11B NMR spectra were recorded as a function of pH and both systems 
showed upfield shifts at comparable pKa1 values to the pH titrations. This shift 
corresponds to a change of hybridisation around the boron from sp2 to sp3. 
Deprotonation at pKa1 precedes formation of a dative bond with the boron, which 
becomes tetrahedral in character. At neutral pH, the 11B NMR shifts showed good 
correlation for both species.  
 
The author therefore postulated that at neutral pH, species 69b predominated (Scheme 
22) which was supported by X-ray crystallographic data published in 2002 by Norrild 
et al. of a related secondary amine complex 70 (Figure 17). The X-ray crystallography 
data of this compound confirmed the favoured formation of N→B bonding which was 













Figure 17 Intramolecular N→B interaction in the solid state.  
 
The authors noted the potential application of incorporating secondary ammonium 
groups adjacent to the boronic acid functionality in assisting boronic ester formation 
with 1,2- and 1,3-diols for saccharide sensors.88, 89 
 
The energy of the N―B bond has been calculated from stepwise formation constants 
measured using potentiometric titrations.83 It was calculated that the lower and upper 




limits of the N―B interaction must be between approximately 15 and 25 kJ mol-1 in 2-
((benzyl(methyl)amino)methyl)phenylboronic acid. This value is in good agreement 
with computational data which estimated the N―B interaction to be ≤ 13 kJ mol-1 in 
the absence of solvent. To qualify this in terms of familiar bonding motifs, the energy 
of the N―B interaction is approximately equivalent to that of a hydrogen bond.  
 
Intramolecular N→B bonding has also been the subject of interest in the synthesis of 
novel metal ligands. In 1997, Ashe et al. reported the synthesis of novel 
aminoboratabenzene ligands 71a, which were shown to form metal complexes and act 
as alternative 6-π-electron ligands to cyclopentadienyl ligands.90 Such ligands, unlike 
their cyclopentadienyl counterparts, can interact with exo-cyclic substituents and thus 
change the properties of the ligand and hence the complex. 
 
 
Figure 18 Ashe et al’s aminoboratabenzene ligand, and complexed to manganese. 
 
In previous work within the group,90 they observed that the degree of N→B π-bonding 
was quite small in the uncomplexed aminoboratabenzenes. However, when metal 
derivatives were synthesised, the strength of the π-bonding increased. This was due to 
the electron withdrawing nature of the metal centre removing electron density from the 
boratabenzene ring. η5 Coordination of the ring was confirmed by X-ray 
crystallography and is characteristic of a highly stable N→B bond. The Lewis acidity 
of the boron atom increases as electron density is removed, corresponding to an 
increased N→B bond strength. 
 
However, despite these many examples of N→B interactions,  it has been reported that 
having the correct alignment for N→B bonding does not necessarily preclude an 
interaction occurring, even at neutral pH.91 For example, Norrild reported on a chiral 
ferroceneboronic acid which was published by Shinkai as an electrochemical 
carbohydrate sensor (S)-72 (Scheme 23).92 It was suggested by Norrild that no N→B 
interaction exists within this complex.  
















































Scheme 23 Shinkai’s novel electrochemical boronic acid sensor to polyol sorbitol. 
 
Support for this hypothesis came from considering the bond lengths and angles in the 
ferroceneboronic acid. The potential N-B bond length was measured to be 
approximately 2.5 Å, with intramolecular N-B bonding requiring a bond length of 
approximately 1.6 – 1.7 Å. Such a disparity was too large to suggest such an interaction 
was present, although it was observed that complex (S)-72 showed good binding 
properties with a polyol in solution. The 2,3,5-bound sorbitol complex contained a 
‘bridging’ hydroxyl group between the boron and the nitrogen (Scheme 23). Therefore, 
it appears that it is crucial that care is taken in designing future carbohydrate sensors to 
maximize the ‘tetrahedral effect’ of co-ordinately bonded nitrogen. 
 
 
From this short overview, it is clear that while boron has been widely used in many 
aspects of organic synthesis, applications of boron that contain an N→B functionality 
are limited. In particular, intramolecular boron-nitrogen coordinate bonds, increasingly 
found in novel saccharide sensors, and used with great success in early CBS 
oxazaborolidine catalysts for asymmetric reduction protocols have yet to be fully 
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2 The Synthesis of Stable Boronates with an Intramolecular Imino 






This chapter describes the successful synthesis and applications of a variety of stable 
boronate esters containing either an imino or amino intramolecular N→B coordinate 
bond.  
 
Previous work within the group had reported that this intramolecular coordinate 
bonding interaction can be advantageously applied to the one-pot construction of pairs 
of diastereomerically distinct imino-boronate esters whose 1H NMR spectrum may be 
used to determine the enantiomeric excess of the parent primary amine.1, 2 Therefore, 
1.0 equivalent of 2-formylphenylboronic acid 73 was stirred with 1.1 equivalent of 
enantiopure (S)-BINOL (S)-74 and 1.0 equivalent of (rac)-4-methoxy-α-
methylbenzylamine (rac)-75 in CDCl3 in the presence of 4 Å molecular sieves (Scheme 



































Scheme 1 Determination of the enantiomeric excess of primary amines. 
 




The resultant 1H NMR spectrum revealed that a 50 : 50 mixture of two 
diastereoisomeric complexes (α-R,S)-75a and (α-S,S)-75b had been formed in 
quantitative yield, whose respective imine, α-methine, α-methyl and p-methoxy 
resonances were all well resolved. This was highly promising because it meant that 
comparison of the relative intensities of four different sets of integrals could potentially 
be used to accurately confirm the enantiopurity of a scalemic sample of this amine by 
1H NMR spectroscopy.  
 
To investigate the scope and limitation of this chiral derivatisation protocol, a range of 
eight additional racemic amines containing stereogenic centres at their α-positions were 
then derivatised. The diagnostic differences in their chemical shifts are summarized 
below (Table 1). Analysis of the 300 MHz 1H NMR spectra of the resultant 50 : 50 
mixture of diastereoisomeric imino-boronate esters revealed that baseline resolution 




















Table 1 Chemical shift differences (Δδ) in the 300 MHz CDCl3 1H NMR spectra of 50 : 50 mixtures of 





















































































A negative value indicates that the resonance corresponding to the (S,S)-diastereoisomer is more 
deshielded than the (S,R)-diastereoisomer. a The quartet corresponding to the methine proton of the (S,S)-
diastereoisomer partially overlaps with the resonance of phenolic protons of residual (S)-BINOL; these 
signals no longer overlap on addition of 5 mol% of d6-acetone to the NMR tube. b The quartet 
corresponding to the methine proton of (S,R)-77a partially overlaps with the resonance of phenolic 
protons of residual (S)-BINOL. c 1.1 equivalents of cesium carbonate were added to liberate the free 
amine, with excess cesium carbonate being removed by filtration, through a small plug of celite prior to 
1H NMR spectroscopic analysis. 
 
Therefore, these results clearly demonstrated that this derivatisation approach appeared 
to be well suited for determining the enantiopurity of a wide range of chiral primary 
amines, including, α-arylethylamines, α-methylalkylamines, β-amino ethers, α-amino 
esters and β-amino esters. 




We then considered whether these types of complexes could be used to determine the 
enantiopurity of primary amines that contain remote stereogenic centres (Table 2). It 
was found that treatment of racemic amines 84 - 87 with 2-formylphenylboronic acid 
and enantiopure (S)-BINOL under standard conditions afforded pairs of 
diastereoisomeric complexes whose stereogenic methyl groups were all baseline 
resolved in their 1H NMR spectra. 
 
Table 2 Chemical shift differences (Δδ) in the 300 MHz CDCl3 1H NMR spectra of 50 : 50 mixtures of 































a 1H NMR run in d6-acetone. b Unable to assign a sign to the Δδ values of these resonances because an 
enantiopure sample of the parent amines were not available. 
 
Therefore, this derivatisation approach is also capable of determining the enantiomeric 
excesses of amines 84 - 87 that contain stereogenic centres at positions up to five bonds 
away from the amine functionality. 
 
The detection limits of this method were determined by derivatising three samples of 
(R)-α-methylbenzylamine (R)-76 of 80%, 90% and 98% ee, respectively, using 
enantiopure (S)-BINOL as the chiral diol. Analysis of the 1H NMR spectrum of each 
sample revealed that the calculated diastereoisomeric excesses (de’s) for the resultant 
mixture of (S,R)-76a and (S,S)-76b were in excellent agreement with the known 
enantiomeric purity of the starting α-methylbenzylamine. Thus, the 1H NMR integrals 
measured for formation of (S,R)-76a of 80%, 90% and 97% de correlated well with the 




known enantiopurity of the starting (R)-amine 76 of 80%, 90% and 98% ee, 
respectively, thus indicating that little or no kinetic resolution had occurred. 
 
Following this success, we envisaged that this protocol could be extended to 
determination of the enantiomeric excess of a wider range of classes of organic 
compounds.  This chapter, therefore, details the investigation into utilising these 




2.1.1 Determination of Enantiomeric Excess by NMR Spectroscopy 
 
The rapid emergence of the field of asymmetric synthesis has led to the development of 
several methods to determine the enantiomeric excess of chiral compounds.4 One, long-
standing technique for determination of the enantiomeric excess of a chiral molecule 
has been by obtaining the specific rotation of the sample using a polarimeter. This is a 
highly sensitive technique and depends greatly on temperature, solvent, concentration 
at a given wavelength and purity. However, several examples have been reported where 
this method breaks down, either through inaccurate optical rotations published in the 
literature or through the non-linear relationship between specific rotation and 
enantiopurity.5, 6  
 
More recently, methods based around NMR spectroscopy have attracted great interest 
due to the ease of use and general availability of NMR spectrometers.7 These methods 
rely on transformation of a mixture of enantiomers into diastereomers which then show 
non-equivalency in their NMR spectra. If these resonances are suitably resolved, their 
relative integration would reveal their diastereomeric ratio and hence, if no kinetic 
resolution has occurred, the enantiomeric composition of the original substrate. In 
recent years, this has been achieved using a variety of methodologies, including chiral 
solvating agents, chiral shift reagents and chiral derivatising agents. This affords the 
potential for developing a database of NMR protocols for determining the enantiomeric 
purity and absolute configuration of different classes of chiral compound. 
 




2.1.1.1 Chiral Solvating Agents 
 
Chiral solvating agents (CSAs), like chiral shift reagents, form in situ, reversible 
diastereomeric complexes with enantiomers through non-covalent bonding interactions. 
One such example is the host-guest complex 88a, which binds through three hydrogen 
bonds to a carboxylic acid moiety (Scheme 2).8 Such diastereomeric complexes are in 
rapid equilibrium in solution with the uncomplexed enantiomeric mixture. Here, 
determination of the ee of a chiral acid arises from non-equivalent diastereomeric 
signals of the complexed substrates in its 1H NMR spectrum. 
 
 
Scheme 2 Host-guest intermolecular hydrogen bonding interaction in chiral solvating agents. 
 
The simplicity of this method is its main advantage. Racemisation of the substrates is 
unlikely as is kinetic resolution. The main drawback of this approach is that the 
chemical shift differences (Δδ) between the diastereoisomeric complexes are often 
small, with only nuclei that are close to the stereogenic centre likely to show non-
equivalency and even these peaks may not be resolved enough to permit accurate 
determination of the enantiopurity of the mixture. Another limitation of this method is 
the limited range of co-solvents which can be used. Non-polar solvents such as CDCl3 
and C6D6 tend to show better resolution for diastereomeric complexes, while more 
polar solvents can preferentially solvate the enantiomeric mixture over the CSA, 
causing (Δδ) to fall to zero. 
 
The best known example of a chiral solvating agent was published in 1966 by Pirkle 
who reported the use of (S)-2,2,2-trifluoro-1-phenyl ethanol (S)-TFAE 89 as a CSA to 
determine the enantiomeric excess of chiral primary amines by 19F NMR analysis 
(Figure 1).9 
 






(S)-TFAE 89  
Figure 1 Chiral solvating agent reported by Pirkle et al. 
 
Other examples of chiral solvating agents include acids (R)-907 and (S)-9110 which 
have been used to determine the enantiomeric purity of chiral amines and amino acids, 
and the highly versatile (-)-(S)-t-butylphenylphosphinothioic acid (S)-92 used in the 
determination of ees of alcohols, diols, thiols, mercaptoalcohols and amines (Figure 
2).11-14 
 




2.1.1.2 Lanthanide Chiral Shift Complexes 
 
Chiral shift reagents (CSRs) form transient diastereomeric complexes from reaction of 
a metal ion (most commonly from the Lanthanide series such as Eu3+, Pr3+ and Yb3+) 
with a large variety of organic compounds containing electron-donating functionalities 
(Figure 3). Lanthanide ions form weak addition complexes which are in rapid 
equilibrium with the uncomplexed substrate mixture. This method is more 
advantageous than chiral solvating agents in that a more pronounced chemical shift 
difference is observed. However, the size of this shift diminishes as the separation 
between the stereocentre and the metal centre increases. This upfield or downfield shift 
is associated with an increase in peak broadening, and in cases where a large shift is 
observed, the fine-coupling can be lost. This is due to the paramagnetism of the metal 
centre and is of particular significance at higher magnetic fields. 
 






































Figure 3 Examples of common chiral shift reagent lanthanide complexes.7, 15  
 
 
2.1.1.3 Chiral Derivatising Agents 
 
Where chiral solvating agents and chiral shift reagents utilise in situ formation of 
diastereomeric complexes, chiral derivatising agents (CDAs) form long-lived 
diastereomeric complexes through covalent derivatisation of the substrate with an 
enantiomerically pure reagent. Such diastereoisomeric complexes generally show much 
greater chemical shift differences than both chiral solvating agents and chiral shift 
reagents. Indeed, using chiral derivatising agents, it is easier to develop models to 
account for the observed chemical shift patterns which have been used to predict the 
absolute configuration of the substrate under analysis.  
 
Limitations to this approach include the need to use enantiomerically pure derivatising 
agents and the possibility of kinetic resolution due to differing reaction rates of the 
substrate enantiomers. Despite these limitations, this approach continues to be the most 
widely used NMR method for determining enantiomeric excess. 
 




A common characteristic of chiral derivatising agents is the utilisation of the 
anisotropic effect of an aromatic ring in the CDA to induce a difference between the 
chemical shift differences (ΔΔδ) of enantiomeric substrates following derivatisation 
with the CDA. 
 
In 2004, Chin et al. reported the synthesis of a novel chiral derivatising agent for 
determining the enantiomeric excess of amino-acids using resonance-assisted hydrogen 
bonded imines derived from a chiral aldehyde CDA (Figure 4).16 This involves 
hydrogen bonding between the BINOL hydroxyl group and a conjugated imine (in this 
case with the bi-naphthyl rings of (R)-BINOL). In this case the imine proton shows a 















Figure 4 A chiral derivatising agent complex reported by Chin and co-workers. 
 
The most commonly used chiral derivatising agent, Mosher’s reagent (MTPA, α-
methoxy-α-trifluoromethyl-phenylacetic acid), (R)-94, was introduced in 1969 as a 
novel CDA for determining the enantiomeric excess of chiral amines and alcohols 






Figure 5 Mosher’s reagent was first reported in 1969. 
 
MTPA succeeded MPA (α-methoxyphenylacetic acid) because epimerisation of the 
stereogenic centre was observed during ester formation with more hindered secondary 
carbinols. MTPA is stable to epimerisation due to the absence of hydrogens α to the 




carboxyl moiety. Determination of the absolute configuration of secondary alcohols 
using this CDA is well reported and is deduced by interpretation of the signs of the Δδ 
values using empirical models.19, 20 Mosher’s reagent also has the potential for 
determining the enantiopurity of an alcohol or amine substrate by 19F NMR 



























Scheme 3 Derivatisation of a secondary alcohol using Mosher’s acid or acid chloride. 
 
However, there have been several examples where Mosher’s reagent has proven 
unsuccessful in the accurate determination of enantiomeric excess.21 This can be due 
either to poor reactivity towards more sterically demanding substrates, resulting in 
kinetic resolution or incomplete derivatisation, or a negligible chemical shift difference 
for pairs of diastereoisomeric resonances. This has proven to be a particular problem 
for substrates with remote stereocentres. As such, this is an area which has yet to be 















2.2 A Novel Chiral Derivatising Agent for Determination of the 
Enantiomeric Excess of 1,2- 1,3- and 1,4-Diols 
 
Following on from previous work within the group that developed a novel protocol for 
the chiral derivatisation of primary amines, we envisaged that this approach might also 
be suitable for determination of the enantiopurity of chiral diol fragments.  
 
 
2.2.1 Chiral Derivatising Agents for Chiral Diols 
 
The prevalence of chiral diols as synthetic intermediates23 and as fragments of 
biologically active compounds24 has led to a great demand for reliable techniques to 
accurately determine the enantiopurity of this class of compound. Therefore, the 
development of an inexpensive chiral derivatisation protocol that enables their 
enantiomeric excess to be simply determined by 1H NMR spectroscopic analysis is 
currently of great interest to the synthetic community.  
 
The use of chiral derivatisation agents (CDAs)7 to determine the enantiomeric excess of 
diols is well established,19, 25-27 with many having been derivatised to afford either 
MTPA (Mosher)18 or MPA (Trost)28 esters. The main drawback of using this type of 
approach is the potential for the two diol moieties of the parent diol to react at different 
rates, which can give rise to possible kinetic resolution of the diastereomers, severely 
impeding the application of this CDA for accurate determination of the ee of diols.29 
 
When Mosher’s acid is employed for a chiral diol, two equivalents of MTPA are 
required. This increases the potential for kinetic resolution of the parent enantiomers. 
Derivatisation of chiral diols with alternative CDAs that contain either a boronic 
acid,30-33 dichlorophosphine,34 dichlorophosphate,35 or an aldehyde36 moiety avoid such 
limitations since a single chiral derivatisation agent reacts with both alcohol 
functionalities of the diol substrate (Figure 6). 
 





Figure 6 Limited examples of chiral derivatising agents for diols in the literature. 
 
The dichlorophosphate system 96 is only suitable for determining the enantiomeric 
excess of C2-symmetric diols,35 while other CDAs of this type afford diastereoisomers 
that only show nonequivalence in their 13C or 31P NMR spectra.33-35 Furthermore, while 
the aldehyde system 99 (Figure 7) has been used to determine the absolute 
configuration of diols using NOE experiments, the observed 1H NMR chemical shift 





Figure 7 Chiral aldehyde CDA. 
 
The chemical shift differences observed by Burgess et al. for diastereoisomeric 
boronate esters prepared via treatment of diols with enantiopure (R)-2-(1-
methoxyethyl)-phenylboronic acid (R)-97 were also low in the range of Δδ 0.005-0.020 
ppm.30 Prior to my studies, diol derivatisation approaches based on the use of (S)-
acetamido(phenyl)methylboronic acid (S)-98 and derivatives appear to be the most 
effective for determining the enantiopurity of chiral diols, affording a resolution of Δδ 
0.060-0.360 ppm for the resultant diastereoisomeric boronate esters. However, a 
complex multi-step synthesis is required with low overall yields (20 - 30%) and 
rigorous purification was required including column chromatography of the protected 
boronate (Scheme 4).37 
 





Scheme 4 Synthesis of chiral derivatising agent (S)-acetamido(phenyl)methylboronic acid ((S)-98). 
 
All boronic acid CDAs reported to date form derivatisation complexes that contain a 
trigonal sp2 hybridised boron atom. If the boron atom can adopt an sp3 geometry then 
condensation with a diol is known to proceed much more rapidly. Furthermore, an sp3 
boron would generally afford a more rigid structure which then is more likely to give 
better shielding / deshielding for the diastereomeric complexes. 
 
 
2.2.2 Determination of the Enantiomeric Excess of Chiral 1,2- 1,3- 
and 1,4- Diols 
Dunn et al. first reported the 3-component synthesis of stable imino-boronate esters in 
1968 from a refluxing mixture of 2-formylphenylboronic acid, catechol and a series of 
achiral primary amines (Scheme 5).38 They noted the formation of trimeric boronic 
anhydride Schiff bases from the condensation of the trimeric anhydride of o-
formylphenylboronic acid with a series of primary amines. On addition of catechol, an 
infra-red absorption was observed at 1220 cm-1 which was postulated as a B-N stretch, 
consistent with formation of imino-boronate esters 101a-d. 
 





Scheme 5 Synthesis of imino-boronate esters from the one-pot reaction of 2-formyphenylboronic acid, 
catechol and an achiral primary amine. 
As discussed earlier, previous work within the group reported a 3-component coupling 
protocol employing (S)-BINOL and 2-formylphenylboronic acid for determination of 
the enantiopurity of a wide range of primary amines by 1H NMR analysis, including 
amines that contain remote stereocentres (Scheme 1). 
It was postulated that such a system utilising a primary amine with an α-stereogenic 
centre could also be applied to determination of the enantiopurity of chiral diols. 
Therefore, 1.0 equivalent of a bifunctional aryl template, 2-formylphenylboronic acid 
73, 1.0 equivalent of (S)-α-methylbenzylamine (S)-76 and 1.0 equivalent of (rac)-1-
phenylethane-1,2-diol (rac)-102 were stirred in CDCl3 (Scheme 6) and the 1H NMR 
spectra of an aliquot acquired after 5 minutes. Two discreet sets of signals were 
observed as a 50 : 50 mixture in the 1H NMR spectrum, indicating that diastereomeric 
































Scheme 6 Multi-component coupling reaction to afford diastereomeric imino-boronate esters (α-S,R)-
102a and (α-S,S)-102b. 
 
Analysis of the 1H NMR spectroscopy in acetone-d6 showed distinct resonances for the 
imine and benzylic diol protons (Figure 8). Baseline resolution of these signals allows 
for accurate determination of the relative integration of the two diastereoisomers. This 




value directly reflects the enantiopurity of the parent diol, the reliability of which can 
be corroborated by comparison with other pairs of discreet diastereoisomeric 
resonances in the 1H NMR spectrum. In this way, comparison of the relative intensities 
of a series of different sets of integrals could potentially be used to accurately confirm 
the enantiomeric composition of a scalemic sample of chiral 1,2- 1,3- or 1,4- diols by 



















Figure 8 d6-acetone 400 MHz 1H NMR spectrum showing two distinct sets of resonances corresponding 
to the diastereomeric iminoboronate esters of (rac)-1-phenylethane-1,2-diol. 
 
In order to investigate the scope and limitation of this chiral derivatisation protocol, a 
series of eight further racemic diols – bearing primary, secondary and tertiary hydroxyl 
moieties – were then derivatised to afford diastereoisomeric iminoboronate esters with 









Table 3 Chemical shift differences (Δδ) in the 300 MHz CDCl3 1H NMR spectra of 50 : 50 mixtures of 




















































a 1H NMR spectra run in acetone-d6 b Enantiopure samples of diols 103 and 105 were unavailable for 
derivatisation. Therefore, individual assignment of resonances to each diastereomer could not be 
performed. c The values for Δδ  were obtained from deducting the resonances for (α-S,4R,5S)-106b from 
(α-S,4S,5R)-106a d The values for Δδ were obtained from deducting the resonances for (α-
S,3aS,7aS,10S,11R)-107b from (α-S,3aR,7aR,10R,11S)-107a e The values for Δδ were obtained from 
deducting the resonances for (α-S,4S,5S)- 108b from (α-S,4R,5R)- 108a.  
 
Derivatisation of the racemic parent diols was carried out by stirring 1.0 equivalent of 
diol 102-110 with 1.0 equivalent of (S)-α-methylbenzylamine and 1.0 equivalent of 2-
formylphenylboronic acid in CDCl3 in the presence of 4 Å molecular sieves, before an 
aliquot was taken for 1H NMR analysis after 5 minutes. 




Analysis of the 1H NMR spectra of the resultant 50 : 50 mixture of diastereomeric 
iminoboronate esters 102-110a and 102-110b revealed that baseline resolution was 
achieved for at least 1 set of signals in all cases, with up to four distinct resonances 
observed in some instances (Figure 9). It was therefore reasoned that this approach 
would be suitable for accurate determination of the enantiopurity of a wide range of 























Figure 9 400MHz CDCl3 1H NMR spectrum of a 50 : 50 mixture of imino-boronate esters (α-S,4S,5R)-
106a and (α-S,4R,5S)- 106b. 
 
For example, analysis of the 400 MHz 1H NMR spectra of a 50 : 50 mixture of imino-
boronate esters derived from (rac)-methyl-2,3-dihydroxy-3-phenylpropionate (α-
S,4S,5R)-106a and (α-S,4R,5S)-106b revealed that baseline resolution was achieved for 
four distinct sets of resonances with Δδ values of up to 0.510 ppm for the benzylic 
proton (Figure 9). 
The individual resonances corresponding to each pair of diastereomers were assigned 
by comparison with the 1H NMR spectra of diastereomerically pure iminoboronate 




esters 102-110a and 102-110b prepared individually via reaction of enantiopure diols 
102-110 with enantiomerically pure (S)-α-methylbenzylamine (S)-76. Complete 
derivatisation occurred for both diastereomers in all cases. Therefore, no kinetic 
resolution was occurring in the condensation of each diol with the boronic acid. 
Interestingly, the rate of complexation of this derivatisation reaction appears to agree 
with work by Wulff et al. who reported a kinetic study on the reversible formation of 
boronate esters.41 It has been shown that formation of a boronate ester complex occurs 
much more rapidly when the boron atom sits in an sp3 tetrahedral environment rather 
than a trigonal planar sp2 environment. Considering the rapid formation of these 
iminoboronate esters, whose condensation is complete in 5 minutes, one might 
postulate that the three-component formation of the imine and the cyclic boronate ester 
functionality is facilitated by N→B coordination that affords partial tetrahedral 
character to the boron centre. 
 
The detection limits of this new derivatisation method were then determined by 
derivatisation of three samples of (2S,3R)-106a of 80%, 90%, and 98% ee respectively, 
using enantiopure (S)-α-methylbenzylamine (S)-76 for complex formation. Analysis of 
the CDCl3 1H NMR spectrum of each sample revealed that the calculated 
diastereomeric excess (de) for the resultant mixture of (α-S,2S,3R)-106a and (α-
S,2R,3S)-106b were in excellent agreement with the known enantiomeric purity of their 
respective starting diols (2S,3R)-106. Therefore, the 1H NMR integrals measured for 
formation of (α-S,2S,3R)-106a of 81%, 89%, and 98% de correlated well with the 
known enantiopurity of the starting (2S,3R)-diol of 80%, 90%, and 98% ee 
respectively, thus indicating that little or no kinetic resolution had occurred (Figure 10). 
These values are well within the accepted 5% error limit normally accepted for CDA 
analysis with NMR spectroscopy.42, 43 
 
 





4 . 64 . 74 . 8 p p m  
Figure 10 Expansion of the 400 MHz CDCl3 1H NMR spectra of a mixture of iminoboronate esters (α-
S,2S,3R)-106a and (α-S,2R,3S)-106b prepared from diol (2S,3R)-106 of 80%, 90%, and 98% ee. 
 
 
With this novel chiral derivatising protocol in hand, we decided to further test its 
discriminatory abilities for determining the ee of two further chiral 1,2-diols; butane-
2,3-diol 111 and 1,2-diphenylethane-1,2-diol 112 which are commercially available in 
their enantiopure (1R,2R), (1S,2S) and (meso) forms. Therefore, 1.0 equivalent of 
butane-2,3-diol 111, 1.0 equivalent of 2-formylphenylboronic acid 73 and 1.0 
equivalent of (S)-α-methylbenzylamine, (S)-76 were stirred in CDCl3 for 5 minutes 
before an aliquot was removed and its 1H NMR was obtained. The spectrum is shown 
below (Figure 11). 
 
We found that the imine signal for all 3 diastereomers were individually baseline 
resolved sufficient for accurate integration to be performed, thus inferring the relative 
composition of the parent diol. This is particularly impressive since the substituents of 
the boronate ester fragment are sterically non-demanding methyl groups. 
 



























Figure 11 400 MHz CDCl3 1H NMR splitting of three sets of imine signals for iminoboronate esters 
derived from a 1 : 1 : 1 mixture of (1R,2R), (1S,2S) and (meso)-butane-2,3-diol 111. 
 
Such discrimination was also observed for the three possible stereoisomers of 1,2-
diphenylethane-1,2-diol 112, a 1 : 1 : 1 mixture of which was derivatised in a similar 
manner (Figure 12).  
 
Again, splitting of the three imino signals is observed in the 1H NMR spectrum. This 
further demonstrates that this protocol is a powerful tool for determination of the 
enantiopurity of a wide range of chiral 1,2- 1,3- and 1,4-diols. Furthermore, the 
boronate ring protons may be used in the determination of the enantiomeric excess of a 
mixture of (1S,2S) and (1R,2R)-1,2-diphenylethane-1,2-diol appearing as sharp 2H 
singlets at 5.03 and 4.90 ppm respectively. 
 



































Figure 12 400 MHz CDCl3 1H NMR resolution of three sets of resonances for the imine signals for 
imino-boronate esters derived from (1R,2R) (1S,2S) and (meso)-1,2-diphenylethane-1,2-diol 112. 
 
 
2.2.3 Influence of the Parent Amine on the Resolution of 
Diastereomeric Iminoboronate Esters 
 
Following the highly successful resolution of pairs of diastereomeric iminoboronate 
ester resonances using enantiopure (S)-α-methylbenzylamine in the three-component 
chiral derivatisation protocol, our attention turned to changing the nature of the chiral 
amine in an effort to improve this resolution in their 1H NMR spectra. 
  
In order to investigate this, a new three-component coupling protocol was employed 
using (S)-(-)-1-(naphthalen-3-yl)ethanamine (S)-77 as the parent amine which we 
hoped would lead to improved anisotropic shielding / deshielding of its resultant 
iminoboronate ester diastereoisomers. Therefore, 1.0 equivalent of (rac)-1-phenyl-1,2-




ethanediol 102 was stirred in CDCl3 with 1.0 equivalent of (S)-(-)-1-(naphthalen-3-
yl)ethanamine (S)-77 and 1.0 equivalent of 2-formylphenylboronic acid 73 at room 
temperature with an aliquot removed after 5 minutes (Scheme 7).  
 
 
Scheme 7 Three-component coupling using chiral amine (S)-(-)-1-(naphthalen-3-yl)ethanamine (S)-77. 
 
The resulting 1H NMR spectrum again showed two sets of signals in a 50 : 50 ratio 
corresponding to two diastereomeric iminoboronate esters 113a and 113b (Figure 13). 
Again, complete derivatisation was observed for both diastereomers indicating that no 

















Figure 13  400 MHz CDCl3 1H NMR resolution of diastereomers of 1-phenylethane-1,2-diol using (S)-(-
)-1-(naphthalen-3-yl)ethanamine. 
 




Splitting of the imine signal was again observed with a Δδ value of +/- 0.055. 
Surprisingly, in comparison with the equivalent spectrum for (S)-(-)-α-
methylbenzylamine, poorer splitting was observed for this chiral amine with only the 
imine signals splitting in both cases, indicating that the greater potential anisotropic 
shielding effect of the naphthyl ring had minimal influence on the discrimination of the 
diastereomers. Despite this poor splitting, (S)-1-(naphthalen-3-yl)ethanamine (S)-77 
was screened as a chiral auxiliary for three-component derivatisation of the range of 
diols considered previously. 
 
Table 4: Chemical shift differences (Δδ) in the 400 MHz CDCl3 1H NMR spectra of 50 : 50 mixtures of 






















































It may be concluded that the original rationale for the splitting of diastereoisomeric 
resonances through anisotropic effects appears largely unfounded. Although some sets 
of iminoboronate esters showed improved splitting ((α-S,4S,5R)-117a and (α-S,4R,5S)-
117b (derived from parent diol (rac)-106) displayed resolution of five sets of signals 
compared to the four distinct sets previously observed for (S)-α-methylbenzylamine 
(S)-76 (Figure 14), the improved resolution was not consistent and largely constituted 




Figure 14 Slightly improved resolution observed in the 400 MHz CDCl3 1H NMR when naphthyl CDA 
is used for (α-S,4S,5R)-117a and (α-S,4R,5S)-117b. 
 
 
2.2.4 Influence of the Parent Boronic Acid on Resolution of 
Diastereomers 
 
Continuing our work towards determining the cause of the resolution of the 
iminoboronate esters, our attention then turned to investigating the boronic acid 




component of the coupling protocol. The potential for forming an intramolecular N→B 
coordinate bond was considered essential both for catalysing Lewis-acid assisted imine 
formation and for improved resolution of the diastereomers through anisotropic effects. 
Therefore, movement of the ortho-formyl group around the ring to the meta- and para-
positions, thereby breaking the intramolecular N→B bond might be predicted to 
destroy any resolution of diastereoisomeric signals observed in the 1H NMR spectrum 
of its resultant iminoboronate esters.  
 
Therefore 1.0 equivalent of 3-formylphenylboronic acid 122, 1.0 equivalent of (S)-(-)-
α-methylbenzylamine (S)-76 and 1.0 equivalent of (rac)-methyl-2,3-dihydroxy-3-
phenylpropionate (rac)-106 was stirred in CDCl3 for 18 h in the presence of 4 Å 
molecular sieves (Scheme 8) before an aliquot was removed and a 1H NMR spectrum 








































Scheme 8 3-component coupling using 3-formylphenylboronic acid 122. 
 
Whilst imine formation again proceeded quantitatively, potentially due to 
intermolecular Lewis-acid catalysis, the 1,2-diol did not condense with the boronic acid 
under such mild conditions, thus suggesting that N→B interaction appears to be a pre-
requisite for the efficient three-component complexation to occur. 
 
4-formylphenylboronic acid was then considered and again, since no N→B coordinate 
bonding was present, no complexation of the chiral diol unit to the boronic acid was 
observed. 
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2.3 A Novel Chiral Derivatising Agent for Determination of the 




2.3.1 Chiral Derivatising Agents for Diamines 
 
Enantiopure diamines have proven to be highly effective components in a wide range 
of catalysts designed to induce enantioselectivity in a variety of asymmetric synthetic 
transformations. C2-symmetric diamines 1,2-diphenylethane-1,2-diamine 124 and 
cyclohexane-1,2-diamine 125 have proven to be popular chiral building blocks for the 
synthesis of chiral auxiliaries and chiral reagents,1,2 chiral sensors3-5 and chiral 
derivatising or solvating agents.6-12 They have also been widely used as chiral ligands 
for preparing transition metal complexes for asymmetric catalysis, and have recently 
been used for the preparation of highly enantioselective organocatalysts.13-15  
 
Whilst a range of different strategies have been developed for their asymmetric 
synthesis, these C2-symmetric amines are most commonly prepared in enantiopure 
form via resolution protocols.16-19 This most often involves treatment of their respective 
racemic amines with either tartaric or mandelic acid, affording mixtures of 
diastereoisomeric salts that are then separated and individually decomplexed to afford 
both enantiomers of the parent diamine.20-22 Since these chiral C2-symmetric amines are 
normally used in chiral environments,23 it is essential that their enantiopurity is 
determined accurately and, consequently, we envisaged extending our successful 
protocol for the determination of the enantiomeric excesses of primary amines and diols 
to diamines.24  
 
 
Figure 1 Two common diamines used in asymmetric transformations. 




2.3.2 Determination of the Enantiomeric Excess of 1,2-
Diphenylethane-1,2-diamine 
 
Following our successful development of a 3-component strategy for determining the 
enantiopurity of chiral primary amines and diols, we reasoned that this type of NMR 
derivatisation protocol might also be useful for analysing the enantiopurity of chiral 
vicinal diamines such as 1,2-diphenylethane-1,2-diamine or cyclohexane-1,2-diamine.  
 
Therefore, (rac)-diamine 124 was treated with one equivalent of 2-
formylphenylboronic acid 73 and one equivalent of enantiopure (R)-BINOL (R)-74 in 
CDCl3 in the presence of 4 Å molecular sieves (Scheme 1) and its 1H NMR spectrum 
acquired after five minutes. This 1H NMR spectrum revealed that an efficient 
complexation reaction had occurred to afford a 50 : 50 mixture of two 
diastereoisomeric imidazolidine complexes (R,2S,4S,5S)-126a and (R,2S,4R,5R)-126b 
in quantitative yield.25 
 
 
Scheme 1 Derivatisation protocol to afford a mixture of imidazolidine boronate esters. 
 
The individual resonances of each diastereoisomer were assigned by comparison with 
the 1H NMR spectra of authentic samples of (R,2S,4S,5S)-126a and (R,2S,4R,5R)-126b 
prepared independently via reaction of the individual (1R,2R)-124 and (1S,2S)-124 
enantiomers of 1,2-diphenyl-1,2-ethanediamine with 2-formylphenylboronic acid 73 
and (R)-BINOL (R)-74.  
 
Analysis of the 1H NMR spectra of (R,2S,4S,5S)-126a and (R,2S,4R,5R)-126b revealed 
structures consistent with formation of complexes containing an imidazolidine ring 
system. For example, resonances corresponding to the two NH protons of (R,2S,4S,5S)-




126a were assigned using a standard D2O exchange experiment which revealed that one 
of its nitrogen atoms NHA was coordinated to the central boron atom in an 
intramolecular manner. This was evident from the non-equivalence of the NH 
resonances of the imidazolidine ring system of (R,2S,4S,5S)-126a with the deshielded 
NHA proton coordinated to the boron atom appearing downfield at δ 5.02, the 




Figure 2 500 MHz CDCl3 1H NMR spectrum showing imidazolidine boronate ester (R,2S,4S,5S)-126a 
formed in quantitative yield with complete stereocontrol over the new imidazolidine stereocentre. 
 
The imidazolidine proton HC appears as a doublet of doublets at δ 6.14, with a large 
syn-diaxial coupling constant J(AC) = 12.3 Hz and a small axial-equatorial coupling 
constant J(BC) = 5.8 Hz. NOESY experiments revealed cross-peaks between the 
imidazolidine HC proton and the benzylic proton HE that was vicinal to HB, consistent 
with the imidazolidine ring structure of (R,2S,4S,5S)-126a (Figure 3). 
































Figure 3 NOESY coupling to determine the absolute stereochemistry at the imidazolidine stereocentre. 
 
The diastereoisomeric complexes (R,2S,4S,5S)-126a and (R,2S,4R,5R)-126b were 
sufficiently stable to allow for deuterium exchange of both their NH protons on shaking 
their NMR samples with D2O which resulted in both diastereoisomers exhibiting much 
simplified 1H NMR spectra, with their imidazolidine HC protons collapsing from a 




























Figure 4 Simplification of the imidazolidine signals using a D2O shake (500 MHz, CDCl3). 
 
Close examination of the 1H NMR spectrum of the 50 : 50 mixture of complexes 
(R,2S,4S,5S)-126a and (R,2S,4R,5R)-126b revealed baseline resolution of a number of 




complementary pairs of diastereoisomeric resonances. Most notably, two sets of 
resonances corresponding to their HA protons (∆∂ 0.42 ppm) and HD protons (∆∂, 0.32 
ppm) were baseline resolved which allowed them to be integrated to accurately 
determine the diastereoisomeric ratio of the sample. 
 
The detection limits of this method were determined by derivatisation of three samples 
of scalemic (1S,2S)-1,2-diphenyl-1,2-ethanediamine (1S,2S)-124 of 80%, 90% and 98% 
ee respectively. Comparison of the relative intensities of the integrals for the 
diastereoisomeric pairs of HA and HD protons in the 500 MHz 1H NMR spectrum of 
these mixtures revealed calculated diastereomeric excesses of 81%, 90% and 99% of 
(R,2S,4S,5S)-126a. These values were in excellent agreement with the known 
enantiomeric purity of their corresponding starting diamine (1S,2S)-124, thus indicating 
that little or no kinetic resolution had occurred in the derivatisation process. 
 
We can therefore conclude that the standard three-component protocol can be 
successfully translated to the formation of imidazolidine boronate esters for 
determination of the enantiomeric excess of 1,2-diphenylethane-1,2-diamine. 
 
 
2.3.3 Determination of the Enantiomeric Excess of Cyclohexane-1,2-
diamine 
 
Following the successful application of the 3-component coupling strategy for 
formation of a pair of imidazolidine boronates under standard conditions for 1,2-
diphenylethane-1,2-diamine, this approach was extended to cyclohexane-1,2-diamine 
125. 
 
Derivatisation of the (1R,2R)-enantiomer with 2-formylphenylboronic acid and (S)-
BINOL proceeded in quantitative yield to afford its corresponding imidazolidine 
(S,4R,5R)-127a. However, derivatisation of the (1S,2S)-enantiomer afforded a 50 : 50 
mixture of its imidazolidine (S,4S,5S)-127b and its corresponding imine (S,2S,3S)-128. 
The failure of the (1S,2S)-enantiomer of 125 to undergo clean ring-closure reaction 
under these conditions is presumably due to the added strain involved in forming a 




tricyclic imidazolidine ring system caused by unfavourable interactions between the 
methylene backbone of the cyclohexane ring system and the proximal aryl ring of the 









































Scheme 2 Derivatisation of (rac)-diamine (rac)-125 affords a mixture of imidazolidines (S,4R,5R)-127a 
and (S,4S,5S)-127b and imine (S,2S,3S)-128. 
 
This clearly meant that the imidazolidine derivatisation protocol employed for 1,2-
diphenylethane-1,2-diamine was unsuited to determining the enantiomeric excess of 
cyclohexane-1,2-diamine.  
 
Indeed, a similar story was found with other chiral diamines that were tested. All 
diamines tested using BINOL as a chiral auxiliary displayed either broad spectra or 
incomplete reaction. We thought that the broad spectra were caused by free rotation of 
the imidazolidine fragment in solution, for example in the derivatisation of achiral 
ethane-1,2-diamine 129 (Scheme 3).  
 
 
Scheme 3 Formation of an imidazolidine boronate ester using achiral ethane-1,2-diamine. 
 




A short solvent screen was run for reaction of (1S,2S)-cyclohexane-1,2-diamine 
(1S,2S)-125 with 2-formylphenylboronic acid 73 and (S)-BINOL (S)-74 in an attempt 
to drive the equilibrium to the tricyclic ring-closed imidazolidine species (Scheme 4). 
 
 
Scheme 4 Attempted ring closure to afford an imidazolidine in different solvents. 
 
Best results were obtained with THF-d8 which showed some imidazolidine formation 
although as with CDCl3 and CD2Cl2 some ring-opened imine signals were observed. In 
most instances, aside from sterically undemanding diamines such as ethane-1,2-diamine 
129 where signal broadening was more problematic, the steric bulk of the newly 
cyclised ring presented the main barrier to cyclisation. We therefore decided to look 
towards substituting BINOL for a different chiral diol moiety in the protocol which 
would allow a more facile imidazolidine ring formation to occur. 
 
Dimethyl-L-tartrate was selected since it is commercially available in both enantiopure 
forms and is far less sterically demanding than BINOL. Therefore, 1.0 equivalent of 
dimethyl-L-tartrate 108 was stirred with 1.0 equivalent of 2-formylphenylboronic acid 
73 and 1.0 equivalent of (1S,2S)-cyclohexane-1,2-diamine (1S,2S)-125 in CDCl3 in the 
presence of 4 Å molecular sieves for 5 minutes (Scheme 5) before an aliquot (0.7 mL) 
was removed and its 1H NMR spectrum acquired. 
 
 
Scheme 5 Incomplete stereoselectivity at the new chiral centre with dimethyl-L-tartrate. 
 




Whilst the switch to less sterically demanding dimethyl-L-tartrate proved highly 
successful in forcing complete cyclisation to the corresponding imidazolidine, a 
corresponding loss of stereoselectivity at the newly formed chiral centre was observed 
in all diamines tested, including 1,2-diphenylethane-1,2-diamine 124. This was 
confirmed by the presence of two distinct sets of signals in its 1H NMR spectrum. 
Whilst no imine resonances were observed, indicating complete imidazolidine boronate 
ester formation, two imidazolidine proton resonances were observed at δ 5.88 and 5.71 
ppm. 
 
We presumed that this was due to the steric influence being so greatly reduced so as to 
bring the energy gap between the two diastereomers (with differing stereochemistry at 
the new imidazolidine chiral centre) much closer together such that, despite the 
complex being in dynamic equilibrium in solution, it resulted in one ring form no 
longer predominating.  
 
 
2.3.4 Diol Screen Using a Secondary Diamine 
 
We therefore required a diol which would both promote quantitative cyclisation whilst 
still exerting complete control over the configuration at the new stereocentre. In order 
to test this, we used N,N’-dimethylethylamine as our parent diamine in a diol screen 
using the diols from our previous work to look for complete stereoselectivity at the new 
stereocentre. 
 
Therefore, 1.0 equivalent of N,N’-dimethylethylamine 131 was stirred with 1.0 
equivalent of 2-formylphenylboronic acid 73 and 1.0 equivalent of (R)-1-phenylethane-
1,2-diol (R)-102 was stirred in CDCl3 in the presence of 4 Å molecular sieves for 5 
minutes (Scheme 6) before its 1H NMR spectrum was acquired. 
 



























Scheme 6 Formation of imidazolidine boronate ester (R)-132 via cyclisation onto an activated iminium 
intermediate. 
 
Of the diols tested, only (R)-1-phenylethane-1,2-diol (R)-102 and (1S,2S)-hydrobenzoin 
(1S,2S)-112 showed complete cyclisation combined with 100% stereocontrol at their 
newly-formed imidazolidine centres (Figure 5). These diols were then tested with (rac)-
cyclohexane-1,2-diamine (rac)-125 as before. 
 
 
Figure 5 Successful formation of a single diastereoisomer was observed with two diols. 
 
1H NMR analysis of the crude samples revealed that the diol (1S,2S)-hydrobenzoin 
(1S,2S)-112 showed quantitative formation of a pair of cyclised imidazolidine boronate 
esters with complete stereoselectivity at their new imidazolidine stereocentres. 
Furthermore, resolution of a number of individual pairs of resonances was observed 
sufficient for baseline integration to be accurately performed (Scheme 7). 
 
 
Scheme 7 Successful formation of a 50 : 50 mixture of diastereoisomeric imidazolidine boronate esters. 
 
The 1H NMR spectrum showed resolution for several pairs of diastereoisomeric 
resonances which were individually resolved allowing for accurate integration of the 
individual signals (Figure 6). Although broadening of the individual peaks made 




absolute assignment of the imidazolidine chiral centre impossible by consideration of 
the 1H NMR spectrum alone, NOESY coupling again allowed for their configuration to 
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Figure 6 500 MHz CDCl3 1H NMR spectrum of a 50:50 mixture of imidazolidineboronate esters from 
parent diamine (rac)-125. 
 
Splitting was observed between pairs of resonances for protons on the boronate ester 
ring with the two CH(Ph)O doublets showing resolution of Δδ 0.32 and 0.13. 
Furthermore, resonances for the imidazolidine protons (Δδ 0.25) and the coordinating 
amine proton (Δδ 0.29) were also distinct enough to be able to accurately determine 
their diastereoisomeric excess. Indeed, additional sets of signals corresponding to a pair 
of highly shielded aromatic and cyclohexane ring protons show baseline resolution 
sufficient to make this a particularly powerful tool for directly determining the 
enantiopurity of cyclohexane-1,2-diamine. 
 
Detection limits for this technique were then determined by derivatisation of three 
samples of (1R,2R)-cyclohexane-1,2-diamine (1R,2R)-125 of 80% ee, 90% ee and 98% 
ee (Figure 7). Analysis of the 1H NMR spectrum of each sample revealed that the 
calculated diastereomeric excess (de) for the resultant mixtures of (2S,3aR,7aR,4′S,5′S)-
134a and (2S,3aS,7aS,4′S,5′S)-134b were in excellent agreement with the known 
enantiomeric purity of the starting diamine. Baseline integration of four pairs of 
resonances revealed that (2S,3aR,7aR,4′S,5′S)-134a had been formed in 83%, 92% and 




97% de which correlated well with the known enantiopurities of the starting (1R,2R)-
diamine (1R,2R)-125 thus indicating that no kinetic resolution had occurred and, 





































Figure 7 Two independent sets of signals used in the calculation of the ee of cyclohexane-1,2-diamine 
(500 MHz, CDCl3). 
 
Having successfully found a protocol for the derivatisation of cyclohexane-1,2-diamine, 
we then returned to 1,2-diphenylethane-1,2-diamine to test if this diol could be applied 
to that compound making this protocol more generally useful for chiral diamines 
(Scheme 8). 
 
Therefore, 1.0 equivalent of (rac)-1,2-diphenylethane-1,2-diamine (rac)-124 was 
stirred with 1.0 equivalent of (1S,2S)-hydrobenzoin (1S,2S)-112 and 1.0 equivalent of 
2-formylphenylboronic acid  73 in CDCl3 in the presence of 4 Å molecular sieves. An 
aliquot was removed after 5 minutes for 1H NMR analysis. 
 












































Scheme 8 Derivatisation of (rac)-1,2-diphenylethane-1,2-diamine (rac)-124 with (1S,2S)-hydrobenzoin 
(1S,2S)-112. 
 
Although 1H NMR analysis showed complete formation of a pair of imidazolidine 
boronate esters with apparent total stereocontrol over the new imidazolidine centre, 
their resonances were significantly broadened with most signals appearing as broad 



































As a result, the significant broadening of the signals renders accurate integration of the 
diastereoisomers more difficult, which infers less accuracy in determination of 
enantiomeric excess. Nevertheless, three independent pairs of protons were available 
for baseline integration. This demonstrates that the diol used in the derivatisation 




2.3.5 mono-Boc Protection Strategy for the General Determination of 
the Enantiopurity of Chiral Diamines 
 
However, despite our confidence that such a protocol could be utilised successfully in 
the determination of the enatiomeric excess of any chiral diamine, it was decided to 
investigate whether a mono-protection strategy could be devised to enable an 
iminoboronate ester approach to be employed. 
 
For this investigation, we again used troublesome cyclohexane-1,2-diamine as our test 
compound since this would present many of the difficulties that would arise with other 
types of chiral diamine. Consequently, an alternative approach was conceived involving 
mono-N-Boc protection of one of the amino functionalities of (rac)-cyclohexane-1,2-
diamine (rac)-125  using 2-(tert-butoxycarbonyloxyimino)-2-phenylacetonitrile 136 to 
afford (rac)-N-Boc-amine (rac)-137 (Scheme 9) whose free amino functionality could 
then be derivatised using our previously reported procedure.26 
 
 
Scheme 9 mono-N-Boc-protection of cyclohexane-1,2-diamine (rac)-125. 
 
Therefore, 1.0 equivalent of (rac)-N-Boc-carbamate (rac)-137 was treated with 1.0 
equivalent of 2-formylphenylboronic acid 73 and 1.0 equivalent of (S)-BINOL (S)-74 




in CDCl3 in the presence of 4 Å molecular sieves (Scheme 10) and the 1H NMR 
































Scheme 10 mono-Boc protection followed by derivatisation to afford a mixture of diastereomeric 
iminoboronate esters. 
 
The resultant 1H NMR spectrum revealed, as expected, a mixture of two diastereomeric 
imino-boronate ester complexes (S,1R,2R)-138a and (S,1S,2S)-138b that had been 
formed in a 50 : 50 ratio in quantitative yield with baseline resolution of five pairs of 
diastereoisomeric signals (Figure 9).  
























Figure 9 300 MHz CDCl3 1H NMR spectrum of a pair of mono-Boc protected iminoboronate esters 
derived from parent (rac)-cyclohexane-1,2-diamine. 
 




Significant splitting of the imine resonances (Δδ = 0.125 ppm) and the NHBoc protons 
(Δδ = 0.767 ppm) allowed for accurate determination and reliable confirmation of the 
enantiopurity of a scalemic sample of cyclohexane-1,2-diamine. 
 
The detection limits of this method were determined by derivatisation of three samples 






















Figure 10 Expansion of the 300 MHz 1H NMR spectrum of a mixture of (S,1R,2R)-138a and (S,1S,2S)-
138b prepared from (1S,2S)-125 of 60%, 80%, and 96% ee. 
 
Analysis of the 1H NMR spectrum of each sample revealed that the calculated de for 
the resultant mixtures of (S,1R,2R)-138a and (S,1S,2S)-138b were in excellent 
agreement with the known enantiomeric purity of the starting diamine. Therefore, the 
integrals measured for their imine resonances revealed that (S,1S,2S)-138b had been 
formed in 60%, 84% and 98% de which correlated well with the known enantiopurities 
of their starting (1S,2S)-diamine, thus indicating that no kinetic resolution had occurred. 
 




We have therefore developed two novel protocols for determination of the enantiomeric 
excesses of 1,2-diphenylethane-1,2-diamine and cyclohexane-1,2-diamine. The first 
approach employs our original three-component protocol employed for the formation of 
iminoboronate esters for determination of the ee of primary amines and diols to form a 
pair of diastereoisomeric imidazolidine boronate esters, which display 
diastereoisomeric resonances that are distinct under 1H NMR analysis. However, this 
protocol proved unsuccessful when applied to some more sterically demanding 
diamines so a novel mono-Boc protection-iminoboronate ester formation strategy was 
conceived, which again led to significant resolution of a series of diastereoisomeric sets 
of signals in the 1H NMR spectrum for the corresponding diastereoisomeric 
iminoboronate esters. We expect that such a protocol will prove to be useful for other 
chiral diamines, such is the ease of the mono-Boc protection step and the reliability of 
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2.4 A Novel Chiral Derivatising Agent for Determination of the 
Enantiomeric Excess of Chiral Amino Alcohols 
 
 
2.4.1 Chiral Derivatising Agents for Amino Alcohols 
 
There are few examples of chiral derivatisation protocols for the determination of the 
enantiopurity of chiral amino alcohols reported in the literature.1 In 1997, Lindner et al 
reported the synthesis of a new chiral derivatising agent which acts as a stable, selective 
reagent for the indirect resolution of chiral primary and secondary amino alcohols.2 
Their reagent, (1S,2S)-N-((2-isothiocyanato)-cyclohexyl)-pivaloyl amide 139 ((1S,2S)-
PIDTC), prepared from enantiopure cyclohexane-1,2-diamine via a two-step synthesis, 
then reacts with a pair of enantiomers of an amino alcohol to generate corresponding 
pairs of diastereomeric thioureas which can then be separated by non-chiral high 
performance liquid chromatography (HPLC) techniques (Scheme 1). 
 
 
Scheme 1: Chiral derivatisation of parent amino alcohol (rac)-140. 
 
 
Although this pre-column derivatisation process showed dramatic improvement on its 
literature precedents, and relatively good separation between the diastereomers was 
observed, this method still relies on HPLC analysis which is more costly, less reliable, 
and less readily available than NMR spectroscopic techniques.  
 
In 2006, Galanski et al published work employing (-)-myrtenal 142, a bicyclic 
monoterpene, as a chiral derivatising agent for β-amino alcohols.3 This technique 




allowed for determination of the enantiomeric excess of primary amines and amino 
alcohols using NMR techniques (Scheme 2). 
 
 
Scheme 2: Derivatisation of an amino alcohol using (-)-myrtenal affords a pair of diastereomeric imines. 
 
Whilst this technique was primarily useful for determination of the enantiopurity of 
chiral primary amines, the authors also reported the successful derivatisation of two 
amino alcohols; (rac)-2-aminobutanol (rac)-143 and (rac)-2-amino-4-methyl-1-
pentanol (rac)-145. 1H NMR spectroscopy failed to successfully determine the 
enantiopurity of these amino alcohols because the resolution of the diastereomers was 
not sufficient to allow for accurate integration of the diastereomeric resonances. 
However, in the 13C NMR spectrum, resolution of the diastereomers was observed with 
baseline separation of the resonances of between Δδ = 0.2 - 0.3 ppm for 2-
aminobutanol and Δδ = 0.3 ppm for leucinol. When a racemic mixture of 2-
aminobutanol 143 was employed, the relative integration of corresponding 
diastereomers was determined to be 48.2 : 51.8 ((R) : (S)) from the 13C NMR spectrum. 
This fell well within the accepted error limits for determination of enantiopurity using 
spectroscopic techniques. 
 
It is clear that the development of a novel chiral derivatisation protocol for 
determination of the enantiopurity of chiral amino alcohols would be of great use to the 
synthetic community. Simple extension of literature protocol for primary amines, while 
successfully applied in the above instances, often results in problematic cyclisation to 










2.4.2 Unsuccessful 3-Component Coupling Protocol for Formation of 
Oxazolidine Boronates 
  
Having completed a successful investigation into the determination of the enantiomeric 
excess of synthetically useful chiral diamines 1,2-diphenylethane-1,2-diamine 124 and 
cyclohexane-1,2-diamine 125, our attention then turned to expanding this protocol to 
consider chiral amino alcohols.  
 
We postulated that a simple 3-component protocol involving condensation of the amino 
alcohol with 2-formylphenylboronic acid 73 and tandem imine formation with (S)-4-
methoxy-α-methylbenzylamine (S)-75 would afford a pair of diastereoisomeric 
oxazaborolidines which might exhibit resolved pairs of resonances as previously 
described for chiral diols (Scheme 3).  
 
Therefore, 1.0 equivalent of 2-formylphenylboronic acid 73 was stirred with 1.0 
equivalent of (S)-4-methoxy-α-methylbenzylamine (S)-75 and 1.0 equivalent of (rac)-
valinol (rac)-146 in CDCl3 in the presence of 4 Å molecular sieves for 5 minutes 




Scheme 3 Postulated formation of diastereoisomeric oxazaborolidine complexes. 
 
Instead of forming the expected oxazaborolidines, the 1H NMR spectrum showed 
complete selectivity for imine formation on the amino alcohol nitrogen with free 
unreacted (S)-4-methoxy-α-methylbenzylamine remaining in solution (Figure 1). 
 




8.5 8.0 7.5 7.0 6.5 6.0 5.5 5.0 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 ppm  
Figure 1 Selective imine formation for the stabilised aminoalcohol iminoboronic acid (300 MHz, 
CDCl3). 
  
We postulated that this selectivity was due to added stabilisation from an O→B 
interaction driving the equilibrium towards iminoboronic acid formation with the amino 
alcohol (Figure 2). 
 
 
Figure 2 Cyclic iminoboronate ester formation proposed to drive selectivity in imine formation. 
 
However, subsequent X-ray crystallographic analysis (Appendix II) revealed in situ 
formation of a highly stabilised oxygen-bridged di-boron species through dehydration 
of two imino alcohol boronic acid molecules (Figure 3). 
 












Figure 3 Stable oxygen-bridged di-boron species. 
 
Having observed complete selectivity for imine formation from the amino alcohol in 
the presence of the competing (S)-4-methoxy-α-methylbenzylamine (S)-75, we decided 
to consider an alternative protocol similar to that used for determination of the 
enantiomeric excess of chiral diols. It was hoped that imine formation with a racemic 
amino alcohol followed by condensation of an enantiopure diol with 2-
formylphenylboronic acid 73 would afford a pair of diastereomeric iminoboronate ester 
derivatives which would be distinguishable by 1H NMR analysis. 
 
Therefore, 1.0 equivalent of 2-formylphenylboronic acid 73 was stirred with 1.0 
equivalent of (rac)-2-phenylglycinol (rac)-150 and 1.0 equivalent of (R)-BINOL (R)-74 
in CDCl3 in the presence of 4 Å molecular sieves (Scheme 4). An aliquot was removed 



























Scheme 4 Envisaged 3-component coupling protocol for determination of the ee of amino alcohols. 
 
However, the resultant 1H NMR spectrum showed a complicated mixture of products 
including resonances ascribed to the expected iminoboronate esters, along with peaks 
from a small amount of cyclised oxazolidine structures, presumably formed via a 
similar pathway to the imidazolidines observed previously, as well as possible oxygen-
bridged di-boron species (Figure 4). 
 





Multiple imine signals Oxazolidine protons and BINOLOH protons
 
Figure 4 300 MHz 1H NMR spectrum of racemic phenylglycinol (rac)-150 and (R)-BINOL (R)-74 
showing multiple products. 
 
As in our previous investigation toward determining the ee of chiral diamines, it 
appeared that a mixture of ring-open and closed forms were present with the 
















































Figure 5 Incomplete ring-closure for (R)- and (S)-2-phenylglycinol 150 due to steric crowding with the 
BINOL rings. 
 




Furthermore, the ratio of cyclised : ring-opened products was shown to depend on the 
individual diastereomer being formed, which is presumably dependant on the different 
degrees of steric crowding between the proximal binaphthyl rings and the α-
substituents that sit axially or equatorially within the oxazolidine ring as determined by 
the configuration of the amino alcohol enantiomer being derivatised.  
 
Thus, since enantiopure BINOL did not promote complete cyclisation or block it - 
thereby forming the desired pair of iminoboronate esters - an alternative approach was 
required. Worthy of note is that in this instance, unlike cyclohexane-1,2-diamine 125, 
neither enantiomer of the amino alcohol when derivatised independently afforded a 
single diastereomer of completely cyclised oxazolidine product. We concluded that this 
might be due to either the lower nucleophilicity of the oxygen atom driving the 
cyclisation or the increased steric bulkiness of the phenyl substituent on the oxazolidine 
ring. 
 
Consequently, we proceeded to derivatise a short series of chiral amino alcohols with 
racemic BINOL (rac)-74 and 2-formylphenylboronic acid 73 to investigate whether 
incomplete cyclisation was independent of the amino alcohol α-substituent (Figure 6). 
In all cases a mixture of ring-open and closed forms were observed for both oxazolidine 
diastereoisomers. Therefore, it was concluded that this approach was unsuitable for 
determination of the enantiopurity of a chiral amino alcohol. 
 
 
Figure 6 Short series of amino alcohols screened with 2-formylphenylboronic acid 73 and (rac)-BINOL 
(rac)-74. 
 
Fortuitously, during the derivatisation of (S)-leucinol (S)-145 (Scheme 5), selective 
crystallisation of oxazolidine boronate ester (S,2R,4S)-154 from the crude mixture 
afforded crystals suitable for X-ray crystallographic analysis. 
 





Scheme 5 Crystallisation of (S,2R,4S)-154 confirmed oxazolidine formation. 
 
The resultant structure confirmed the presence of an oxazolidine ring, with an 
intramolecular N→B interaction that had presumably assisted O-nucleophilic attack 







Figure 7 X-ray structure of oxazolidine (S,2R,4S)-154. 
 
The X-ray structure confirmed that the boron atom adopts the expected sp3 geometry, 
consistent with 11B NMR spectroscopic data which showed a broad singlet at δ 11.6. 
This indicates some N→B dative interaction in solution. The tetrahedral bond character 
of the boron centre was calculated from the crystallography data allowing for 
comparison of the strength of the N→B interaction with the solution phase 11B NMR 
data. The tetrahedral bond character of an N→Boron centre can be calculated from 
structural data using two different formulae, both of which use values of bond angles 









Table 1 Bond angles and bond lengths for (S,2R,4S)-154. 
Bond Bond Length / Å Bonds A-B-C Angle / ° 
B – N  1.665 O(1) – B – O(2) 112.99 
B – O (1) 1.448 O(1) – B – C 115.30 
B – O (2) 1.471 O(2) – B – C 113.87 
B – C  1.586 O(1) – B – N 112.90 
  O(2) – B – N 101.44 
  C – B – N 98.55 
 
The most recent approach is that reported by Höpfl who expanded on earlier work by 
Ōki and co-workers which considered the three bond angles between the boron atom 
and its covalently-bonded neighbours to considering all six bond angles including those 
arising from the N→B coordination.4, 5 





































Equation 2 Donor – Acceptor equation for determination of Tetrahedral Bond Character. 
 
Using the methods reported by Ōki and Höpfl, the tetrahedral bond character of the 
boron atom in (S,2R,4S)-154 was determined to be 57% and 98% respectively. Both 
values indicate a strong interaction between the Lewis basic nitrogen atom and the 
Lewis acidic boron atom. In 2001, Wiskur et al. proposed that when a boron atom was 
in an sp2 trigonal planar environment, the 11B NMR shift would be approximately 30 
ppm and when in a tetrahedral sp3 environment, the resonance would be closer to 0 
ppm.6 If we compare our two tetrahedral bond character results, the 11B NMR shift and 
the report by Wiskur, the 57% sp3 character calculated for THCOKI would agree closer 
with the 11B NMR data in this case. Therefore, it would appear that the equation 




reported by Ōki et al. provides a more accurate representation of the strength of our 
N→B interaction. 
 
Since BINOL had proven unsuccessful, our attention turned to tuning the diol used 
derivatisation, as previously attempted in our diamine work, to try and confer complete 
cyclisation whilst retaining diastereoselectivity at the newly generated chiral centre. 
Dimethyl-L-tartrate 108 was selected as our chiral diol unit again since it is much less 
sterically demanding than BINOL and its individual enantiomers are both commercially 
available.  
 
Therefore, 1.0 equivalent of dimethyl-L-tartrate (1R,2R)-108 was stirred with 1.0 
equivalent of 2-formylphenylboronic acid 73 and 1.0 equivalent of (rac)-2-
phenylglycinol (rac)-151 in CDCl3 in the presence of 4 Å molecular sieves (Scheme 6) 

























































Scheme 6 Incomplete cyclisation of a single diastereomer with dimethyl-L-tartrate 108. 
 
Once again, a mixture of multiple diastereoisomeric products was observed, with 
signals corresponding to two oxazolidine boronates ((4S,4′R,5′R)-155 and (4R,4′R,5′R)-
155) along with a set of resonances corresponding to a single diastereomer of un-
cyclised imine (α-R,4′R,5′R)-156. Although some resolution was observed between the 
two oxazolidines, significant broadening of the resonances of the tartrate moiety 




impeded their integration. Therefore, it appeared that while one diastereomer showed 
complete cyclisation to the ring-closed oxazolidine (Scheme 7), the other was in 
equilibrium with its open-chain, uncyclised form with the equilibrium lying toward the 
oxazolidine product. 
 
Scheme 7 Quantitative oxazolidine formation using (S)-2-phenylglycinol (S)-176. 
 
Variable temperature studies were performed on diastereomerically pure (4S,4′R,5′R)-
155 since its 1H NMR spectrum at 298 K showed significant broadening of the 
resonances corresponding to the dimethyl singlets and the two CH(OB) protons (Figure 
8). We postulated that the broadening of the diol protons was due to rapid rotation 
about the C-B bond at 298 K. 11B NMR spectroscopic analysis showed a broad signal at 
δ 14.3 ppm which is in accordance with the partial sp3 character (unbind-rotate-bind 
N→B interaction) expected for a rapidly rotating C-B bond. 
 
2.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm  
Figure 8 Room temperature 1H NMR spectrum of (4S,4′R,5′R)-155 showing signal broadening of the 
protons on the boronate ester ring and both CO2Me resonances (400 MHz, CDCl3). 
 




The temperature was raised stepwise to 368 K (sample temperature after calibration, all 
high temperature spectra were run in toluene-d8) and some sharpening of the signals 
was observed (Figure 9). 
2.53.03.54.04.55.05.56.06.57.07.58.0 ppm  
Figure 9 1H NMR spectrum of (4S,4′R,5′R)-155 at 368 K (400 MHz, toluene-d8). 
 
The two methoxy CH3 resonances coalesced to a single 6H singlet (δ 3.24 ppm), as did 
the two CH(OB) protons (δ 4.68 ppm). The two oxazolidine CHAHB ring protons were 
found as a 2H multiplet (δ 3.68 - 3.52 ppm) and significant deshielding was observed of 
an aromatic proton (δ 8.08 ppm). 
 
Signal sharpening extended only to the broad signals of the diol protons with all 
resonances showing a loss of fine coupling. Despite this, sufficient sharpening of the 
spectrum confirmed the formation of a single diastereomer, crucial if accurate 
determination of enantiopurity is required. 
 
The temperature was also lowered stepwise to 250 K (sample temperature after 
calibration, all low temperature spectra were run in CDCl3). Again, sharpening of the 
peaks was observed, this time with retention of some fine coupling of certain signals 
(Figure 10). 
 




2.02.53.03.54.04.55.05.56.06.57.07.58.08.5 ppm  
Figure 10 250 K 1H NMR spectrum showing well resolved pairs of CO2Me and CHOB signals (400 
MHz, CDCl3). 
 
At lower temperatures, we see discrimination of the individual CO2CH3 singlets (δ 3.82 
and 3.20 ppm) with significant splitting (Δδ = 0.62 ppm) between the two. The two 
CH(OB) protons also appear as sharp singlets (δ 4.68 and 4.45 ppm), Δδ = 0.23 ppm. 
 
11B NMR showed a small upfield shift to δ 11.5 ppm (from 13.5 ppm), slightly more 
shielded than at 298 K, inferring a more sp3 environment at the boron centre. This 
proved particularly interesting since varying the sample temperature allowed rotation 
about the C-B bond to be controlled such that both freely rotating and locked structures 
could be observed by 1H NMR spectroscopy. 
 
We thought that if (4S,4′R,5′R)-155 showed less facile dissociation of the N→B bond at 
lower temperatures, it should also be the case for the problematic (4R,4′R,5′R)-155 
diastereoisomer. The imine carbon might then be more electrophilic at lower 
temperature favouring cyclisation to afford its oxazolidine ring. Therefore, 
diastereoisomer (4R,4′R,5′R)-155 was prepared from 1.0 equivalent of (S)-2-
phenylglycinol (S)-150, 2-formylphenylboronic acid 73 and dimethyl-L-tartrate 
(1R,2R)-108 which were stirred in CDCl3 in the presence of 4 Å molecular sieves for 5 
minutes (Scheme 8) before a 1H NMR spectrum of the crude product was recorded. 
 




Scheme 8 Equilibrium between oxazolidine and iminoboronate ester forms of (4R,4′R,5′R)-155. 
 
As in the racemate, resonances corresponding to both oxazolidine and imine products 
were observed in the 1H NMR spectrum (Figure 11). By comparing the relative 
integrals of the oxazolidine (δ 6.50 ppm) and imine protons (δ 8.43 ppm), we found that 








imine proton oxazolidine proton
 
Figure 11 298 K 1H NMR spectrum of (4R,4′R,5′R)-155 showing both imine and oxazolidine products 
(400 MHz, CDCl3). 




The temperature was then lowered stepwise to 250 K (sample temperature after 
calibration) to look for a change in the ratio of the two competing structures (Figure 
12). Interestingly, as the temperature was lowered a change in the ratio of the two 
products was observed, with the equilibrium shifting towards the ring-closed 
oxazolidine. However, the equilibrium did not shift completely to the oxazolidine 








imine proton oxazolidine proton
 
Figure 12 250 K 1H NMR of (4R,4′R,5′R)-155 (400 MHz, CDCl3). 
 
Following all variable temperature analysis, the NMR samples were re-analysed at 
room temperature and showed the same broad signals for (4S,4′R,5′R)-155 and the 
same ratio of oxazolidine : imine for (4R,4′R,5′R)-155. 
 
Despite (4S,4′R,5′R)-155 showing successful cyclisation and complete stereocontrol at 
its new stereogenic centre, the incomplete ring-closure seen for (4R,4′R,5′R)-155 
clearly demonstrated that dimethyl-tartrate 108 was not a suitable diol for determining 
the ee of amino alcohols using this protocol.  
 
Following the previous successful use of hydrobenzoin 112 for determining the ee of 
chiral diamines, we screened a range of the chiral diols from our previous investigation 
to look for a diol that promotes stereoselective cyclisation in both diastereomeric 
oxazolidine products. We decided to use secondary amino alcohol 2-
pyrrolidinemethanol 157 since it would result in formation of an iminium ion which 
would be highly susceptible to nucleophilic attack (Figure 13). This should ensure 












Figure 13 Secondary amino alcohol used to screen diols for stereoselective oxazolidine formation. 
 
Therefore, 1.0 equivalent of (S)-(+)-2-pyrrolidinemethanol (S)-157 was stirred with 1.0 
equivalent of a racemic diol and 1.0 equivalent of 2-formylphenylboronic acid 73 in 
CDCl3 for 5 minutes in the presence of 4 Å molecular sieves before an aliquot was 
removed and their 1H NMR spectra acquired. Two diols ((rac)-3,3-dimethyl-1,2-butane 
diol (rac)-105 and (rac)-methyl-2,3-dihydroxy-3-phenylpropionate (rac)-106) showed 
quantitative cyclisation to afford pairs of oxazolidine diastereomers (Figure 14) with 
sufficient stereocontrol for a 1 : 1 mixture of diastereoisomers to be observed via 
integration of oxazolidine ring protons in their 1H NMR spectra. 
 
 
Figure 14 Successful formation of two pairs of oxazolidine diastereoisomers in 1 : 1 ratios. 
 
Disappointingly, when these diols were screened with chiral amino alcohols, neither 












2.4.3 Alternative O-Protection Strategy for Determination of 
Enantiomeric Excess of Amino Alcohols 
 
Having been unable to find a suitable protocol for formation of a pair of 
diastereoisomeric oxazolidine boronate esters from the parent chiral amino alcohol, we 
decided to pursue a protection - derivatisation strategy similar to that employed with 
demanding chiral diamines described previously. 
 
Therefore, we proposed a facile silyl protection strategy for the amino alcohol oxygen 
moiety which would remove the nucleophilicity of the oxygen and block any 
cyclisation onto the imine (Scheme 9).  
 
 
Scheme 9 O-protection strategy to impede oxazolidine formation. 
 
Protection of the oxygen functionality of racemic phenylglycinol proceeded cleanly to 
afford a quantitative yield of O-silyl protected alcohol (rac)-160.  
 
Following the protection of (rac)-2-phenylglycinol (rac)-150 as its TBDMS ether, 
work within the group by Miss Magdalena Powell proceeded to employ the 3-
component protocol described previously for the determination of the ee of chiral diols 
to form a pair of diastereomeric iminoboronate esters who are spectroscopically distinct 
using 1H NMR analysis.7 She has shown that methyl-2,3-dihydroxy-3-phenylpropionate 
106 afforded the greatest resolution of diastereomers (Scheme 10).  
 




Scheme 10 Formation of diastereoisomeric iminoboronate esters from parent O-protected (rac)-160. 
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Figure 15 Resolution of 6 sets of signals of (α-R,4S,5R)-161a and (α-S,4S,5R)-161b (500 MHz, CDCl3). 
 
The 1H NMR spectrum showed successful formation of a pair of diastereomerically 
independent iminoboronate esters with no signals corresponding to any oxazolidine 
product. Therefore, it appears that imine formation proceeds quantitatively, followed 
swiftly by N→B assisted diol condensation as expected. Importantly, no kinetic 
resolution was observed, confirmed by the relative integrals for the two 
diastereoisomers being in a 1 : 1 equimolar ratio. A pair of baseline-resolved imine 
singlets were observed (δ 8.27 and 8.57, Δδ = -0.30 ppm) as well as two distinct 
resonances for the α-N proton (Δδ = 0.05 ppm) and the two protons on the boronate 
ring (CH(Ph)OB and CH(CO2Me)OB Δδ = 0.37 ppm and Δδ = 0.10 ppm respectively),  
all of which may be used to determine the ee of the parent amino alcohol (Figure 15). 
 




Further work by Miss Magdalena Powell has used this as a basis for the determination 
of the enantiomeric excess of a wide range of O-silyl amino alcohols (Figure 16).7 
 
 
Figure 16 Series of chiral amino alcohols used to test the derivatisation protocol. 
 
1H NMR spectroscopy revealed that in every case a pair of diastereomeric 
iminoboronate esters were formed in a 1 : 1 ratio. Baseline resolution was achieved for 
up to six separate resonances and a chemical shift difference was obtained for at least 
one set of protons independent of the O-silyl amino alcohol under investigation. In all 
cases, splitting of the imine signal was observed in a region of the 1H NMR spectrum 
that was free of any other resonances. 
 
We have therefore developed a series of expeditious protocols for the determination of 
the enantiomeric excess of a wide range of chiral compounds bearing primary amine, 
diol, diamine or amino alcohol functionalities. These procedures involve the 
condensation of 2-formylphenylboronic acid, a chiral diol and either a primary amine or 
diamine. This affords a pair of diastereoisomeric iminoboronate esters or imidazolidine 
boronate esters whose protons show sufficient baseline resolution in their 1H NMR 















2.5.1 Selective Imine-formation for Amino Alcohols over Primary 
Amines 
 
During our previous investigation towards the development of a protocol for the 
determination of the enantiomeric excess of chiral amino alcohols, we observed 
complete selectivity towards imine formation from the amino alcohol amine moiety, 
while the chiral amine remained unreacted in solution (Figure 2). At the time, it was 
proposed that this selectivity arose from intramolecular zwitterion formation arising 
from coordination of the amino alcohol hydroxyl group with the boron centre.  
 
Crystals suitable for x-ray analysis were obtained after evaporation from CHCl3. X-ray 
















Figure 17 Oxygen-bridged di-boron ‘bowl’ structure observed by X-ray crystallography. 




The structure obtained by X-ray diffraction showed several interesting points. Firstly, 
the ‘bowl’ structure is formed by apparent condensation of two imino boronic acid 
molecules with loss of three equivalents of water to leave an oxygen bridge.  
 
Secondly, both boron atoms adopt an sp3 geometry in the crystalline state. 11B NMR 
spectroscopic data showed a broad singlet at δ 10.70, comparable to the 11B NMR data 
for the sp3 iminoboronate esters reported previously and indicates some N→B dative 
interaction in solution. Applying the two tetrahedral bond character formulae for 
determination of the degree of sp3 character at the two boron centres shows a strong 











Figure 18 Atom labelling for determination of tetrahedral bond character of ‘bowl’ species. 
 
Table 2 Bond angles and bond lengths 
Bond Bond Length / Å Bonds A-B-C Angle / ° 
B (1) – N (1) 1.684 O (1) – B (1) – O (3) 116.00 
B (1) – O (1) 1.454 O (1) – B (1) – C (1) 115.72 
B (1) – O (3) 1.425 O (3) – B (1) – C (1) 113.44 
B (1) – C (1)  1.629 O (1) – B (1) – N (1) 106.58 
  O (3) – B (1) – N (1) 106.95 
  C (1) – B (1) – N (1) 95.28 




Bond Bond Length / Å Bonds A-B-C Angle / ° 
B (2) – N (2)  1.658 O (2) – B (2) – O (3) 115.94 
B (2) – O (2) 1.463 O (2) – B (2) – C (2) 114.60 
B (2) – O (3) 1.427 O (3) – B (2) – C (2) 113.28 
B (2) – C (2) 1.627 O (2) – B (2) – N (2) 104.57 
  O (3) – B (2) – N (2) 109.42 
  C (2) – B (2) – N (2) 96.69 
 
Using the formulae proposed by Ōki, the two boron centres have tetrahedral bond 
characters of 47% and 51%, while application of the donor – acceptor formulae 
proposed by Höpfl suggests a stronger tetrahedral character of 97% in both cases. 
Comparison with 11B NMR spectroscopic data (δ 10.70 ppm) again suggests that the 
equation reported by Ōki provides a more accurate assessment of the tetrahedral bond 
character of the boron centres in these structures. We can now consider the 1H NMR 
data again in light of the X-ray diffraction information. 
 
 











Figure 19 300 MHz 1H NMR data showing clean formation of (R,R)-149 and (S,S)-149. 




A single set of signals is observed in the 1H NMR spectrum of (R,R)-149 and (S,S)-149 
which we can now rationalise as being due to the axis of symmetry in the ‘bowl’ 
structure rendering the two imine signals, for example, identical. Furthermore, to 
substantiate the proposal that the ‘bowl’ structures remain un-dissociated in solution, 
the apparent total selectivity of this imine formation, over the competing formation with 
(S)-(-)-4-methoxy-α-methylbenzylamine indicates that formation of these molecules are 
non-reversible under these conditions, thus pulling any equilibrium between 
iminoboronic acids towards this structure. 
 
The extended structure of the ‘bowl’ molecule shows hydrogen bonding between two 




Figure 20 Two molecules of CHCl3 hydrogen bonded to the ‘bowl’ structure (R,R)-149. 
 
We then proceeded to synthesise a range of these di-boron oxygen bridged structures 




2.5.2 Synthesis of a Range of Oxygen-Bridged Complexes 
 
A recent publication by Norman et al. reported the synthesis of several achiral 
iminoboronic acid structures as novel Schiff bases.8 They reported the generation of an 
oxygen-bridged structure of the type described above using the parent amino alcohol 2-




aminophenol 166 and either the pinacol protected, or unprotected, 2-
formylphenylboronic acid (Scheme 12). 
 
 
Scheme 12 Formation of an oxygen-bridged di-boron species first reported by Norman et al. 
 
Using the tetrahedral bond character equation reported by Ōki, the above species was 
found to have a 65% tetrahedral character, comparable to our chiral ‘bowl’ (R,R)-149. 
Formation was reported in an EtOH / H2O mix which is both coordinating to the boron 
and can potentially hydrolyse the imine bond, indicating that formation of the ‘bowl’ 
structure is energetically favourable, with complexation occurring despite requiring 
initial deprotection of the pinacol group, and highly stable since imine hydrolysis is 
common in aqueous conditions. This seems to fit with our experimental data which 
shows selective imine condensation due to the formation of the bowl. 
 
We then proceeded to synthesise a range of oxygen-bridged di-boron species using a 
variety of chiral amino alcohols (Table 3). 1.0 equivalent of the amino alcohol was 
stirred with 1.0 equivalent of 2-formylphenylboronic acid 73 in CDCl3 for 5 minutes in 
the presence of 4 Å molecular sieves before an aliquot was removed and its 1H NMR 
spectrum acquired. Where the HCl salt form of the amino alcohol was used, 1.0 
equivalent of CsCO3 was added to form the free amine in situ. 
 
 












































































































Mass spectrometry was used to confirm the formation of the bridged species since 1H 
NMR data alone was not conclusive. In several cases, 1H NMR analysis showed a 
single set of resonances when a racemic amino alcohol was employed. This strongly 
indicated that complete homocoupling was occurring, affording a 50 : 50 mixture of 
(R,R)- and (S,S)-bowls which were then spectroscopically identical. However, sole 
formation of the heterochiral (R,S)-bowl would also give the same spectrum. X-ray data 




for (R,R)-149, a crystallised product of the reaction of (rac)-146, showed homocoupling 
which indicates that this is the most likely explanation for observing a single species by 
NMR.  
 
However, this is not observed consistently, with two overlapping sets of signals 
observed in the complicated 1H NMR spectrum when some racemic amino alcohols are 
used. This is particularly evident with parent amino alcohol 2-amino-1-butanol (R)-143 
and (rac)-143. Here, we clearly see a second set of resonances in its 1H NMR spectrum, 

















Figure 21: Two sets of resonances observed in the 1H NMR spectrum where (rac)-2-amino-1-butanol is 
used (b) (300 MHz, CDCl3). 
 
As expected, a single set of peaks is observed when enantiopure (R)-2-amino-1-butanol 
(R)-143 is used (Figure 21(a) above). When the same racemic amino alcohol is used, 
Figure 21(b), two pairs of signals are found in the 1H NMR spectrum. Those 
overlapping with the original peaks (a) are therefore due to the homochiral pairs (R,R)-
171 and (S,S)-171, which being enantiomers of one another are indistinct by 1H NMR 
analysis. The second set of peaks correspond to the newly formed heterochiral pair 
(meso)-171 which is a diastereomer of the homochiral pairs and show some resolution 
in the 1H NMR spectrum. 
 




Following the formation of bowls using a variety of enantiopure and racemic amino 
alcohols, it would appear that the steric demands of the chiral substituent on the β-
carbon controls the selectivity of homo : heterocoupling. Amino alcohols with less 
steric bulk such as 2-amino-1-propanol 153 and 2-amino-1-butanol 143 affords a 
mixture of both homo and heterocoupling whereas the larger 2-amino-3-methyl-1-
butanol 146 or 2-phenylglycinol 150 show predominantly the homocoupling products 
by 1H NMR spectroscopy, although partial heterochiral formation is still observed. 
 
 
2.5.3 Variation of Boronic Acid Scaffold 
 
In order to consider these structures further, we decided to replace 2-
formylphenylboronic acid 73 with 3-formylfuran-2-boronic acid 177. This boronic acid 
was chosen since it presented a more challenging bowl formation due to the larger B-C-
C-C-O bond angle than 2-formylphenylboronic acid. Therefore, 1.0 equivalent of 3-
formylfuran-2-boronic acid 177 was stirred with 1.0 equivalent of (S)-leucinol 145 in 
CDCl3 for 5 minutes in the presence of 4 Å molecular sieves (Scheme 13) before an 
aliquot was removed and its 1H NMR acquired. 
 
 
Scheme 13 Formation of bowl structure using 3-formylfuran-2-boronic acid. 
 
The bowl structure was again confirmed using mass spectrometry which showed an [M 
+ H]+ molecular ion peak at m/z 425. 1H NMR analysis showed a shielded imine signal 
at δ 8.13 ppm, a characteristic found in several 2-formylphenylboronic acid-based bowl 
structures (Figure 22).  
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Figure 22: Quantitative formation of (S,S)-178 using 3-formylfuran-2-boronic acid 177 (300 MHz, 
CDCl3). 
 
11B NMR spectroscopic data showed a broad resonance at δ 5.1 ppm. This is consistent 
with a tetrahedral boron centre and indicates a strong N→B coordinate bond, stronger 
(δ ~ 4 - 7 ppm) than the 2-formylphenylboronic acid bowls (δ ~ 10 - 13 ppm). A series 
of chiral bowls were then synthesised from a range of parent amino alcohols with 
successful formation confirmed using mass spectrometry (Table 4Error! Reference 
source not found.). 
 
Unlike with bowls formed from 2-formylphenylboronic acid, a mixture of homo and 
heterocoupling was seen when the sterically demanding (rac)-2-phenylglycinol (rac)-
150 was used. This is potentially due to the more rigid nature of the 3-formylfuran-2-
boronic acid-based structures although it is not completely clear why this is the case. 






































































A further variation of the structure was considered by changing the ring size to use 















2.5.4 Application of the Di-Boron Bridged Species as a Receptor 
 
Following our successful syntheses of a wide variety of chiral bowl structures, we 
proceeded to consider their application as chiral receptors, potentially exploiting the 
twin electron deficient boron centres in host-guest binding of nucleophiles or anions.  
 
Towards this end, we carried out a preliminary screen using chiral bowl (S,S)-180 and a 
series of primary amine hydrochloride salts. Using Mass Spectrometry analysis, it 
would appear that there is some interaction between the amines and the chiral bowl, 
although this is difficult to quantify and no apparent change is observed in the 1H NMR 
spectra of the crude mixtures (Table 5). 
 
Table 5 Mass Spectrometry analysis of interaction with 3-formylfuran-2-boronic acid bowl (S,S)-180. 
 
 




















1.0 100 15 25 53 
 
1.0 100 17 27 56 
 
1.0 100 21 24 49 





1.0 100 22 25 57 
 
1.0 100 16 30 43 
Table 4 shows intensities in their Mass Spectrum relative to the chiral bowl. 
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3.1 General Procedures  
 
The solvents and reagents that were used throughout this project were reagent grade 
unless otherwise stated and were purchased from Acros Organics, Alfa Aesar, Fisher 
Scientific UK, Frontier Scientific Europe Ltd., Sigma-Aldrich Company Ltd., and were 
used without further purification.  
 
Infra-red spectra were recorded on a Perkin Elmer Spectrum RX spectrometer between 
4400 cm-1 and 450 cm-1. Samples were either evaporated from CHCl3 on a NaCl disc 
(neat) or mixed with KBr in a mortar and pressed into a KBr disc (KBr). All vibrations 
(n) are given in cm-1. 
 
Nuclear magnetic resonance spectra were run in CDCl3, CD3OD or (CD3)2CO. A 
Bruker AVANCE 300 was used to acquire most NMR spectra, 1H-NMR spectra were 
recorded at 300.22 MHz, 11B-NMR spectra at 96.32 MHz and {1H}-13C-NMR spectra 
at 75.50 MHz. 19F-NMR spectra were recorded on a Bruker AVANCE 400 at 376.5 
MHz. For greater resolution of signals, some spectra were recorded on a Bruker 
AVANCE 500 at 500.13 MHz. Chemical shifts (δ) are expressed in parts per million 
and are reported relative to the residual solvent peak or to tetramethylsilane as an 
internal standard in 1H and {1H}-13C NMR spectra, boron trifluoride diethyl etherate as 
an external standard in 11B NMR spectra and CFCl3 as an external standard for 19F 
NMR spectra. The multiplicities and general assignments of the spectroscopic data are 
denoted as: singlet (s), doublet (d), triplet (t), quartet (q), quintet (quin), sextet (sxt), 
doublet of doublets (dd), doublet of triplets (dt), triplet of doublets (td), unresolved 
multiplet (m), broad (br) and aryl (Ar). Coupling constants (J) are expressed in Hertz. 
 
The Mass Spectra used in this report were recorded either by the EPSRC National Mass 
Spectrometry Service Centre, Swansea, or using a micrOTOFQ electrospray time-of-
flight (ESI-TOF) mass spectrometer (Bruker Daltonik GmbH) at the University of 
Bath. The National Mass Spectrometry Service Centre records mass spectra using 
electron impact (EI), chemical ionisation (CI) or electrospray (ESI) techniques. A 
Micromass Quattro II triple quadrupole was used for low resolution measurements 
using ammonia as the CI reagent gas. A MAT900 high resolution spectrometer was 
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used for high resolution measurements. The micrOTOFQ spectrometer was coupled to 
an Agilent Technologies 1200 LC system.  10 μL of sample was directly injected into 
the mass spectrometer. The nebulising gas used was nitrogen, which was applied at a 
pressure of 1 bar.  Nitrogen was also used as a drying gas, supplied at a flow rate of 8 
L/min and a temperature of 110 °C.  
 
Optical rotations were recorded on an Optical Activity Limited AA-10 automatic 
polarimeter with a path length of 1 dm. Concentrations (c) are quoted in g/100 mL. 
 
All capillary melting points were recorded using a Büchi 535 melting point apparatus. 
The readings were taken from a mercury-in-glass thermometer and were reported 
uncorrected as the meniscus point. Where the sample changed colour or evolved gas 
during or after the melt, thermal decomposition (dec) is noted. 
 














 (R)-(+)-1-Phenylethane-1,2-diol (R)-102 (55 mg, 0.4 mmol), 2-formylphenylboronic 
acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 (51 μL, 0.4 mmol) 
were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. 
The sieves were removed using gravity filtration and the solvent removed in vacuo to 
afford the title compound as a yellow oil (139 mg, 98%); [ ]20Dα  -49.35 (c 1.925, 
CH2Cl2); vmax (film)/cm-1 1633 (C=N); δH (300 MHz; CDCl3) 8.00 (1H, s, CHN), 7.56 
(1H, d, J 7.0, ArH), 7.57-7.12 (13H, m, ArH), 5.25 (1H, app t, J 7.3, CH(OB)Ph), 5.09 
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(1H, q, J 6.8, CH(CH3)N), 4.32 (1H, app t, J 7.3, CHAHB(OB)), 3.78 (1H, app t, J 7.3, 
CHAHB(OB)), 1.67 (3H, d, J 6.8, C(CH3)(H)N); δC (75 MHz; CDCl3) 165.2 (C=N), 
142.2, 139.1, 136.7, 132.1, 129.8, 127.8, 127.6, 127.3, 127.2, 127.1, 126.9, 126.8, 
126.4, 126.2, 126.0, 125.3, 124.5, 117.5, 71.4, 57.5, 28.6 and 20.1; δB (100 MHz; 
CDCl3) 15.9; m/z LRMS (CI+) 356 [(M+H)+, 100%], 210.1 (64), 122.1 (27), 52.2 (10); 














 (S)-(-)-1-Phenylethane-1,2-diol (S)-102 (55 mg, 0.4 mmol), 2-formylphenylboronic 
acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 (51 μL, 0.4 mmol) 
were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. 
The sieves were removed using gravity filtration and the solvent removed in vacuo to 
afford the title compound as a yellow oil (137 mg, 96%); [ ]20Dα  -44.18 (c 1.725, 
CH2Cl2); vmax (film)/cm-1 1633 (C=N); δH (300 MHz; CDCl3) 8.06 (1H, s, CHN), 7.56 
(1H, d, J 7.1, ArH), 7.37-7.10 (13H, m, ArH), 5.11-5.02 (2H, m, CH(OB)Ph and 
CH(CH3)N), 4.35 (1H, app t, J 7.7, CHAHB(OB)), 3.75 (1H, app t, J 7.7, CHAHB(OB)), 
1.61 (3H, d, J 6.9, C(CH3)(H)N); δC (75 MHz; CDCl3) 165.1 (C=N), 142.3, 139.4, 
136.7, 132.0, 129.8, 127.8, 127.5, 127.3, 127.2, 126.9(4), 126.9(1), 126.8, 126.3, 126.2, 
126.0, 125.3, 124.7, 124.6, 71.5, 57.7, 28.6 and 20.3; δB (100 MHz, CDCl3) 16.4; m/z 
LRMS (CI+) 356 [(M+H)+, 20%], 210.1 (100), 122.1 (40), 106.1 (22), 52.2 (11); 
HRMS (ESI+) found 356.1818 ([M+H]+ C23H22BNO2 requires 356.1816). 
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(α-S,R)-103a and (α-S,S)-103b 




2-Phenylpropane-1,2-diol (rac)-103 (61 mg, 0.4 mmol), 2-formylphenylboronic acid 73 
(60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 (51 μL, 0.4 mmol) were 
stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The 
sieves were removed using gravity filtration and the solvent removed in vacuo to afford 
the title compound as a yellow oil as a 50 : 50 mixture (146 mg, 99%); vmax (film)/cm-1 
1634 (C=N); δH (300 MHz; CDCl3) 8.13 (1H, s, CHN), 8.06 (1H, s, CHN), 7.53-7.13 
(28H, m, ArH), 5.00-4.90 (2H, m, 2 x CH(CH3)N), 4.18-4.09 (3H, m, 2 x CHAHB(OB) 
and CHAHB(OB)), 4.03 (1H, d, J 8.3, CHAHB(OB)), 1.66 (3H, s, C(CH3)OB), 1.63 (3H, 
s, C(CH3)OB), 1.59 (6H, m, 2 x C(CH3)(H)N); δC (75 MHz; CDCl3) 166.3 (C=N), 
166.2 (C=N), 149.0, 148.9, 141.1, 140.8, 138.7, 138.6, 133.4(9), 133.4(7), 131.8(4), 
131.8(2), 131.7(9), 131.7(0), 129.4, 129.3, 129.2(8), 129.2(6), 129.0(3), 129.0(0), 
128.8, 128.7, 128.6(7), 128.6(5), 128.5(8), 128.5(6), 128.4, 128.3, 127.8, 127.6, 
127.0(5), 127.0(0), 126.8(4), 126.8(1), 126.2, 126.1, 125.3, 125.2, 81.8(2), 81.8(0), 
59.1, 58.9, 31.4(4), 31.4(2), 31.3, 31.2, 22.0 and 21.7; δB (100 MHz, CDCl3) 16.9; m/z 
LRMS (CI+) 370 [(M+H)+, 100%], 210.2 (30), 122.1 (6), 106.1 (8); HRMS (ESI+) 



















(R)-(+)-1,2-Propanediol (30 mg, 0.4 mmol) (R)-104, 2-formylphenylboronic acid 73 
(60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 (51 μL, 0.4 mmol) were 
stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The 
sieves were removed using gravity filtration and the solvent removed in vacuo to afford 
the title compound as a yellow oil (116 mg, 99%); [ ]20Dα  -29.14 (c 1.750, CH2Cl2); vmax 
(film)/cm-1 1634 (C=N); δH (300 MHz; (CD3)2CO) 8.08 (1H, s, CHN), 7.50 (1H, d, J 
7.4, ArH), 7.33-7.12 (8H, m, ArH), 4.92 (1H, q, J 6.8, CH(CH3)N), 4.37 (1H, app q, J 
12.2 and 6.1, CHAHB(OB)), 4.07 (1H, app t, J 12.2, CHAHB(OB)), 3.54 (1H, m, 
CH(CH3)(OB)), 1.62 (3H, d, J 6.8, C(CH3)(H)N), 1.22 (3H, d, J 6.0, C(CH3)(OB)); δC 
(75 MHz; CDCl3) 163.7 (C=N), 140.2, 137.3, 131.2, 130.3, 127.7, 127.5(3), 127.5(0), 
127.2(3), 127.2(0), 126.7, 126.2, 125.4, 71.1, 70.9, 59.3, 20.7 and 20.4; δB (100 MHz, 
CDCl3) 18.8; m/z LRMS (CI+) 294 [(M+H)+, 100%], 210.2 (58); HRMS (ESI+) found 























(S)-(-)-1,2-Propanediol (S)-104 (30 mg, 0.4 mmol), 2-formylphenylboronic acid 73 (60 
mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-94 (51 μL, 0.4 mmol) were stirred in 
CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The sieves were 
removed using gravity filtration and the solvent removed in vacuo to afford the title 
compound as a yellow oil (115 mg, 98%); [ ]20Dα  -30.30 (c 0.825, CH2Cl2); vmax 
(film)/cm-1 1634 (C=N); δH (300 MHz; (CD3)2CO) 8.12 (1H, s, CHN), 7.49 (1H, d, J 
7.1, ArH), 7.36-7.16 (8H, m, ArH), 4.91 (1H, q, J 6.8, CH(CH3)N), 4.28 (1H, app q, 
12.8 and 6.4, CHAHB(OB)), 4.08 (1H, app t, J 12.8, CHAHB(OB)), 3.53 (1H, m, 
CH(CH3)(OB)), 1.62 (3H, d, J 6.8, C(CH3)(H)N), 1.24 (3H, d, J 6.0, C(CH3)(OB)); δC 
(75 MHz; CDCl3) 163.7 (C=N), 140.3, 137.3, 131.3, 130.3, 127.9, 127.7, 127.6, 127.2, 
126.7, 126.1, 125.7, 125.4, 71.1, 70.9, 59.4, 20.9 and 20.4; δB (100 MHz, CDCl3) 19.0; 
m/z LRMS (CI+) 294 [(M+H)+, 41%], 249.2 (11), 210.1 (78), 122.1 (100), 106.1 (20); 
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(α-S,R)-105a and (α-S,S)-105b 




3,3-Dimethylbutane-1,2-diol (rac)-105 (61 mg, 0.4 mmol), 2-formylphenylboronic acid 
73 (60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 (51 μL, 0.4 mmol) were 
stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The 
sieves were removed using gravity filtration and the solvent removed in vacuo to afford 
the title compound as a yellow oil as a 50 : 50 mixture (127 mg, 95%); vmax (film)/cm-1 
1636 (C=N); δH (300 MHz; CDCl3) 8.52 (1H, s, CHN), 8.45 (1H, s, CHN), 7.74 (2H, 
app d, 7.1, ArH), 7.69-7.34 (16H, m, ArH), 5.08-4.96 (2H, m, 2 x CH(CH3)N), 4.21-
4.01 (6H, m, 2 x CHAHB(OB) and 2 x CH(CH3)(OB)), 1.80 (6H, m, 2 x C(CH3)(H)N), 
1.05 (9H, s, C(CH3)3), 1.01 (9H, s, C(CH3)3); δC (75 MHz; CDCl3) 163.9(4) (C=N), 
163.9(1) (C=N), 142.9, 142.7, 139.8, 139.7, 136.2(4), 136.2(1), 133.5, 133.4, 132.8, 
132.7, 132.0, 131.9, 131.4, 131.2, 129.4, 129.3(5), 129.0(4), 129.0(0), 127.9, 127.8, 
127.5, 127.3, 127.2, 127.1(1), 85.8, 84.7, 67.0, 66.9, 63.2, 34.2, 34.1, 31.3, 25.7, 
25.6(6), 25.6(0), 25.5(4), 25.5(1), 25.1, 23.1 and 22.9; δB (100 MHz, CDCl3) 22.8; m/z 
LRMS (CI+) 336 [(M+H)+, 100%], 210.2 (35), 121.9 (66), 105.9 (27), 52.2 (49); 























Methyl-(2S,3R)(-)-2,3-dihydroxy-3-phenylpropionate (2S,3R)-106 (78 mg, 0.4 mmol), 
2-formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-
76 (51 μL, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 
Å molecular sieves. The sieves were removed using gravity filtration and the solvent 
removed in vacuo to afford the title compound as a yellow oil (164 mg, 99%); [ ]20Dα      
-28.04 (c 2.675, CH2Cl2); vmax (film)/cm-1 1731 (C=O), 1633 (C=N); δH (300 MHz; 
CDCl3) 7.95 (1H, s, CHN), 7.49 (1H, d, J 7.0, ArH), 7.47-7.15 (13H, m, ArH), 5.49 
(1H, q, J 6.8, CH(CH3)N), 5.33 (1H, d, J 7.6, CH(Ph)(OB)), 4.60 (1H, d, J 7.6, CHCO2 
CH3), 3.73 (3H, s, CO2CH3), 1.74 (3H, d, J 6.8, C(CH3)(H)N); δC (75 MHz; CDCl3) 
174.3 (C=O), 168.4 (C=N), 143.0, 139.9, 137.8, 134.1, 134.0, 130.8, 129.4, 129.3, 
129.2, 128.9, 128.8(5), 128.6, 128.4, 128.3, 128.0, 126.6, 126.3, 126.0, 82.8, 81.3, 57.1, 
52.4, and 21.0; δB (100 MHz, CDCl3) 14.1; m/z LRMS (CI+) 414 [(M+H)+, 100%], 
239.1 (18), 210.1 (51), 106.0 (17), 52.1 (60); HRMS (ESI+) found 414.1872 ([M+H]+ 























Methyl-(2R,3S)(+)-2,3-dihydroxy-3-phenylpropionate (2R,3S)-106 (78 mg, 0.4 mmol), 
2-formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-
76 (51 μL, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 
Å molecular sieves. The sieves were removed using gravity filtration and the solvent 
removed in vacuo to afford the title compound as a yellow oil (161 mg, 97%); [ ]20Dα      
-21.43 (c 2.450, CH2Cl2); vmax (film)/cm-1 1731 (C=O), 1633 (C=N); δH (300 MHz; 
CDCl3) 8.35 (1H, s, CHN), 7.68 (1H, d, J 7.0, ArH), 7.40-7.11 (13H, m, ArH), 5.38 
(1H, q, J 6.8, CH(CH3)N), 4.81 (1H, d, J 7.7, CH(Ph)(OB)), 4.47 (1H, d, J 7.7, 
CHCO2CH3), 3.73 (3H, s, CO2CH3), 1.74 (3H, d, J 6.8, C(CH3)(H)N); δC (75 MHz; 
CDCl3) 174.2 (C=O), 167.9 (C=N), 143.0, 140.8, 137.8, 134.1, 130.9, 129.2, 129.1, 
128.7(3), 128.7(0), 128.6(9), 128.5, 128.4(8), 127.9, 127.6, 127.5(6), 126.7, 126.6(6), 
126.5(9), 82.7, 80.8, 57.5, 52.3 and 22.0; δB (100 MHz, CDCl3) 14.4; m/z LRMS (CI+) 
414 [(M+H)+, 100%], 210.2 (48); HRMS (ESI+) found 414.1871 ([M+H] + 


























(1S,2S,3R,5S)-(+)-Pinan-2,3-diol (1S,2S,3R,5S)-107 (68 mg, 0.4 mmol), 2-
formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 
(51 μL, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å 
molecular sieves. The sieves were removed using gravity filtration and the solvent 
removed in vacuo to afford the title compound as a yellow oil (148 mg, 96%); [ ]20Dα  
+6.06 (c 1.625, CH2Cl2); vmax (film)/cm-1 1637 (C=N); δH (300 MHz; CDCl3) 8.81 (1H, 
s, CHN), 7.91 (1H, d, J 7.4, ArH), 7.66 (1H, dd, J 7.0 and 1.2, ArH), 7.37-7.09 (7H, m, 
ArH), 4.57 (1H, q, J 6.7, CH(CH3)N), 4.30 (1H, dd, J 8.3 and 1.3, CH(OB)), 2.33-2.22 
(1H, m, CHAHBC(OB)), 2.19-2.10 (1H, m, CHAHBC(OB)), 2.05 (1H, app t, J 5.0, 
CHC(CH3)(OB)), 1.88-1.82 (2H, m, CHAHBCH), 1.53 (3H, d, J 6.7, C(CH3)(H)N), 1.38 
(3H, s, C(CH3)OB), 1.20 (4H, br s, C(CH3)eq(CH3)ax and CHC(CH3)2), 0.77 (3H s, 
C(CH3)eq(CH3)ax); δC (75 MHz; CDCl3) 161.9 (C=N), 145.2, 142.0, 135.5, 130.9, 
130.0, 128.9, 128.8(1), 128.7, 127.4, 127.3, 127.2(3), 127.2(0), 86.4, 78.5, 68.7, 52.0, 
40.0, 38.6, 36.0, 29.1, 27.6, 26.9, 24.6 and 24.5 δB (100 MHz, CDCl3) 31.8; m/z LRMS 
(CI+) 388 [(M+H)+, 100%], 210.1 (54), 196.2 (16), 122.1 (39); HRMS (ESI+) found 























(1R,2R,3S,5R)-(-)-Pinan-2,3-diol (1R,2R,3S,5R)-107 (68 mg, 0.4 mmol), 2-
formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 
(51 μL, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å 
molecular sieves. The sieves were removed using gravity filtration and the solvent 
removed in vacuo to afford the title compound as a yellow oil (142 mg, 91%); [ ]20Dα      
-4.15 (c 1.625, CH2Cl2); vmax (film)/cm-1 1637 (C=N); δH (300 MHz; CDCl3) 8.84 (1H, 
s, CHN), 7.92 (1H, d, J 8.6, ArH), 7.66 (1H, dd, J 7.0 and 1.2, ArH), 7.37-7.09 (7H, m, 
ArH), 4.56 (1H, q, 6.7, CH(CH3)N), 4.31 (1H, dd, J 8.5 and 1.5, CH(OB)), 2.33-2.23 
(1H, m, CHAHBC(OB)), 2.19-2.11 (1H, m, CHAHBC(OB)), 2.05 (1H, app t, J 5.0, 
CHC(CH3)(OB)), 1.88-1.81 (2H, m, CHAHBCH), 1.53 (3H, d, J 6.7, C(CH3)(H)N), 1.36 
(3H, s, C(CH3)OB), 1.21 (4H, br s, C(CH3)eq(CH3)ax and CHC(CH3)2), 0.78 (3H s, 
C(CH3)eq(CH3)ax); δC (75 MHz; CDCl3) 161.9 (C=N), 145.4, 142.0, 136.0, 135.5, 
133.4, 130.9, 130.0, 129.3, 128.7, 127.4, 127.2, 127.1, 86.5, 78.6, 68.7, 52.0, 40.0, 
38.6, 36.0, 29.1, 27.6, 26.9, 24.6 and 24.5; δB (100 MHz, CDCl3) 31.9; m/z LRMS (CI+) 
388 [(M+H)+, 100%], 284.3 (4), 210.2 (8); HRMS (ESI+) found 388.2443 ([M+H]+ 























Dimethyl-L-tartrate (1R,2R)-108 (71 mg, 0.4 mmol), 2-formylphenylboronic acid 73 
(60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 (51 μL, 0.4 mmol) were 
stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The 
sieves were removed using gravity filtration and the solvent removed in vacuo to afford 
the title compound as a yellow oil (146 mg, 92%); [ ]20Dα  +39.05 (c 1.575, CH2Cl2); vmax 
(film)/cm-1 1740 (C=O), 1633 (C=N); δH (300 MHz; CDCl3) 8.25 (1H, s, CHN), 7.47 
(1H, d, J 7.0, ArH), 7.44-7.09 (8H, m, ArH), 5.32 (1H, q, J 6.8, CH(CH3)N), 4.58 (2H, 
s, CHA(OB)CHB(OB)), 3.75 (6H, s, 2 x CH3CO), 1.68 (3H, d, J 6.8, C(CH3)(H)N); δC 
(75 MHz; CDCl3) 173.6 (C=O), 173.5 (C=O), 168.7 (C=N), 140.6, 137.6, 134.2, 131.0, 
129.1, 128.9, 128.4, 128.3, 127.4, 126.6, 126.5, 115.0, 77.4, 77.2, 56.8, 52.9, 52.6 and 
21.8; δB (100 MHz, CDCl3) 14.3; m/z LRMS (CI+) 396 [(M+H)+, 100%], 221.1 (10), 




























Dimethyl-D-tartrate (1S,2S)-128 (71 mg, 0.4 mmol), 2-formylphenylboronic acid 73 
(60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 (51 μL, 0.4 mmol) were 
stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The 
sieves were removed using gravity filtration and the solvent removed in vacuo to afford 
the title compound as a yellow oil (151 mg, 96%); [ ]20Dα  -48.33 (c 2.525, CH2Cl2); vmax 
(film)/cm-1 1740 (C=O), 1631 (C=N); δH (300 MHz; CDCl3) 7.94 (1H, s, CHN), 7.53 
(1H, d, J 6.8, ArH), 7.40-7.09 (8H, m, ArH), 5.44 (1H, q, J 7.0, CH(CH3)N), 4.87 (2H, 
s, CHA(OB)CHB(OB)), 3.73 (6H, s, 2 x CH3CO), 1.68 (3H, d, J 7.0, C(CH3)(H)N); δC 
(75 MHz; CDCl3) 173.6 (C=O), 172.2 (C=O), 169.3 (C=N), 139.8, 137.5, 134.2, 131.0, 
129.4, 129.3, 128.8, 128.3, 127.1, 126.6, 126.5, 118.9, 72.6, 72.5, 56.5, 53.3, 52.9 and 
20.8; δB (100 MHz, CDCl3) 14.7; m/z LRMS (CI+) 396 [(M+H)+, 13%], 210.1 (46), 
























(R)-(-)-1,3-Butanediol (R)-109 (36 mg, 0.4 mmol), 2-formylphenylboronic acid 73 (60 
mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 (51 μL, 0.4 mmol) were stirred in 
CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The sieves were 
removed using gravity filtration and the solvent removed in vacuo to afford the title 
compound as a yellow oil (114 mg, 93%); [ ]20Dα  +18.23 (c 1.975, CH2Cl2); vmax 
(film)/cm-1 1644 (C=N); δH (300 MHz; (CD3)2CO) 8.70 (1H, s, CHN), 7.76-7.71 (1H, 
m, ArH), 7.67-7.62 (1H, m, ArH), 7.47-7.25 (7H, m, ArH), 4.71 (1H, q, J 6.7, 
CH(CH3)N), 4.27-3.96 (3H, m, CHAHB(OB) and CH(CH3)(OB)), 1.96-1.81 (2H, m, 
CHAHBC(OB)), 1.68 (3H, d, J 6.7, C(CH3)(H)N), 1.34 (3H, d, J 6.3, C(CH3)(OB)); δC 
(75 MHz; CDCl3) 162.0 (C=N), 145.3, 140.4, 133.3, 130.4, 130.3, 129.7, 129.5, 128.8, 
128.7(5), 127.2, 127.1(6), 127.1(3), 68.5, 68.1, 62.0, 34.7, 24.6 and 23.5; δB (100 MHz, 
CDCl3) 27.9; m/z LRMS (CI+) 308 [(M+H)+, 100%], 210.1 (10); HRMS (ESI+) found 























(S)-(+)-1,3-Butanediol (S)-109 (36 mg, 0.4 mmol), 2-formylphenylboronic acid 73 (60 
mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 (51 μL, 0.4 mmol) were stirred in 
CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The sieves were 
removed using gravity filtration and the solvent removed in vacuo to afford the title 
compound as a yellow oil (116 mg, 94%); [ ]20Dα  +16.66 (c 1.800, CH2Cl2); vmax 
(film)/cm-1 1641 (C=N); δH (300 MHz; (CD3)2CO) 8.72 (1H, s, CHN), 7.77-7.71 (1H, 
m, ArH), 7.67-7.64 (1H, m, ArH), 7.48-7.26 (7H, m, ArH), 4.70 (1H, q, J 6.7, 
CH(CH3)N), 4.26-4.20 (1H, m, CH(CH3)(OB)), 4.15-4.09 (1H, m, CHAHB(OB)), 4.07-
3.98 (1H, m, CHAHB(OB)),  1.95-1.80 (2H, m, CHAHBC(OB)), 1.69 (3H, d, J 6.7, 
C(CH3)(H)N), 1.33 (3H, d, J 6.3, C(CH3)(OB)); δC (75 MHz; CDCl3) 160.5 (C=N), 
143.9, 139.0, 131.9, 128.7, 128.0, 127.9(8), 127.3, 127.2, 127.1(7), 127.1(1), 125.7(4), 
125.7(0), 67.0, 66.6, 60.3, 33.2, 23.1 and 22.0; δB (100 MHz, CDCl3) 27.7; m/z LRMS 
(CI+) 308 [(M+H)+, 100%], 210.1 (60), 122.1 (67), 116.1 (94), 105.9 (35), 52.2 (44); 






















(R)-BINOL (R)-74 (115 mg, 0.4 mmol), 2-formylphenylboronic acid 73 (60 mg, 0.4 
mmol) and (S)-(-)-1-phenylethylamine (S)-76 (51 μL, 0.4 mmol) were stirred in CDCl3 
(5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The sieves were removed 
using gravity filtration and the solvent removed in vacuo to afford the title compound 
as a white solid (197 mg, 98%); m.p. 165-172 °C (dec); [ ]20Dα  -561.55 (c 1.375, 
CH2Cl2); vmax (film)/cm-1 1626 (C=N); δH (300 MHz; CDCl3) 7.93 (1H, s, CHN), 7.81-
7.57 (4H, m, ArH), 7.36-6.96 (16H, m, ArH), 6.72 (1H, d, J 7.0, ArH), 4.80 (1H, q, J 
7.0, CH(CH3)N), 1.60 (3H, d, J 7.0, C(CH3)(H)N); δC (75 MHz; CDCl3) 169.5 (C=N), 
155.0, 154.6, 140.5, 137.3, 134.2, 133.9, 133.6, 131.7, 130.7, 130.6, 130.1, 129.3, 
129.1, 129.0, 128.8, 128.7(6), 128.7(1), 128.3, 128.1, 127.8, 127.6, 127.5, 126.8, 125.6, 
125.5, 124.4, 123.8, 123.7, 123.6, 123.4, 123.2, 122.2, 57.0 and 21.1; δB (100 MHz, 
CDCl3) 12.5; m/z LRMS (CI+) 504 [(M+H)+, 100%], 237.2 (9), 210.2 (10); HRMS 























(S)-BINOL (S)-74 (115 mg, 0.4 mmol), 2-formylphenylboronic acid 73 (60 mg, 0.4 
mmol) and (S)-(-)-1-phenylethylamine (S)-76 (51 μL, 0.4 mmol) were stirred in CDCl3 
(5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The sieves were removed 
using gravity filtration and the solvent removed in vacuo to afford the title compound 
as a yellow solid (193 mg, 96%); m.p. 167-173 °C (dec); [ ]20Dα  +353.00 (c 1.700, 
CH2Cl2); vmax (film)/cm-1 1625 (C=N); δH (300 MHz; CDCl3) 8.08 (1H, s, CHN), 7.80-
7.57 (4H, m, ArH), 7.33-6.95 (16H, m, ArH), 6.72 (1H, d, J 6.9, ArH), 4.94 (1H, q, J 
6.9, CH(CH3)N), 1.40 (3H, d, J 6.9, C(CH3)(H)N); δC (75 MHz; CDCl3) 169.3 (C=N), 
154.9, 154.5, 139.7, 137.1, 134.2, 134.1, 133.8, 133.7, 130.8, 130.6, 130.2, 129.6, 
129.4, 129.2, 129.0, 128.6, 128.4, 128.2, 128.0, 127.7, 127.6, 127.0, 126.9, 125.8, 
125.7(6), 123.9, 123.7, 123.5, 123.4, 123.3, 122.3, 118.4, 59.0 and 21.5; δB (100 MHz, 
CDCl3) 12.7; m/z LRMS (CI+) 504 [(M+H)+, 25%], 237.1 (16), 210.2 (100), 122.0 (44), 























(2S,3S)-Butane-2,3-diol (2S,3S)-111 (36 mg, 0.4 mmol), 2-formylphenylboronic acid 
73 (60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 (51 μL, 0.4 mmol) were 
stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The 
sieves were removed using gravity filtration and the solvent removed in vacuo to afford 
the title compound as a yellow oil (113 mg, 92%); [ ]20Dα  -5.00 (c 1.375, CH2Cl2); vmax 
(film)/cm-1 1633 (C=N); δH (300 MHz; CDCl3) 8.18 (1H, s, CHN), 7.48 (1H, d, J 7.2, 
ArH), 7.35-7.12 (8H, m, ArH), 4.93 (1H, q, J 7.0, CH(CH3)N), 3.82-3.77 (2H, m, 2 x 
CH(CH3)O), 1.60 (3H, d, J 7.0, C(CH3)(H)N), 1.19 (6H, d, J 6.0, 2 x C(CH3)O); δC (75 
MHz; CDCl3) 165.3 (C=N), 141.8, 138.9, 132.7, 132.4, 132.1, 131.9, 129.1, 128.9, 
128.7, 128.2, 127.8, 126.8, 79.7, 77.0, 61.0, 60.8, 22.1 and 20.5; δB (100 MHz, CDCl3) 
19.3; m/z LRMS (CI+) 308 [(M+H)+, 100%], 210.1 (17), 122.1 (14); HRMS (ESI+) 














(2R,3R)-Butane-2,3-diol (2R,3R)-111 (36 mg, 0.4 mmol), 2-formylphenylboronic acid 
73 (60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 (51 μL, 0.4 mmol) were 
stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The 
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sieves were removed using gravity filtration and the solvent removed in vacuo to afford 
the title compound as a yellow oil (118 mg, 96%); [ ]20Dα  -4.33 (c 0.925, CH2Cl2); vmax 
(film)/cm-1 1633 (C=N); δH (300 MHz; CDCl3) 8.16 (1H, s, CHN), 7.51 (1H, d, J 7.0, 
ArH), 7.38-7.12 (8H, m, ArH), 4.93 (1H, q, J 7.0, CH(CH3)N), 3.85-3.69 (2H, m, 2 x 
CH(CH3)O), 1.62 (3H, d, J 7.0, C(CH3)(H)N), 1.19 (6H, d, J 4.7, 2 x C(CH3)O); δC (75 
MHz; CDCl3) 165.2 (C=N), 142.1, 138.9, 132.7, 132.3, 132.0, 129.1, 128.8, 128.5, 
128.0, 127.8, 127.6, 126.8, 79.6, 77.1, 61.3, 61.2, 22.5 and 20.5; δB (100 MHz, CDCl3) 
19.5; m/z LRMS (CI+) 308 [(M+H)+, 100%], 210.2 (16), 122.1 (15); HRMS (ESI+) 














(2R,3S)-Butane-2,3-diol (2R,3S)-111 (36 mg, 0.4 mmol), 2-formylphenylboronic acid 
73 (60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 (51 μL, 0.4 mmol) were 
stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The 
sieves were removed using gravity filtration and the solvent removed in vacuo to afford 
the title compound as a yellow oil (119 mg, 97%); [ ]20Dα  -2.00 (c 1.875, CH2Cl2); vmax 
(film)/cm-1 1634 (C=N); δH (300 MHz; CDCl3) 8.13 (1H, s, CHN), 7.49 (1H, d, J 7.2, 
ArH), 7.37-7.13 (8H, m, ArH), 4.94 (1H, q, J 6.8, CH(CH3)N), 4.36-4.24 (2H, m, 2 x 
CH(CH3)O), 1.62 (3H, d, J 6.8, C(CH3)(H)N), 1.16 (3H, d, J 6.4, C(CH3)O), 1.13 (3H, 
d, J 6.4, C(CH3)O); δC (75 MHz; CDCl3) 164.9 (C=N), 142.0, 139.1, 132.9, 132.5, 
132.0, 129.1, 128.8, 128.4, 128.1, 127.6, 126.9, 74.8, 74.7, 61.5, 61.2, 22.4, 17.7 and 
17.3; δB (100 MHz, CDCl3) 19.8; m/z LRMS (CI+) 308 [(M+H)+, 100%], 210.2 (52), 
122.1 (18), 106.1 (13), 52.1 (17); HRMS (ESI+) found 308.1819 ([M+H]+ C19H22BNO2 
requires 308.1816). 
 













(1S,2S)-1,2-Diphenylethane-1,2-diol (S,S)-112 (86 mg, 0.4 mmol), 2-
formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 
(51 μL, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å 
molecular sieves. The sieves were removed using gravity filtration and the solvent 
removed in vacuo to afford the title compound as a yellow solid (160 mg, 93%); m.p. 
151-154 °C; [ ]20Dα  -30.00 (c 0.650, CH2Cl2); vmax (film)/cm-1 1631 (C=N); δH (400 
MHz; CDCl3) 8.27 (1H, s, CHN), 7.91 (1H, d, J 6.6, ArH), 7.51 (1H, m, ArH), 7.45-
6.95 (17H, m, ArH), 5.68 (1H, q, J 6.8, CH(CH3)N), 5.00 (2H, s, 2 x CH(Ph)O), 1.82 
(3H, d, J 6.8, C(CH3)(H)N); δC (75 MHz; CDCl3) 167.9 (C=N), 141.9, 140.7, 140.3, 
140.0, 134.0, 131.1, 130.7, 130.4, 130.3(6), 130.3(2), 130.2, 130.0, 129.5, 129.4(9), 
129.2, 128.5, 128.4(7), 128.4(0), 127.7(3), 127.7(1), 127.0, 126.9, 126.8, 126.4, 87.6, 
85.7, 58.2 and 21.9; δB (100 MHz, CDCl3) 14.4; m/z LRMS (CI+) 432 [(M+H)+, 64%], 
343.2 (39), 210.1 (100), 122.0 (63), 106.0 (35); HRMS (ESI+) found 432.2127 ([M+H]+ 





















(1R,2R)-1,2-Diphenylethane-1,2-diol (R,R)-112 (86 mg, 0.4 mmol), 2-
formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 
(51 μL, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å 
molecular sieves. The sieves were removed using gravity filtration and the solvent 
removed in vacuo to afford the title compound as a yellow solid (171 mg, 99%); m.p. 
150-152 °C; [ ]20Dα  +31.66 (c 2.225, CH2Cl2); vmax (film)/cm-1 1631 (C=N); δH (300 
MHz; CDCl3) 8.18 (1H, s, CHN), 7.80 (1H, d, J 7.2, ArH), 7.46-6.93 (18H, m, ArH), 
5.46 (1H, q, J 7.0, CH(CH3)N), 4.89 (2H, s, 2 x CH(Ph)O), 1.81 (3H, d, J 7.0, 
C(CH3)(H)N); δC (75 MHz; CDCl3) 166.6 (C=N), 140.1, 140.0, 138.8, 138.7, 136.4, 
132.5, 129.4, 129.1, 128.6, 128.2, 128.1, 127.8, 127.4(3) 127.4(0), 127.3(8), 127.3(3), 
127.1, 126.9, 126.5, 126.3, 125.7, 125.4, 125.3, 124.9, 86.1, 84.6, 56.6 and 20.2; δB 
(100 MHz, CDCl3) 14.6; m/z LRMS (CI+) 432 [(M+H)+, 100%], 210.2 (77), 122.0 (12), 























(1R,2S)-1,2-Diphenylethane-1,2-diol (R,S)-112 (86 mg, 0.4 mmol), 2-
formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-phenylethylamine (S)-76 
(51 μL, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å 
molecular sieves. The sieves were removed using gravity filtration and the solvent 
removed in vacuo to afford the title compound as a dark yellow solid (159 mg, 91%); 
m.p. 150-152 °C; [ ]20Dα  -26.28 (c 1.115, CH2Cl2); vmax (film)/cm-1 1634 (C=N); δH (300 
MHz; CDCl3) 8.13 (1H, s, CHN), 7.82 (1H, d, J 7.2, ArH), 7.57-6.95 (18H, m, ArH), 
5.44 (1H, d, J 7.5, CHACHB(Ph)O), 5.42 (1H, d, J 7.5, CHACHB(Ph)O), 5.32 (1H, q, J 
7.0, CH(CH3)N), 1.82 (3H, d, J 7.0, C(CH3)(H)N); δC (75 MHz; CDCl3) 166.3 (C=N), 
141.6, 141.5, 140.8, 138.8, 133.6, 132.0, 129.4, 129.3, 129.1, 128.8, 128.1, 128.6, 
128.2, 127.9, 127.8, 127.7(9), 127.7(6), 127.6(5), 127.6(3), 127.4, 127.3, 127.2(9), 
127.1(6), 126.9, 82.7, 82.5, 59.9 and 22.0; δB (100 MHz, CDCl3) 17.4; m/z LRMS (CI+) 






















(R)-(+)-1-Phenylethane-1,2-diol (R)-102 (55 mg, 0.4 mmol), 2-formylphenylboronic 
acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-(naphthalen-3-yl)ethanamine (S)-77 (68 mg, 
0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a pale yellow solid (149 mg, 92%) m.p. 138-140 
°C; [ ]20Dα  +22.00 (c 1.000, CH2Cl2); vmax (film)/cm-1 1632 (C=N); δH (300 MHz; 
CDCl3) 8.07 (1H, s, CHN), 7.76-7.73 (4H, m, ArH), 7.60 (1H, d, J 7.0, ArH), 7.43-7.15 
(11H, m, ArH), 5.30-5.17 (2H, m, CH(CH3)N and CH(Ph)O), 4.41 (1H, t, J 8.1, 
CHAHBO), 3.82 (1H, t, J 8.1, CHAHBO), 1.83 (3H, d, J 6.8, C(CH3)(H)N); δC (75 MHz; 
CDCl3) 167.1 (C=N), 143.9, 138.2(4), 138.2(2), 133.7, 133.6, 133.5(9), 133.5(0), 
131.3, 129.7, 129.6, 129.3(3), 129.3(1), 128.7, 128.6(7), 128.5(5), 128.2, 127.6, 127.0, 
126.9, 126.3, 126.2, 126.1, 78.1, 73.0, 59.0 and 21.6; δB (100 MHz, CDCl3) 16.3; m/z 
LRMS (CI+) 406 [(M+H)+, 22%], 262.2 (25), 260.1 (76), 172.2 (46), 155.1 (61), 107.9 



















(S)-(+)-1-Phenylethane-1,2-diol (S)-102 (55 mg, 0.4 mmol), 2-formylphenylboronic 
acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-(naphthalen-3-yl)ethanamine (S)-77 (68 mg, 
0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a yellow oil (151 mg, 92%); [ ]20Dα  +15.33 (c 
1.375, CH2Cl2); vmax (film)/cm-1 1633 (C=N); δH (300 MHz; CDCl3) 8.02 (1H, s, 
CHN), 7.80-7.75 (4H, m, ArH), 7.59 (1H, d, J 6.8, ArH), 7.46-7.33 (6H, m, ArH), 7.26-
7.13 (5H, m, ArH), 5.33-5.26 (2H, m, CH(CH3)N and CH(Ph)O), 4.39 (1H, t, J 8.3, 
CHAHBO), 3.82 (1H, t, J 8.3, CHAHBO), 1.81 (3H, d, J 7.0, C(CH3)(H)N); δC (75 MHz; 
CDCl3) 167.2 (C=N), 143.7, 138.2, 138.0, 133.7, 133.6(8), 133.5, 131.2, 129.4, 128.7, 
128.6, 128.5, 128.4, 128.3, 128.2, 127.9, 127.5, 127.4(9), 127.4(7), 126.8, 126.5, 126.3, 
126.0, 78.2, 73.0, 58.7 and 21.4; δB (100 MHz, CDCl3) 16.0; m/z LRMS (CI+) 406 
[(M+H)+, 10%], 260.2 (19), 172.1 (48), 155.1 (53), 107.9 (100), 106.1 (64); HRMS 
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(α-S,R)-114a and (α-S,S)-114b 




2-Phenylpropane-1,2-diol (rac)-103 (61 mg, 0.4 mmol), 2-formylphenylboronic acid 73 
(60 mg, 0.4 mmol) and (S)-(-)-1-(naphthalen-3-yl)ethanamine (S)-77 (68 mg, 0.4 
mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a yellow oil as a 50 : 50 mixture (163 mg, 97%);  
vmax (film)/cm-1 1633 (C=N); δH (300 MHz; CDCl3) 8.32 (1H, s, CHN), 8.22 (1H, s, 
CHN), 7.96-7.88 (7H, m, ArH), 7.81 (1H, br s, ArH), 7.73-7.69 (2H, m, ArH), 7.64-
7.29 (22H, m, ArH), 5.29 (2H, m, 2 x CH(CH3)N), 4.41-4.29 (3H, m, 2 x CHAHBO and 
CHAHBO), 4.21 (1H, d, J 8.5, CHAHBO), 1.90-1.83 (12H, m, 2 x C(CH3)(H)N and 2 x 
C(CH3)(Ph)O); δC (75 MHz; CDCl3) 173.3(3), 173.3(1), 169.3 (C=N), 169.0 (C=N), 
137.8, 137.7(7), 137.7(4), 137.2(2), 137.2(0), 137.1(1), 137.1(0), 134.0, 133.9, 133.3, 
133.2(8), 133.2(4), 133.2(1), 133.1(7), 133.1(4), 133.0(9), 133.0(6), 130.8, 130.7, 
129.1, 128.9, 128.8(8), 128.8(5), 128.8(2), 128.2(4), 128.2(0), 128.1, 128.0, 127.8, 
127.7, 126.6(3), 126.6(0), 126.5, 126.4(9), 126.4(6), 126.4(1), 126.3(3), 126.3(1), 
126.2(7), 126.2(3), 125.6(4), 125.6(2), 77.6(2), 77.6(0), 56.5, 56.2, 52.4(3), 52.4(0), 
52.3(6), 52.3(1), 21.3 and 20.4; δB (100 MHz, CDCl3) 16.7; m/z LRMS (CI+) 420 
[(M+H)+, 100%], 335.2 (23), 286.1 (11), 191.1 (10); HRMS (ESI+) found 420.2131 
([M+H]+ C28H26BNO2 requires 420.2129). 
 
 













(R)-(+)-1,2-Propanediol (R)-104 (30 mg, 0.4 mmol), 2-formylphenylboronic acid 73 
(60 mg, 0.4 mmol) and (S)-(-)-1-(naphthalen-3-yl)ethanamine (S)-77 (68 mg, 0.4 
mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a yellow solid (125 mg, 91%); m.p. 130-133 °C; 
[ ]20Dα  +3.00 (c 2.050, CH2Cl2); vmax (film)/cm-1 1634 (C=N); δH (300 MHz; CDCl3) 
8.25 (1H, s, CHN), 7.95-7.87 (4H, m, ArH), 7.69 (1H, d, J 7.5, ArH), 7.54-7.43 (5H, m, 
ArH), 7.30 (1H, t, J 7.2, ArH), 5.28 (1H, q, J 6.8, CH(CH3)N), 4.53 (1H, br s, 
CH(CH3)O), 4.29 (1H, br t, J 7.4, CHAHBO), 3.74 (1H, t, J 7.4, CHAHBO), 1.90 (3H, d, 
J 6.8, C(CH3)(H)N), 1.40 (3H, d, J 5.8, C(CH3)(H)O); δC (75 MHz; CDCl3) 165.9 
(C=N), 138.9, 138.6, 133.7, 133.3, 133.0, 131.7, 129.1, 128.7, 128.5, 128.1, 128.0(5), 
128.0(0), 126.8, 126.7, 126.3, 126.2, 72.6, 72.5, 60.3, 22.3 and 21.9; δB (100 MHz, 
CDCl3) 18.5; m/z LRMS (CI+) 344 [(M+H)+, 100%], 190.1 (70), 155.1 (10); HRMS 




















(S)-(-)-1,2-Propanediol (S)-104 (30 mg, 0.4 mmol), 2-formylphenylboronic acid 73 (60 
mg, 0.4 mmol) and (S)-(-)-1-(naphthalen-3-yl)ethanamine (S)-77 (68 mg, 0.4 mmol) 
were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. 
The sieves were removed using gravity filtration and the solvent removed in vacuo to 
afford the title compound as a pale yellow solid (135 mg, 99%); m.p. 134-135 °C; [ ]20Dα  
+4.18 (c 0.675, CH2Cl2); vmax (film)/cm-1 1634 (C=N); δH (300 MHz; CDCl3) 8.29 (1H, 
s, CHN), 7.96-7.87 (4H, m, ArH), 7.68 (1H, d, J 7.0, ArH), 7.59-7.40 (5H, m, ArH), 
7.33-7.29 (1H, m, ArH), 5.29 (1H, q, J 6.8, CH(CH3)N), 4.60-4.50 (1H, m, 
CH(CH3)O), 4.30 (1H, t, J 7.7, CHAHBO), 3.73 (1H, t, J 7.7, CHAHBO), 1.91 (3H, d, J 
6.8, C(CH3)(H)N), 1.39 (3H, d, J 6.0, C(CH3)(H)O); δC (75 MHz; CDCl3) 165.8 (C=N), 
139.0, 138.7, 133.7, 133.3, 133.0, 131.7, 129.1, 128.7, 128.6, 128.5, 128.1, 127.0, 
126.8, 126.7, 126.1, 125.8, 72.6, 72.4, 60.5, 22.1 and 21.9; δB (100 MHz, CDCl3) 18.7; 
m/z LRMS (CI+) 344 [(M+H)+, 100%], 190.1 (77), 155.1 (12); HRMS (ESI+) found 
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(α-S,R)-116a and (α-S,S)-116b 




3,3-Dimethylbutane-1,2-diol (rac)-105 (61 mg, 0.4 mmol), 2-formylphenylboronic acid 
73 (60 mg, 0.4 mmol) and (S)-(-)-1-(naphthalen-3-yl)ethanamine (S)-77 (68 mg, 0.4 
mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a yellow oil as a 50 : 50 mixture (131 mg, 85%); 
vmax (film)/cm-1 1634 (C=N); δH (300 MHz; CDCl3) 8.48 (1H, s, CHN), 8.40 (1H, s, 
CHN), 7.95-7.83 (8H, m, ArH), 7.70 (2H, d, J 7.2, ArH), 7.63-7.45 (10H, m, ArH), 
7.40-7.30 (2H, m, ArH), 5.18-5.10 (2H, m, 2 x CH(CH3)N), 4.17-4.00 (6H, m, 2 x 
CH(tBu)O, 2 x CHAHBO and 2 x CHAHBO), 1.86-1.82 (6H, m, 2 x C(CH3)(H)N), 1.01 
(9H, s, C(CH3)3), 0.95 (9H, s, C(CH3)3); δC (75 MHz; CDCl3) 163.9 (C=N), 163.8 
(C=N), 140.0, 139.8, 139.5, 139.4(4), 139.4(1), 133.6, 133.4, 132.9, 132.7, 132.6, 
132.5, 132.4(9), 132.4(0), 131.7, 131.3, 131.1, 131.0, 129.7, 129.0, 128.9, 128.5, 128.1, 
128.0, 127.8, 127.7, 126.8, 126.3, 126.2, 126.1(5), 126.1(2), 126.0(2), 126.0(0), 125.7, 
125.6(8), 125.6(0), 125.5, 125.4(8), 125.4(3), 84.4, 84.3, 63.0, 62.8, 33.8, 33.7, 25.2 
(3C, C(CH3)3), 25.1 (3C, C(CH3)3), 22.6 and 22.4; δB (100 MHz, CDCl3) 22.7; m/z 
LRMS (ESI+) 386 [(M+H)+, 100%], 301.2 (7), 232.2 (25), 155.1 (4); HRMS (ESI+) 




















Methyl-(2S,3R)(-)-2,3-dihydroxy-3-phenylpropionate (2S,3R)-106 (78 mg, 0.4 mmol),  
2-formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-(naphthalen-3-
yl)ethanamine (S)-77 (68 mg, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in 
the presence of 4 Å molecular sieves. The sieves were removed using gravity filtration 
and the solvent removed in vacuo to afford the title compound as a white solid (182 
mg, 98%); m.p. 146-148 °C; [ ]20Dα  -12.42 (c 1.880, CH2Cl2); vmax (film)/cm-1 1736 
(C=O), 1632 (C=N); δH (300 MHz; CDCl3) 8.35 (1H, s, CHN), 7.95-7.84 (4H, m, 
ArH), 7.82 (1H, d, J 7.4, ArH), 7.61-7.28 (11H, m, ArH), 5.64 (1H, q, J 6.8, 
CH(CH3)N), 5.09 (1H, d, J 7.7, CH(Ph)O), 4.67 (1H, d, J 7.7, CH(CO2 CH3)O), 3.89 
(3H, s, CO2CH3), 2.03 (3H, d, J 6.8, C(CH3)(H)N); δC (75 MHz; CDCl3) 173.9 (C=O), 
168.0 (C=N), 142.6, 137.8, 137.6, 137.5, 134.8, 134.2, 133.9, 133.2, 133.1, 133.0, 
130.6, 128.9, 128.4, 128.1, 127.8, 127.6, 126.5, 126.4(7), 126.4(1), 126.1, 125.8, 125.6, 
82.4, 80.6, 57.2, 52.0 and 21.3; δB (100 MHz, CDCl3) 14.6; m/z LRMS (ESI+) 464 
[(M+H)+, 100%], 310.1 (15), 278.2 (10), 230.1 (10), 202.2 (6), 155.1 (9); HRMS (ESI+) 





















Methyl-(2R,3S)-(-)-2,3-dihydroxy-3-phenylpropionate (2R,3S)-106 (78 mg, 0.4 mmol), 
2-formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-(naphthalen-3-
yl)ethanamine (S)-77 (68 mg, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in 
the presence of 4 Å molecular sieves. The sieves were removed using gravity filtration 
and the solvent removed in vacuo to afford the title compound as a yellow oil (183 mg, 
99%); [ ]20Dα  +10.57 (c 1.005, CH2Cl2); vmax (film)/cm-1 1735 (C=O), 1632 (C=N); δH 
(300 MHz; CDCl3) 8.10 (1H, s, CHN), 8.05 (1H, br s, ArH), 7.99-7.85 (3H, m, ArH), 
7.80 (1H, d, J 7.6, ArH), 7.70-7.30 (11H, m, ArH), 5.77 (1H, q, J 6.8, CH(CH3)N), 5.50 
(1H, d, J 7.5, CH(Ph)O), 4.76 (1H, d, J 7.5, CH(CO2CH3)), 3.86 (3H, s, CO2CH3), 2.01 
(3H, d, 6.8, C(CH3)(H)N); δC (75 MHz; CDCl3) 174.0 (C=O), 168.3 (C=N), 142.7, 
137.5, 137.1, 133.8, 133.3, 133.1, 133.2, 131.7, 131.1, 130.5, 130.0, 129.2, 128.5, 
128.3, 128.1, 127.8, 127.7, 126.7, 126.6(5), 126.6(0), 126.3, 126.0, 82.5, 81.0, 56.8, 
52.1 and 20.6; δB (100 MHz, CDCl3) 14.4; m/z LRMS (ESI+) 464 [(M+H)+, 100%], 
























(1S,2S,3R,5S)-(+)-Pinan-2,3-diol (1S,2S,3R,5S)-107 (68 mg, 0.4 mmol), (61 mg, 0.4 
mmol), 2-formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-(naphthalen-3-
yl)ethanamine (S)-77 (68 mg, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in 
the presence of 4 Å molecular sieves. The sieves were removed using gravity filtration 
and the solvent removed in vacuo to afford the title compound as a light yellow solid 
(171 mg, 98%); m.p. 125-129 °C; [ ]20Dα  +2.00 (c 1.975, CH2Cl2); vmax (film)/cm-1 1639 
(C=N); δH (300 MHz; CDCl3) 8.11 (1H, s, CHN), 7.95 (1H, br s, ArH), 7.91-7.86 (5H, 
m, ArH), 7.65 (1H, dd, J 8.5 and 1.7, ArH), 7.53-7.44 (4H, m, ArH), 4.92 (1H, q, J 6.8, 
CH(CH3)N), 4.43 (1H, dd, J 7.0 and 1.9, CH(OB)), 2.46-2.38 (1H, m, CHAHBC(OB)), 
2.32-2.24 (1H, m, CHAHBC(OB)), 2.15 (1H, app t, J 5.0, CHC(CH3)(O)), 2.07-1.97 
(2H, m, CHAHBCH), 1.80 (3H, d, J 6.8, C(CH3)(H)N), 1.52 (3H, s, C(CH3)O), 1.35 
(4H, br s, C(CH3)eq(CH3)ax and CHC(CH3)2), 0.75 (3H, s, C(CH3)eq(CH3)ax); δC (75 
MHz; CDCl3) 161.9 (C=N), 142.3, 141.6, 135.1, 133.6, 132.7, 130.6, 129.7, 128.0(4), 
128.0(1), 127.6, 127.3, 127.1, 126.0, 125.7, 125.6, 125.2, 86.1, 78.1, 68.3, 51.6, 39.6, 
38.2, 35.6, 28.7, 27.2, 26.5, 24.1 and 24.0; δB (100 MHz, CDCl3) 30.4; m/z LRMS 
(ESI+) 438 [(M+H)+, 100%], 353.2 (6), 229.1 (9); HRMS (ESI+) found 438.2600 






















(1R,2R,3S,5R)-(-)-Pinan-2,3-diol (1R,2R,3S,5R)-107 (68 mg, 0.4 mmol), 2-
formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-(-)-1-(naphthalen-3-
yl)ethanamine (S)-77 (68 mg, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in 
the presence of 4 Å molecular sieves. The sieves were removed using gravity filtration 
and the solvent removed in vacuo to afford the title compound as a pale cream solid 
(164 mg, 94%); m.p. 125-127 °C; [ ]20Dα  -5.66 (c 1.555, CH2Cl2); vmax (film)/cm-1 1639 
(C=N); δH (300 MHz; CDCl3)  8.08 (1H, s, CHN), 7.95 (1H, br s, ArH), 7.90-7.86 (5H, 
m, ArH), 7.64 (1H, m, ArH), 7.58-7.46 (4H, m, ArH), 4.93 (1H, q, J 6.6, CH(CH3)N), 
4.42 (1H, dd, J 8.7 and 1.9, CH(OB)), 2.45-2.38 (1H, m, CHAHBCO), 2.33-2.25 (1H, 
m, CHAHBCO), 2.15 (1H, app t, J 5.0, CHC(CH3)(O)), 2.08-1.94 (2H, m, CHAHBCH), 
1.80 (3H, d, J 6.6, C(CH3)(H)N), 1.51 (3H, s, C(CH3)O), 1.37 (4H, br s, 
C(CH3)eq(CH3)ax and CHC(CH3)2), 0.72 (3H, s, C(CH3)eq(CH3)ax); δC (75 MHz; CDCl3) 
161.9 (C=N), 142.3, 141.6, 135.1, 133.6, 133.1, 132.7, 130.8, 130.6, 129.8, 128.1, 
127.7, 127.2, 126.0, 125.8, 125.6, 123.9, 86.1, 78.1, 68.3, 51.6, 39.7, 38.2, 35.7, 28.8, 
27.2, 26.5, 24.2 and 24.1; δB (100 MHz, CDCl3) 30.3; m/z LRMS (ESI+) 438 [(M+H)+, 
100%], 355.3 (52), 324.2 (11), 212.1 (15), 155.1 (29); HRMS (ESI+) found 438.2599 
([M+H]+ C29H32BNO2 requires 438.2599). 
 
 
















Dimethyl-L-tartrate (1R,2R)-108 (71 mg, 0.4 mmol), 2-formylphenylboronic acid 73 
(60 mg, 0.4 mmol) and (S)-(-)-1-(naphthalen-3-yl)ethanamine (S)-77 (68 mg, 0.4 
mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a yellow oil (164 mg, 92%); [ ]20Dα  +10.82 (c 
1.335, CH2Cl2); vmax (film)/cm-1 1744 (C=O), 1631 (C=N); δH (300 MHz; CDCl3) 8.30 
(1H, s, CHN), 7.96-7.80 (4H, m, ArH), 7.68 (1H, d, J 7.2, ArH), 7.62-7.48 (4H, m, 
ArH), 7.38 (1H, d, J 7.3, ArH), 7.31 (1H, dt, J 7.5 and 0.9, ArH), 5.58 (1H, q, J 6.8, 
CH(CH3)N), 4.80 (2H, s, CHA(O)CHB(O)), 3.88 (6H, s, 2 x CO2CH3), 1.95 (3H, d, J 
6.8, C(CH3)(H)N); δC (75 MHz; CDCl3) 173.6(5) (C=O), 173.6(1) (C=O), 169.3 
(C=N), 138.1, 137.6, 134.4, 134.2, 134.1, 133.5, 133.3, 131.2, 129.2, 128.5, 128.1, 
126.9, 126.8, 126.6, 126.0, 125.9, 78.0, 77.9, 56.8, 56.6, 52.7 and 21.6; δB (100 MHz, 
CDCl3) 13.6; m/z LRMS (ESI+) 446 [(M+H)+, 100%], 292.1 (19), 230.1 (6), 155.1 (5); 





















Dimethyl-D-tartrate (1S,2S)-108 (71 mg, 0.4 mmol), 2-formylphenylboronic acid 73 
(60 mg, 0.4 mmol) and (S)-(-)-1-(naphthalen-3-yl)ethanamine (S)-77 (68 mg, 0.4 
mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a yellow oil (170 mg, 96%); [ ]20Dα  +12.00 (c 
1.000, CH2Cl2); vmax (film)/cm-1 1744 (C=O), 1631 (C=N); δH (300 MHz; CDCl3) 8.03 
(1H, s, CHN), 7.99 (1H, br s, ArH), 7.95-7.80 (3H, m, ArH), 7.63-7.47 (5H, m, ArH), 
7.30-7.22 (2H, m, ArH), 5.71 (1H, q, J 7.0, CH(CH3)N), 5.01 (2H, s, CHA(O)CHB(O)), 
3.88 (6H, s, 2 x CO2CH3), 1.95 (3H, d, J 7.0, C(CH3)(H)N); δC (75 MHz; CDCl3) 
173.3(7) (C=O), 173.3(2) (C=O), 169.2 (C=N), 137.2, 137.0, 134.0, 133.2(4), 133.2(3), 
130.7, 129.1, 128.2, 127.7, 126.6(5), 126.6(1), 126.4, 126.3, 126.2, 126.0, 125.9, 77.7, 
72.1, 56.2, 53.1, 52.4 and 20.4; δB (100 MHz, CDCl3) 14.4; m/z LRMS (ESI+) 446 
[(M+H)+, 100%], 363.2 (28), 292.1 (27), 155.1 (26); HRMS (ESI+) found 446.1766 























(R)-(-)-1,3-Butanediol (R)-109 (36 mg, 0.4 mmol), 2-formylphenylboronic acid 73 (60 
mg, 0.4 mmol) and (S)-(-)-1-(naphthalen-3-yl)ethanamine (S)-77 (68 mg, 0.4 mmol) 
were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. 
The sieves were removed using gravity filtration and the solvent removed in vacuo to 
afford the title compound as a yellow solid (141 mg, 99%); m.p. 120-123 °C; [ ]20Dα        
-3.33 (c 1.750, CH2Cl2); vmax (film)/cm-1 1632 (C=N); δH (300 MHz; CDCl3) 8.79 (1H, 
s, CHN), 7.97 (1H, br s, ArH), 7.94-7.89 (3H, m, ArH), 7.83-7.80 (1H, m, ArH), 7.75-
7.72 (1H, ArH), 7.65 (1H, dd, J 8.5 and 1.7, ArH), 7.57-7.45 (4H, m, ArH),  4.91 (1H, 
q, J 7.0, CH(CH3)N), 4.30-3.99 (1H, m, CH(CH3)O), 3.98-3.88 (1H, m, CHAHBO), 
3.87-3.77 (1H, m, CHAHBO), 1.94-1.86 (2H, m, CHAHBC(CH3)O), 1.81 (3H, d, J 7.0, 
C(CH3)(H)N), 1.35 (3H, d, J 6.6, C(CH3)O); δC (75 MHz; CDCl3) 162.4 (C=N), 142.9, 
140.4, 134.5, 133.4, 133.0, 130.4, 129.6, 129.0, 128.5, 128.4, 128.3, 128.1, 126.4, 
126.0, 125.4, 125.0, 68.5, 61.9, 36.2, 34.8, 24.7 and 23.6; δB (100 MHz, CDCl3) 28.0; 
m/z LRMS (ESI+) 358 [(M+H)+, 100%], 273.2 (9), 254.1 (13), 204.1 (23), 155.1 (7); 



















(S)-(+)-1,3-Butanediol (S)-109 (36 mg, 0.4 mmol), 2-formylphenylboronic acid 73 (60 
mg, 0.4 mmol) and (S)-(-)-1-(naphthalen-3-yl)ethanamine (S)-77 (68 mg, 0.4 mmol) 
were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. 
The sieves were removed using gravity filtration and the solvent removed in vacuo to 
afford the title compound as a cream solid (140 mg, 98%); m.p. 121-123 °C; [ ]20Dα         
-4.92 (c 1.645, CH2Cl2); vmax (film)/cm-1 1632 (C=N); δH (300 MHz; CDCl3) 8.78 (1H, 
s, CHN), 7.98 (1H, br s, ArH), 7.96-7.90 (3H, m, ArH), 7.82-7.79 (1H, m, ArH), 7.75-
7.72 (1H, m, ArH), 7.66 (1H, dd, J 8.9 and 1.9, ArH), 7.57-7.48 (4H, m, ArH), 4.93 
(1H, q, J 6.6, CH(CH3)N), 4.22-4.06 (3H, m, CH(CH3)O, CHAHBO and CHAHBO), 
1.94-1.90 (2H, m, CHAHBC(CH3)O), 1.80 (3H, d, J 6.6, C(CH3)(H)N), 1.36 (3H, d, J 
6.2, C(CH3)O); δC (75 MHz; CDCl3) 162.4 (C=N), 142.9, 140.3, 133.9, 133.3, 133.0, 
130.4, 129.5, 128.8, 128.4, 128.0, 126.4, 126.0, 125.9, 125.8, 125.3, 124.7, 68.6, 68.1, 
62.0, 34.7, 24.7 and 23.5; δB (100 MHz, CDCl3) 28.0; m/z LRMS (ESI+) 358 [(M+H)+, 
100%], 282.2 (25), 254.1 (45), 204.2 (30), 155.1 (8); HRMS (ESI+) found 358.1979 



















(R)-BINOL (R)-74 (114 mg, 0.4 mmol), 2-formylphenylboronic acid 73 (60 mg, 0.4 
mmol) and (S)-(-)-1-(naphthalen-3-yl)ethanamine (S)-77 (68 mg, 0.4 mmol) were 
stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The 
sieves were removed using gravity filtration and the solvent removed in vacuo to afford 
the title compound as a bright yellow solid (208 mg, 94%); mp 159-164 °C (dec); [ ]20Dα  
-415.02 (c 2.750, CH2Cl2); vmax (film)/cm-1 1639 (C=N); δH (300 MHz; CDCl3) 8.20 
(1H, s, CHN), 8.03-7.87 (7H, m, ArH), 7.74 (1H, d, J 8.9, ArH), 7.66-7.38 (9H, m, 
ArH), 7.33-7.28 (5H, m, ArH), 6.98 (1H, d, J 7.1, ArH), 5.34 (1H, q, J 6.8, 
CH(CH3)N), 1.78 (3H, d, J 6.8, C(CH3)(H)N); δC (75 MHz; CDCl3) 169.1 (C=N), 
154.6, 154.2, 136.8, 136.7, 133.9, 133.5, 133.4(8), 133.4(0), 133.2, 131.2, 130.5(3), 
130.5(1), 130.3, 129.8, 129.3, 129.2(7), 129.2(5), 129.1, 128.8, 128.3, 128.2, 128.1, 
127.9, 127.8(8), 127.8(3), 126.9, 126.8, 126.6, 126.4, 126.1, 125.7, 125.4, 123.5, 123.3, 
123.1, 121.9, 58.7 and 21.1; δB (100 MHz, CDCl3) 12.4; m/z LRMS (ESI+) 554 
[(M+H)+, 3%], 415.2 (16), 358.2 (18), 299.1 (100), 199.0 (32); HRMS (ESI+) found 





















(S)-BINOL (S)-74 (114 mg, 0.4 mmol), 2-formylphenylboronic acid 73 (60 mg, 0.4 
mmol) and (S)-(-)-1-(naphthalen-3-yl)ethanamine (S)-77 (68 mg, 0.4 mmol) were 
stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The 
sieves were removed using gravity filtration and the solvent removed in vacuo to afford 
the title compound as a bright yellow solid (204 mg, 92%); mp 161-166 °C (dec); [ ]20Dα  
+353.80 (c 1.405, CH2Cl2); vmax (film)/cm-1 1638 (C=N); δH (300 MHz; CDCl3) 8.38 
(1H, s, CHN), 8.00-7.90 (4H, m, ArH), 7.82-7.74 (2H, m, ArH), 7.66-7.21 (16H, m, 
ArH), 6.97 (1H, d, J 6.8, ArH), 5.23 (1H, q, J 7.0, CH(CH3)N), 1.97 (3H, d, J 7.0, 
C(CH3)(H)N); δC (75 MHz; CDCl3) 169.4 (C=N), 154.8, 154.3, 152.8, 137.5, 137.0, 
133.9, 133.7, 133.4, 133.0, 131.3, 130.4, 130.3, 129.9, 129.5, 129.0, 128.8, 128.5, 
128.2, 128.1, 127.8, 127.7, 127.4, 127.2, 126.6, 126.5, 125.8, 125.4, 125.3, 124.4, 
124.0, 123.6, 123.4, 123.1, 123.0, 122.0, 117.9, 56.9 and 20.7; δB (100 MHz, CDCl3) 
12.2; m/z LRMS (ESI+) 554 [(M+H)+, 6%], 415.1 (12), 299.1 (100), 199.0 (27); HRMS 























(1S,2S)-1,2-Diphenyl-1,2-ethanediamine (1S,2S)-124 (85 mg, 0.4 mmol), 2-
formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (R)-BINOL (R)-74 (114 mg, 0.4 
mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a bright yellow solid (233 mg, 98%), mp 220-222 
°C (dec); [ ]20Dα  -302.19 (c 1.150, CH2Cl2); δH (400 MHz; CDCl3) 8.01-7.93 (2H, m, 
ArH), 7.78 (1H, d, J 7.8, ArH), 7.55-7.22 (18H, m, ArH), 7.17-7.13 (1H, m, ArH), 6.89 
(2H, t, J 6.0, ArH), 6.75 (1H, d, J 6.0, ArH), 6.69 (1H, d, J 8.6, ArH), 6.14 (1H, dd, J 
12.3 and 5.8, CH(NH)2), 4.95 (1H, app t, J 5.8, NH(→B)), 4.89 (1H, dd, J 10.6 and 5.8, 
CH(Ph)N→B), 4.75 (1H, dd, J 12.3 and 10.6, CH(Ph)NH), 2.80 (1H, app t, J 12.3, 
NH); δC (75 MHz; CDCl3); 154.6, 153.5, 153.1, 139.9, 136.3(3), 136.3(2), 133.9, 
133.7, 133.5, 131.7, 130.9, 130.6, 130.5, 129.9, 129.8, 129.4, 129.2, 128.8(4), 128.8(1), 
128.5(1), 128.5(0), 128.0, 127.8, 127.6, 127.4, 127.3, 125.7, 124.7, 124.4, 124.0, 123.8, 
123.7(6), 123.7(5), 123.3, 123.0, 121.6, 118.2, 111.6, 85.5, 73.4, 67.3; δB (100 MHz, 
CDCl3) 13.3; m/z LRMS (ESI+) 595 [(M+H)+, 39%], 395 (44), 363 (52), 309 (70), 292 


















 (1R,2R)-1,2-Diphenyl-1,2-ethanediamine (1R,2R)-126 (85 mg, 0.4 mmol), 2-
formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (R)-BINOL (R)-74 (114 mg, 0.4 
mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a bright yellow solid (222 mg, 95%), mp 220-222 
°C (dec); [ ]20Dα  +314.61 (c 1.725, CH2Cl2); δH (400 MHz; CDCl3) 8.00-7.93 (2H, m, 
ArH), 7.87 (1H, d, J 9.0, ArH), 7.82 (1H, d, J 8.1, ArH), 7.69 (1H, d, J 9.1, ArH), 7.50-
7.03 (20H, m, ArH), 6.61 (1H, d, J 7.1, ArH), 6.17 (1H, dd, J 12.6 and 5.8, CH(NH)2), 
5.42 (1H, app t, J 5.8, NH(→B)), 5.17 (1H, dd, J 9.3 and 5.8, CH(Ph)N→B), 4.75 (1H, 
dd, J 12.6 and 9.3, CH(Ph)NH), 2.82 (1H, app t, J 12.6, NH); δC (75 MHz; CDCl3) 
154.3, 153.8, 153.0, 140.6, 137.1, 136.4, 133.9, 133.8, 133.7, 131.6, 131.4, 130.8, 
129.8, 129.6, 129.4, 129.3, 129.0(4), 129.0(0), 128.9, 128.7, 128.5, 128.1, 127.8, 127.6, 
127.5, 127.4, 127.3, 125.6, 124.7, 124.4, 124.0, 123.8, 123.6, 123.5, 123.3, 121.4, 
118.2, 111.7, 84.7, 72.7 and 66.9; δB (100 MHz, CDCl3) 13.8; m/z LRMS (ESI+) 595 
[(M+H)+, 8%] 489.4 (50), 268.3 (84), 239.2 (100); HRMS (EI+) found 594.2469 ([M]+● 













(R)-BINOL (R)-74 (114 mg, 0.4 mmol), 2-formylphenylboronic acid 91 (60 mg, 0.4 
mmol) and ethylenediamine 129 (27 μL, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 
minutes in the presence of 4 Å molecular sieves. The sieves were removed using 
gravity filtration and the solvent removed in vacuo to afford the title compound as a 
yellow oil (166 mg, 94%); [ ]20Dα  -30.66 (c 1.150, CH2Cl2); vmax (film)/cm-1 1469 (s), 
1381 (s), 1095 (s); δH (300 MHz; CDCl3) 7.98 (1H, d, J 8.3, ArH), 7.85-7.63 (4H, m, 
ArH), 7.41-7.03 (7H, m, ArH), 6.95-6.90 (1H, m, ArH), 6.83 (1H, d, J 8.7, ArH), 6.65 
(1H, d, J 9.0, ArH), 6.41 (1H, d, J 7.4, ArH), 6.27 (1H, br s, NH(→B)), 5.74 (1H, br s, 
CH(NH)2), 2.76-2.65 (1H, m, CHax(N→B)), 2.43 (1H, br s NH), 2.22-2.09 (1H, m, 
CHax(NH)) and 1.62-1.45 (2H, m, CHeq(N→B) and CHeq(NH));  δC (75 MHz; CDCl3) 
154.1, 153.0, 137.7, 136.2, 133.8, 131.3(4), 131.3(2), 130.9, 129.8, 129.6, 129.4, 129.3, 
129.1, 129.0, 128.9, 128.8, 128.6, 127.7, 127.5, 125.8, 125.3, 124.3, 124.1, 123.5, 
123.0, 121.1, 89.5, 47.4 and 44.7; δB (100 MHz, CDCl3) 11.9; m/z LRMS (ESI+) 443 
[(M+H)+, 2%], 463.3 (10), 241.3 (30), 189.0 (100), 157.0 (73), 61.3 (58); HRMS (ESI-) 
















(R)-1-Phenyl-1,2-ethanediol (R)-102 (51 mg, 0.4 mmol), 2-formylphenylboronic acid 
73 (60 mg, 0.4 mmol) and N,N’-dimethylethylamine 131 (43 μL, 0.4 mmol) were 
stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The 
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sieves were removed using gravity filtration and the solvent removed in vacuo to afford 
the title compound as a yellow oil (116 mg, 90%); [ ]20Dα  +49.31 (c 1.600, CH2Cl2); vmax 
(film)/cm-1 2859 (s), 2789 (s), 1456 (s), 1223 (s); δH (300 MHz; CDCl3) 7.67 (1H, d, J 
6.8, ArH), 7.53-7.52 (2H, m, ArH), 7.43-7.39 (2H, m, ArH), 7.36-7.31 (3H, m, ArH), 
7.24 (1H, d, J 7.8, ArH), 5.28 (1H, dd, J 8.6 and 6.6, CH(Ph)O), 4.45 (1H, dd, J 8.6 and 
6.6, CHAHBO), 4.40 (1H, s, CH(NCH3)2), 3.87 (1H, app t, J 8.6, CHAHBO), 3.72-3.66 
(1H, m, CHax(N→B)), 3.62-3.55 (1H, m, CHax(NCH3)), 2.95-2.87 (2H, m, CHeq(N→B) 
and CHeq(NCH3)), 2.66 (3H, s, (N→B)CH3), 2.65 (3H, s, NCH3);  δC (75 MHz; CDCl3) 
143.8, 140.7, 131.9, 129.3, 129.1, 129.0, 128.7, 128.5, 128.2, 127.5, 126.2, 124.2, 95.3, 
78.0, 72.7, 54.1, 53.9, 42.5 and 42.3; δB (100 MHz, CDCl3) 16.1; m/z LRMS (ESI+) 323 
[(M+H)+, 66%], 266.1 (11), 219.1 (34), 191.1 (100), 175.1 (9); HRMS (ESI+) found 







(1S,2S)-Hydrobenzoin (1S,2S)-112 (86 mg, 0.4 mmol), 2-formylphenylboronic acid 73 
(60 mg, 0.4 mmol) and N,N’-dimethylethylamine 131 (43 μL, 0.4 mmol) were stirred in 
CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The sieves were 
removed using gravity filtration and the solvent removed in vacuo to afford the title 
compound as a yellow oil (156 mg, 98%); [ ]20Dα  +111.73 (c 2.175, CH2Cl2); vmax 
(film)/cm-1 1495 (s), 1214 (s), 1059 (s); δH (300 MHz; CDCl3) 7.94 (1H, d, J 7.6, ArH), 
7.54-7.28 (7H, m, ArH), 7.18-7.05 (6H, m, ArH), 4.98 (2H, s, CHA(O)CHB(O)), 4.38 
(1H, s, CH(NCH3)2), 3.87-3.60 (2H, m, CHax(N→B) and CHax(NCH3)), 3.07-2.97 (2H, 
CHeq(N→B) and CHeq(NCH3)), 2.82 (3H, s, CH3(N→B)), and 2.70 (3H, s, NCH3); δC 
(75 MHz; CDCl3) 141.9, 141.1, 132.6, 130.3, 130.1, 129.5, 129.4, 128.6, 128.4, 127.8, 
127.6, 127.4, 127.3, 127.1, 126.9, 126.5, 124.7, 124.1, 95.5, 86.0, 82.3, 54.4, 53.6, 
43.2, and 42.4; δB (100 MHz, CDCl3) 15.3; m/z LRMS (ESI+) 399 [(M+H)+, 45%], 
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(1S,2S)-Hydrobenzoin (1S,2S)-112 (86 mg, 0.4 mmol), 2-formylphenylboronic acid 91 
(60 mg, 0.4 mmol) and (1R,2R)-cyclohexane-1,2-diamine (1R,2R)-125 (46 mg, 0.4 
mmol) in were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a light yellow solid (164 mg, 98%); m.p. 147-149 
°C (dec); [ ]20Dα  +75.00 (c 1.625, CH2Cl2); vmax (film)/cm-1 3054 (s), 1455 (s), 1257 (s); 
δH (500 MHz; CDCl3) 7.63 (1H, d, ArH), 7.51-6.98 (12H, m, ArH), 6.63 (1H, d, ArH), 
6.49 (1H, br s, CH(NH)2), 5.08 (1H, d, J 7.6, CHA(O)CHB(O)), 4.89 (1H, s, NH(→B)), 
4.54 (1H, d, J 7.6, CHA(O)CHB(O)), 2.46 (1H, q, J 11.0, CH(N→B)), 2.22 (1H, br s, 
NH), 1.99 (1H, d, J 11.7, CH), 1.74 (1H, d, J 11.7, CH), 1.61 (1H, d, J 13.2, CH), 1.38-
1.04 (4H, m, C2H4), 0.89 (1H, q, J 13.2, CH), -0.14 (1H, q, J 11.0, CHNH);  δC (75 
MHz; CDCl3) 142.1, 141.6, 130.2, 130.1, 130.0, 129.5, 129.4(9), 129.4(3), 129.1, 
129.0, 128.9, 128.7, 128.1, 127.2, 127.1, 126.4, 125.7, 123.2, 87.8, 86.7, 83.4, 65.9, 
63.8, 29.7, 27.3, 24.9 and 24.2; δB (100 MHz, CDCl3) 12.6; m/z LRMS (ESI+) 425 
[(M+H)+, 22%], 345.2 (19), 303.3 (100); HRMS (ESI+) found 425.2395 ([M+H]+ 
C27H29BN2O2 requires 425.2395). 
 
 





























(1S,2S)-Hydrobenzoin (1S,2S)-112 (86 mg, 0.4 mmol), 2-formylphenylboronic acid 73 
(60 mg, 0.4 mmol) and (1S,2S)-cyclohexane-1,2-diamine (1S,2S)-125 (46 mg, 0.4 
mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a gold solid (166 mg, 99%); m.p. 148-150 °C 
(dec);  [ ]20Dα  -88.53 (c 1.825, CH2Cl2); vmax (film)/cm-1 3054 (s), 1455 (s), 1257 (s); δH 
(500 MHz; CDCl3) 7.61-7.45 (6H, m, ArH), 7.30-7.23 (6H, m, ArH), 7.02 (1H, t, J 7.3, 
ArH), 6.58 (1H, d, J 7.3, ArH), 6.21 (1H, br s, CH(NH)2), 5.18 (1H, s, NH(→B)), 4.78 
(1H, d, J 8.8, CHA(O)CHB(O)), 4.66 (1H, d, J 8.8, CHA(O)CHB(O)), 2.39 (1H, q, J 
10.4, CH(N→B)), 2.23 (1H, br s, NH), 1.97 (1H, d, J 10.4, CH), 1.89 (1H, d, J 12.9, 
CH), 1.63 (1H, d, J 12.9, CH), 1.44 (1H, m, CH), 1.32-0.90 (4H, m, C2H4) and 0.10 
(1H, q, J 10.4, CH(NH));  δC (75 MHz; CDCl3) 141.9(4), 141.9(0), 132.8, 132.6, 132.1, 
132.0, 131.7, 131.1, 130.8, 130.6, 130.5, 130.1, 129.1, 128.9, 128.6, 127.7, 126.4, 
122.7, 87.6, 86.2, 83.4, 66.6, 63.8, 29.5, 27.7, 25.2 and 24.5; δB (100 MHz, CDCl3) 
13.1; m/z LRMS (ESI+) 425 [(M+H)+, 3%], 407.3 (13), 303.3 (100); HRMS (ESI+) 




























(1S,2S)-Hydrobenzoin (1S,2S)-112 (86 mg, 0.4 mmol), 2-formylphenylboronic acid 73 
(60 mg, 0.4 mmol) and (1R,2R)-1,2-diphenylethane-1,2-diamine (1R,2R)-124 (85 mg, 
0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a pale grey solid (206 mg, 99%); m.p. 184-186 
°C; [ ]20Dα  -149.66 (c 2.225, CH2Cl2); vmax (film)/cm-1 3054 (s), 1449 (s), 1272 (s); δH 
(500 MHz; CDCl3) 7.73 (1H, d, J 7.3, ArH), 7.48 (1H, t, J 7.3, ArH), 7.40-7.18 (13H, 
m, ArH), 7.12-7.04 (9H, m, ArH), 6.39 (1H, t, J 6.3, NH(→B)), 5.70 (1H, dd, J 10.7 
and 6.3, CH(NH)2), 4.92 (1H, dd, J 10.7 and 6.3, CH(Ph)(N→B)), 4.77 (2H, br s, 
CHA(O)CHB(O)), 3.95 (1H, br t, J 10.7, CH(Ph)(NH)), 2.34 (1H, br t, J 10.7, NH);  δC 
(75 MHz; CDCl3) 141.2, 140.9, 140.8(7), 140.8(5), 140.8(1), 140.6, 140.3, 140.0, 
139.9, 139.8, 139.6, 139.2, 138.7, 138.4, 137.7, 136.8, 136.6, 130.4, 129.7, 129.3, 
129.2, 128.9(4), 128.9(3), 128.8(8), 128.8(2), 127.8, 127.7, 127.4, 127.2, 123.4, 85.7, 
83.4, 73.3, 66.8 and 31.4; δB (100 MHz, CDCl3) 14.0; m/z HRMS (ESI+) found 
























(1S,2S)-Hydrobenzoin (1S,2S)-112 (86 mg, 0.4 mmol), 2-formylphenylboronic acid 73 
(60 mg, 0.4 mmol) and (1S,2S)-1,2-diphenylethane-1,2-diamine (1S,2S)-124 (85 mg, 
0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a white solid (203 mg, 98%); m.p. 184-186 °C; 
[ ]20Dα  -144.33 (c 1.975, CH2Cl2); vmax (film)/cm-1 3054 (s), 1449 (s), 1272 (s); δH (500 
MHz; CDCl3) 7.67 (1H, d, J 7.6, ArH), 7.47 (1H, dt, J 6.9 and 1.6, ArH), 7.43-7.26 
(8H, m, ArH), 7.15-6.80 (14H, m, ArH), 5.91 (1H, br s, NH(→B)), 5.22 (1H, br s, 
CH(NH)2), 4.75 (1H, br s, CH(Ph)(N→B)), 4.68-4.52 (3H, m, CHB(Ph(NH)) and 
CHA(O)CHB(O)) and 2.55 (1H, br s, NH);  δC (75 MHz; CDCl3) 141.6, 141.4, 141.3, 
141.1, 141.0, 139.8, 139.7, 139.6, 139.2, 139.0, 138.7, 138.6(3), 138.6(1), 138.4, 138.0, 
137.3, 135.8, 131.7, 130.1, 130.0, 129.5, 129.2, 129.1, 128.9, 128.5, 128.2, 127.7, 
127.4, 126.9, 123.6, 86.5, 83.1, 74.5, 67.9 and 31.4; δB (100 MHz, CDCl3) 17.3; m/z 







(1R,2R)-Cyclohexane-1,2-diamine (1R,2R)-125 (0.90 g, 7.9 mmol) and 2-(tert-
butoxycarbonyloxyimino)-2-phenylacetonitrile 136 (1.95 g, 7.9 mmol) were heated to 
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reflux in absolute ethanol (50 mL) for 24 hours. The solution was then allowed to cool 
to room temperature and the solvent removed in vacuo. The crude product was re-
dissolved in CH2Cl2 (30 mL), extracted with water (3 x 20 mL) and brine (2 x 20 mL) 
before being dried (MgSO4) and the CH2Cl2 evaporated to afford the title compound as 
a brown solid (156 mg, 98%); m.p. 98-101 °C; [ ]20Dα  -12.00 (c 1.150, CH2Cl2); vmax 
(film)/cm-1 1707 (C=O); δH (300 MHz; CDCl3) 8.03 (1H, s, NH(Boc)), 5.08 (2H, br s, 
NH2), 3.80 (1H, m, CH(NHBoc), 3.15 (1H, m, CHNH2), 1.80-1.72 (2H, m, CH2CNH), 
1.57-1.41 (2H, m, CH2CNH2), 1.38 (9H, s, C(CH3)3), 1.32-1.06 (4H, m, C2H4); δC (75 
MHz; CDCl3) 156.1 (C=O), 79.3, 61.0, 55.0, 35.4, 32.3, 29.1 (3C, C(CH3)3) and 23.6 
(2C, C2H4); m/z LRMS (ESI+) 216 [(M+H), 100%], 159.1 (5); HRMS (ESI+) found 
















tert-butyl-(1R,2R)-2-aminocyclohexylcarbamate (1R,2R)-138 (86 mg, 0.4 mmol), 2-
formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-BINOL (S)-74 (114 mg, 0.4 
mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a yellow solid (236 mg, 99%), m.p. 170-175 °C 
(dec); [ ]20Dα  -429.29 (c 1.050, CH2Cl2); vmax (film)/cm-1 1708 (C=O), 1620 (C=N); δH 
(400 MHz; CDCl3) 8.56 (1H, s, CHN), 7.82-7.75 (4H, m, ArH), 7.48-7.45 (1H, m, 
ArH), 7.34-7.05 (10H, m, ArH), 6.78-6.74 (1H, m, ArH), 4.66 (1H, d, J 10.0, 
NHCO2tBu), 3.89-3.76 (1H, m, CHNHBoc), 3.20 (1H, dt, J 11.3 and 3.8, CHN=C), 
2.36-2.30 (1H, m, CHeqCNHBoc), 1.99-1.93 (1H, m, CHeqCN=C), 1.58-0.99 (14H, m, 
C4H5 and CO2tBu), 0.83-0.67 (1H, m, CH2); δC (75 MHz; CDCl3) 169.6 (C=O), 154.9 
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(C=N), 137.6, 134.0, 133.6, 131.5, 130.7, 130.5, 130.4, 130.3, 130.2, 130.0, 129.5, 
128.9, 128.8, 128.3, 128.1, 127.7, 127.4, 126.9, 125.5, 124.8, 123.9, 123.7, 123.6, 
123.2, 123.1, 122.6, 118.3, 80.8, 63.9, 52.2, 35.3, 34.0, 25.3 and 25.1 (3C, C(CH3)3); δB 
(100 MHz, CDCl3) 12.0; m/z LRMS (CI+) 597 [(M+H)+, 23%], 268.2 (100), 239.1 (97), 
















tert-butyl-(1S,2S)-2-aminocyclohexylcarbamate (1S,2S)-138 (86 mg, 0.4 mmol), 2-
formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-BINOL (S)-74 (114 mg, 0.4 
mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a yellow solid (222 mg, 95%), m.p. 170-173 °C 
(dec); [ ]20Dα  +414.00 (c 1.975, CH2Cl2); vmax (film)/cm-1 1707 (C=O), 1617 (C=N); δH 
(400 MHz; CDCl3) 8.47 (1H, s, CHN), 7.85-7.73 (4H, m, ArH), 7.45 (1H, app d, J 7.5, 
ArH), 7.36-7.06 (10H, m, ArH), 6.82 (1H, app d, J 6.8, ArH), 5.43 (1H, d, J 8.1, 
NHCOOtBu), 3.60-3.48 (1H, m, CHNHBoc), 3.09 (1H, dt, J 11.9 and 3.4, CHN=C), 
2.34-2.29 (1H, m, CHeqCNHBoc), 1.95-1.91 (1H, m, CHeqCN=C), 1.76-0.71 (15H, m, 
C4H6 and CO2tBu) δC (75 MHz; CDCl3)  169.4 (C=O), 156.7 (C=N), 137.6, 134.2, 
133.6(4), 133.6(1), 131.4, 130.8, 130.5, 130.3, 129.8, 129.4, 129.2, 128.8, 128.5, 128.2, 
127.5, 127.2, 125.8, 125.7, 125.0, 124.9, 124.2, 123.9, 123.7, 123.6, 122.6, 122.3, 79.6, 
61.0, 55.5, 34.1, 33.3, 28.6, 25.1 and 25.0 (3C, C(CH3)3); δB (100 MHz, CDCl3) 12.1; 
m/z LRMS (ESI+) 597 [(M+H)+, 10%], 561.4 (26), 347.2 (100), 329.2 (85), 273.1 (24); 
HRMS (ESI+) found 619.2741 ([M+Na]+ C38H37BN2O4 requires 619.2740). 
 













(S)-BINOL (S)-74 (114 mg, 0.4 mmol), 2-formylphenylboronic acid 73 (60 mg, 0.4 
mmol) and (S)-leucinol (S)-145 (47 mg, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 
minutes in the presence of 4 Å molecular sieves. The sieves were removed using 
gravity filtration and the title compound selectively crystallised from the crude solution 
as pale cream needles (32 mg, 16%); mp 161-163 °C (dec); [ ]20Dα  +218.57 (c 2.355, 
CH2Cl2); vmax (film)/cm-1 2959 (s), 1467 (s), 1173 (s); δH (300 MHz; CDCl3) 7.86-7.78 
(4H, m, ArH), 7.30-7.03 (11H, m, ArH), 6.89 (1H, d, J 8.1, ArH), 6.49 (1H, m, NH), 
5.28 (1H, br s, CH(NH)(O)), 4.31 (1H, app d, J 11.3, CHAHBO), 3.88-3.81 (1H, m, 
CHAHBO), 3.39-3.31 (1H, m, CH(NH)), 2.11-2.00 (1H, m, CH(CH3)2), 1.63-1.47 (2H, 
m, CHAHBC(CH3)2), 0.88-0.81 (6H, m, C(CH3)2);  δC (75 MHz; CDCl3) 153.9, 153.2, 
136.6, 134.1, 133.9, 133.5, 131.0, 129.7, 129.4, 128.9, 128.7, 128.6, 128.3, 127.4, 
126.7, 126.2, 126.0, 125.9, 125.8(7), 125.8(0), 124.1, 123.8, 123.5, 123.1, 121.5, 112.2, 
96.0, 66.6, 62.5, 40.6, 24.7, 23.0 and 22.9; δB (100 MHz, CDCl3) 11.6; m/z LRMS 
(ESI+) 500 [(M+H)+, 9%], 268.2 (53), 239.2 (45), 214.2 (48), 158.1 (100); HRMS 





















Dimethyl-L-tartrate (1R,2R)-108 (71 mg, 0.4 mmol), 2-formylphenylboronic acid 73 
(60 mg, 0.4 mmol) and (S)-phenylglycinol (S)-150 (55 mg, 0.4 mmol) were stirred in 
CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular sieves. The sieves were 
removed using gravity filtration and the solvent removed in vacuo to afford the title 
compound as a white solid (156 mg, 95%); m.p. 125-127 °C; [ ]20Dα  -41.66 (c 1.470, 
CH2Cl2); vmax (film)/cm-1 1735 (C=O); δH (300 MHz; CDCl3); 7.80-7.77 (1H, m, ArH), 
7.49-7.38 (8H, m, ArH), 6.66 (1H, d, J 6.1, CH(NH)(O)), 6.43 (1H, br t, J 6.1, NH), 
4.76-4.71 (1H, m, CH(Ph)), 4.70-4.55 (2H, br s, CHA(O)CHB(O)), 4.20 (1H, dd, J 9.1 
and 4.0, CHeqHaxO), 4.02 (1H, dd, J 9.1 and 7.8, CHaxHeqO), 3.97-3.75 (3H, br s, 
CO2CH3) and 3.54-3.26 (3H, br s, CO2CH3); δC (75 MHz; CDCl3) 142.4, 139.1, 137.8, 
137.4, 137.0, 135.5, 132.3, 132.1, 131.7, 130.3, 129.8, 129.4, 128.5, 123.4, 95.1, 77.9, 
72.5, 61.0, 60.7, 53.4 and 53.2; δB (100 MHz, CDCl3) 13.5; m/z LRMS (CI+) 412 
[(M+H)+, 73%], 196.1 (47), 164.1 (44), 120.1 (61), 106.0 (100); HRMS (ESI+) found 
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(4′R,7aS)-158a and (4′S,7aS)-158b 




3,3-Dimethyl-1,2-butane diol (rac)-105 (47 mg, 0.4 mmol), 2-formylphenylboronic 
acid 73 (60 mg, 0.4 mmol) and (S)-(+)-2-pyrrolidinemethanol (S)-157 (40 μL, 0.4 
mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a yellow oil as a 50 : 50 mixture (120 mg, 95%); 
vmax (film)/cm-1 2955 (s), 2873 (s), 1109 (s); δH (300 MHz; CDCl3) 7.43-7.37 (2H, m, 
ArH), 7.26-7.13 (6H, m, ArH), 5.74 (1H, s, CH(N)(O)), 5.70 (1H, s, CH(N)(O)), 4.13-
4.06 (2H, m, CHCH2O), 3.95-3.60 (12H, m, 2 x CHAHBO, 2 x CHAHBN, 2 x 
CHAHBOB and 2 x CH(tBu)(O)), 3.04-2.91 (2H, m, CHAHBN), 2.19-1.65 (8H, m, 
CH2CH2CH), 0.90 (9H, s, C(CH3)3) and 0.86 (9H, s, C(CH3)3); δC (75 MHz; CDCl3) 
140.7, 140.6, 130.9, 129.6, 129.5, 128.2, 128.1(9), 128.1(6), 128.1(0), 127.5, 123.2, 
123.0, 102.7, 102.6, 84.5, 84.0, 71.8, 71.7, 67.0, 66.7, 64.5, 64.4, 55.1, 54.9, 34.3, 34.2, 
32.6, 32.4, 26.7, 26.4, 25.9 (3C, C(CH3)3) and 25.8 (3C, C(CH3)3); δB (100 MHz, 
CDCl3) 15.4; m/z LRMS (ESI+) 316 [(M+H)+, 100%], 299.2 (32), 280.2 (16), 239.2 










Experimental                                                                                                       Chapter 3 
156 
 
(4′S,5′R,7aS)-159a and (4′R,5′S,7aS)-159b 





(rac)-Methyl-2,3-dihydroxy-3-phenylpropionate (rac)-106 (78 mg, 0.4 mmol), 2-
formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-(+)-2-pyrrolidinemethanol (S)-
157 (40 μL, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 
Å molecular sieves. The sieves were removed using gravity filtration and the solvent 
removed in vacuo to afford the title compound as a yellow oil as a 50 : 50 mixture (154 
mg, 98%); vmax (film)/cm-1 1745 (C=O); δH (300 MHz; CDCl3) 7.56 (1H, d, J 7.4, 
ArH), 7.50-7.44 (3H, m, ArH), 7.37-7.16 (14H, m, ArH), 5.86 (1H, s, CH(N)(O)), 5.80 
(1H, s, CH(N)(O)), 5.11 (1H, d, J 7.4, CH(Ph)), 5.04 (1H, d, J 7.9, CH(Ph)), 4.48 (1H, 
d, J 7.4, CH(CO2CH3)), 4.43 (1H, d, J 7.9, CH(CO2CH3)), 4.41-4.34 (1H, m, 
CHCH2O), 4.23-4.15 (1H, m, CHCH2O), 3.71-3.57 (12H, m, 2 x CO2CH3, 2 x 
CHAHBO, 2 x CHAHBO and 2 x CHAHBN), 3.19-3.12 (1H, m, CHAHBN), 3.05-2.97 
(1H, m, CHAHBN), 2.42-2.26 (1H, m, CHAHBCH), 2.20-2.09 (1H, m, CHAHBCH) and 
2.05-1.66 (6H, m, 2 x CHAHBCH and 2 x CH2CH2CH); δC (75 MHz; CDCl3) 174.3, 
173.0, 143.0, 142.5, 140.5, 140.0, 137.4, 134.2, 130.6, 130.5, 130.3, 129.9, 129.8, 
129.0, 128.9(8), 128.9(5), 128.9(2), 128.8, 128.6, 128.5, 128.2, 126.5, 126.3, 123.1, 
122.8, 120.3, 118.0, 117.6, 104.0, 103.3, 83.2, 81.7, 81.1, 72.2, 65.2, 65.2, 55.7, 55.1, 
52.4, 52.1, 32.6, 32.3, 26.4 and 26.3; δB (100 MHz, CDCl3) 14.5; m/z LRMS (ESI+) 394 
[(M+H)+, 100%], 306.2 (11), 280.2 (7); HRMS (ESI+) found 394.1822 ([M+H]+ 












tert-Butyldimethylsilyl chloride (301 mg, 2.0 mmol), (S)-2-phenylglycinol (S)-150 (274 
mg, 2.0 mmol) and Et3N (0.56 mL, 4.0 mmol) were stirred in CH2Cl2 (20 mL) at room 
temperature for 18 hours. The crude solution was washed with brine (2 x 10 mL) and 
saturated sodium bicarbonate solution (2 x 10 mL) before drying (MgSO4), filtration 
and evaporation afforded the title compound as a colourless oil (467 mg, 93%); [ ]20Dα  
+5.44 (c 1.100, CH2Cl2); υmax (film)/cm-1 1089 (O-Si), 700 (O-Si); δH (300 MHz, 
CDCl3) 7.36-7.14 (5H, m, ArH), 4.02 (1H, dd, J 8.4 and 4.0, CHPh),  3.68 (1H, dd, J 
9.8 and 4.0, CHAHB(O)), 3.48 (1H, dd, J 9.8 and 8.4, CHAHB(O)), 1.73 (2H, br s, NH2), 
0.88 (9H, s, C(CH3)3) and 0.00 (6H, s, Si(CH3)2); δC (75 MHz; CDCl3) 142.9, 128.7, 
128.5, 127.7, 127.6, 127.3, 68.4, 51.1, 18.6 (3C, C(CH3)3) -2.8 and -5.1 (2C, Si(CH3)2); 













2-Formylphenylboronic acid 91 (60 mg, 0.4 mmol) and (R)-2-amino-1-butanol (R)-143 
(38 μL, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å 
molecular sieves. The sieves were removed using gravity filtration and the solvent 
removed in vacuo to afford the title compound as a yellow oil (76 mg, 98%); [ ]20Dα        
+14.67 (c 1.875, CH2Cl2); vmax (film)/cm-1 1628 (C=N); δH (300 MHz; CDCl3) 8.13 
(2H, s, CHN), 7.50 (2H, t, J 7.4, ArH), 7.36-7.26 (4H, m, ArH), 7.12-7.07 (2H, m, 
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ArH), 4.33 (2H, dd, J 12.0 and 1.7, CHAHB(O)), 3.78 (2H, dd, J 12.0 and 1.7, 
CHAHB(O)), 3.51 (2H, m, CH(Et)(N)), 2.20-2.09 (4H, m, CHAHBCH3) and 0.93 (6H, t, 
J 7.6, CH3); δC (75 MHz; CDCl3) 167.3 (C=N), 136.9, 133.5, 133.3, 129.3, 127.2, 
126.2, 70.7, 62.4, 24.8 and 11.5; δB (100 MHz; CDCl3) 11.2; m/z LRMS (CI+) 389 
[(M+H)+, 6%], 188.2 (50), 106.0 (46), 72.0 (100); HRMS (EI+) found 388.2126 ([M]+● 













2-Formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-leucinol (S)-145 (51 μL, 0.4 
mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å molecular 
sieves. The sieves were removed using gravity filtration and the solvent removed in 
vacuo to afford the title compound as a yellow solid (83 mg, 93%); m.p. 116-120 °C 
(dec); [ ]20Dα  -26.10 (c 1.025, CH2Cl2); vmax (film)/cm-1 1628 (C=N); δH (300 MHz; 
CDCl3) 8.16 (2H, s, CHN), 7.51 (2H, d, J 7.4, ArH), 7.36-7.27 (4H, m, ArH), 7.11 (2H, 
dt, J 7.4 and 1.1, ArH), 4.35 (2H, dd, J 11.9 and 1.7, CHAHB(O)), 3.81-3.73 (4H, m, 
CHAHB(O) and CH(N)), 2.16-2.06 (2H, m, CHAHBC(N)), 2.02-1.92 (2H, m, 
CHAHBC(N)), 1.72-1.63 (2H, m, CH(CH3)2) and 0.90 (12H, app t, J 6.8, C(CH3)2); δC 
(75 MHz; CDCl3) 166.9 (C=N), 136.9, 133.5, 133.1, 129.4, 127.2, 126.1, 66.7, 62.5, 
40.4, 24.8, 23.0 and 22.9; δB (100 MHz; CDCl3) 11.5; m/z LRMS (ESI+) 445 [(M+H)+, 
14%], 412.4 (100), 292.2 (66), 227.2 (15); HRMS (ESI+) found 445.2833 ([M+H]+ 
C26H34B2N2O3 requires 445.2832). 
 
 












2-Formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (R)-2-amino-3-methyl-1-
butanol (R)-146 (45 μL, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the 
presence of 4 Å molecular sieves. The sieves were removed using gravity filtration and 
the solvent removed in vacuo to afford the title compound as a yellow oil (81 mg, 
98%); [ ]20Dα  +22.77 (c 1.520, CH2Cl2); vmax (film)/cm-1 1628 (C=N); δH (300 MHz; 
CDCl3) 8.08 (2H, s, CHN), 7.51 (2H, d, J 7.4, ArH), 7.35-7.27 (4H, m, ArH), 7.11 (2H, 
dt, J 7.4 and 1.1, ArH), 4.26 (2H, dd, J 12.2 and 1.3, CHAHB(O)), 3.98 (2H, dd, J 12.2 
and 1.3, CHAHB(O)), 3.13 (2H, m, CH(iPr)(N)), 2.96-2.83 (2H, m, CH(CH3)2), 1.02 
(6H, d, J 6.8, C(CH3)(CH3)) and 0.88 (6H, d, J 6.8, C(CH3)(CH3)); δC (75 MHz; 
CDCl3) 167.3 (C=N), 136.8, 133.6, 129.4, 127.2, 127.0, 126.2, 76.0, 60.9, 27.0, 21.1 
and 19.4; δB (100 MHz; CDCl3) 10.7; m/z LRMS (ESI+) 417 [(M+H)+, 13%], 283.2 





















2-Formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (R)-2-phenylglycinol (R)-150 
(55 mg, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å 
molecular sieves. The sieves were removed using gravity filtration and the solvent 
removed in vacuo to afford the title compound as a yellow oil (88 mg, 91%); [ ]20Dα  
+21.10 (c 2.005, CH2Cl2); vmax (film)/cm-1 1627 (C=N); δH (300 MHz; CDCl3) 7.66-
7.63 (4H, m, CHN and ArH), 7.43-7.30 (12H, m, ArH),  7.20 (2H, br t, J 7.4, ArH), 
7.09 (2H, dt, J 7.4 and 0.8, ArH), 5.25 (2H, m, CHAHB(O)), 4.65 (2H, dd, J 11.9 and 
10.4, CH(Ph)(N)) and 3.95 (2H, m, CHAHB(O)); δC (75 MHz; CDCl3) 166.1 (C=N), 
137.0, 135.7, 133.9, 133.5, 132.3, 130.0, 129.9, 129.7, 129.5, 127.2, 126.8, 126.7, 71.4 
and 69.1; δB (100 MHz; CDCl3) 11.3; m/z LRMS (ESI+) 485 [(M+H)+, 9%], 368.2 (10), 














2-Formylphenylboronic acid 73 (60 mg, 0.4 mmol) and (S)-2-phenylglycinol (S)-150 
(55 mg, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å 
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molecular sieves. The sieves were removed using gravity filtration and the solvent 
removed in vacuo to afford the title compound as a yellow oil (92 mg, 95%); [ ]20Dα        
-21.10 (c 1.450, CH2Cl2); vmax (film)/cm-1 1627 (C=N); δH (300 MHz; CDCl3) 7.65-
7.63 (4H, m, CHN and ArH), 7.43-7.30 (12H, m, ArH), 7.20 (2H, br t, J 7.4, ArH), 
7.09 (2H, dt, J 7.4 and 0.8, ArH), 5.25 (2H, m, CHAHB(O)), 4.65 (2H, dd, J 11.7 and 
10.6, CH(Ph)(N)), 3.95 (2H, m, CHAHB(O)); δC (75 MHz; CDCl3) 166.0 (C=N), 137.0, 
135.6, 133.9, 133.5, 132.3, 130.0, 129.9, 129.7, 129.4, 128.0, 127.3, 126.8, 71.3, and 
65.8; δB (100 MHz; CDCl3) 10.8; m/z LRMS (ESI+) 485 [(M+H)+, 27%], 312.1 (100); 




(1R,2R,1′R,2′R)-175 and (1S,2S,1′S,2′S)-175 




2-Formylphenylboronic acid 73 (60 mg, 0.4 mmol) was stirred with trans-2-
aminocyclohexanol hydrochloride 169 (61 mg, 0.4 mmol) and cesium carbonate (130 
mg, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 Å 
molecular sieves. Cesium carbonate and molecular sieves were removed using gravity 
filtration and the solvent removed in vacuo to afford the title compound as a yellow oil 
(85 mg, 96%); m.p. 142-144 °C (dec); vmax (film)/cm-1 1625 (C=N); δH (300 MHz; 
CDCl3) 8.20 (2H, s, CHN), 8.19 (2H, s, CHN), 7.47 (4H, d, J 6.8, ArH), 7.35 (4H, d, J 
7.4, ArH), 7.28 (4H, app dt, J 7.5 and 1.1, ArH), 7.10 (4H, app dt, J 7.5 and 1.1, ArH), 
3.96-3.88 (4H, m, CH(N)), 3.79-3.70 (4H, m, CH(O)), 2.26 (4H, br d, J 12.0, 
CHAHBC(N)), 1.88-1.81 (8H, m, CHAHBC(N) and CHAHBC(O)), 1.71-1.66 (4H, m, 
CHAHBC(O)) and 1.50-1.12 (16H, m, C(N)CC2H4); δC (75 MHz; CDCl3) 164.0 (C=N), 
137.2, 133.2, 129.9, 129.1, 126.9, 126.3, 65.6, 36.3, 29.8, 27.3, 24.9 and 24.8; δB (100 
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MHz; CDCl3) 10.8; m/z LRMS (ESI+) 441 [(M+H)+, 100%], 290.2 (15); HRMS (ESI+) 













2-Formylphenylboronic acid 73 (60 mg, 0.4 mmol) was stirred with (R)-(-)-2-amino-1-
phenylethanol (R)-170 (55 mg, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes 
in the presence of 4 Å molecular sieves. The sieves were removed using gravity 
filtration and the solvent removed in vacuo to afford the title compound as a bright 
yellow solid (140 mg, 95%); m.p. 145-147 °C (dec); [ ]20Dα  +19.43 (c 1.355, CH2Cl2); 
vmax (film)/cm-1 1635 (C=N); δH (300 MHz; CDCl3) 8.25 (2H, s, CHN), 7.64 (2H, d, J 
7.0, ArH), 7.48-7.14 (16H, m, ArH), 5.46 (2H, br d, J 9.8, CHAHB(N)), 4.50-4.42 (2H, 
m, CH(Ph)(O)) and 4.03 (2H, br d, J 9.8, CHAHB(N)); δC (75 MHz; CDCl3) 167.0 
(C=N), 143.5, 137.0, 134.6, 134.2, 133.5, 129.8, 129.5, 128.8, 127.6, 126.9, 126.8, 
126.2, 72.3 and 62.9; δB (100 MHz; CDCl3) 10.5; m/z LRMS (ESI+) 485 [(M+H)+, 













3-Formylfuran-2-boronic acid 177 (56 mg, 0.4 mmol) was stirred with (S)-leucinol (S)-
145 (51 μL, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the presence of 4 
Å molecular sieves. The sieves were removed using gravity filtration and the solvent 
removed in vacuo to afford the title compound as a red oil (82 mg, 97%); [ ]20Dα  -34.04 
(c 1.650, CH2Cl2); vmax (film)/cm-1 1649 (C=N); δH (300 MHz; CDCl3)  8.13 (1H, s, 
CHN), 8.12 (1H, s, CHN), 7.36 (2H, d, J 1.9, CHC(C=N)), 6.32 (2H, d, J 1.9, 
CHC(O)), 4.39 (1H, dd, J 8.9 and 6.0, CHAHB(O)), 4.24-4.15 (2H, m, CH(N)), 3.99 
(2H, dd, J 8.9 and 7.4, CHAHB(O)), 1.77-1.65 (6H, m, CHAHBCH(CH3)2) and 1.00 
(12H, br t, J 5.5, C(CH3)2); δC (75 MHz; CDCl3) 157.2 (C=N), 144.7, 132.7, 122.8, 
110.0, 71.9, 52.2, 32.6, 20.5, 8.9 and 8.1; δB (100 MHz; CDCl3) 4.6; m/z LRMS (ESI+) 
425 [(M+H)+, 32%], 412.4 (27), 389.3 (35), 375.2 (100); HRMS (ESI+) found 425.2422 















3-Formylfuran-2-boronic acid 177 (56 mg, 0.4 mmol) and (S)-2-amino-3-methyl-1-
butanol (S)-146 (45 μL, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes in the 
presence of 4 Å molecular sieves. The sieves were removed using gravity filtration and 
the solvent removed in vacuo to afford the title compound as a dark brown solid (74 
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mg, 93%); m.p. 131-134 °C (dec); [ ]20Dα  -36.75 (c 1.950, CH2Cl2); vmax (film)/cm-1 
1649 (C=N); δH (300 MHz; CDCl3) 8.13 (1H, s, CHN), 8.12 (1H, s, CHN), 7.35 (2H, d, 
J 1.9, CHC(C=N)), 6.33 (2H, d, J 1.9, CHC(O)), 4.39 (2H, dd, J 9.4 and 6.2, 
CHAHB(O)), 4.15 (2H, dd, J 9.4 and 4.0, CHAHB(O)), 3.90-3.84 (2H, m, CH(N)), 2.28-
2.17 (2H, m, CH(CH3)2), 1.06 (6H, d, J 6.0, C(CH3)2), 1.04 (6H, d, J 6.0, C(CH3)2); δC 
(75 MHz; CDCl3) 157.2 (C=N), 144.5, 132.6, 123.3, 110.2, 69.3, 63.5, 32.6, 20.0 and 
17.4; δB (100 MHz; CDCl3) 4.7; m/z LRMS (ESI+) 397 [(M+H)+, 9%], 345.2 (100), 







3-Formylfuran-2-boronic acid 177 (56 mg, 0.4 mmol) was stirred with (R)-2-
phenylglycinol (R)-150 (55 mg, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes 
in the presence of 4 Å molecular sieves. The sieves were removed using gravity 
filtration and the solvent removed in vacuo to afford the title compound as a red solid 
(88 mg, 95%); m.p. 115-118 °C (dec); [ ]20Dα  +39.58 (c 1.125, CH2Cl2); vmax (film)/cm-1 
1657 (C=N); δH (300 MHz; CDCl3) 7.83 (1H, s, CHN), 7.82 (1H, s, CHN), 7.53-7.44 
(10H, m, ArH), 7.42 (2H, d, J 1.9, CHC(C=N)), 6.24 (2H, d, J 1.9, CHC(O)), 5.35-5.28 
(2H, m, CH(Ph)(N)), 4.57-4.45 (4H, m, CHAHB(O)); δC (75 MHz; CDCl3) 158.3 
(C=N), 144.9, 136.6, 131.4, 129.8, 129.6, 129.5(9), 129.5(5), 129.5(0), 124.6, 110.3, 
71.3 and 70.4; δB (100 MHz; CDCl3) 5.4; m/z LRMS (ESI+) 465 [(M+H)+, 100%], 
415.2 (33), 335.2 (36), 292.1 (32), 215.1 (10); HRMS (ESI+) found 465.1794 ([M+H] + 
C26H22B2N2O5 requires 465.1793). 
 
 






3-Formylfuran-2-boronic acid 177 (56 mg, 0.4 mmol) was stirred with (S)-2-
phenylglycinol (S)-150 (55 mg, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes 
in the presence of 4 Å molecular sieves. The sieves were removed using gravity 
filtration and the solvent removed in vacuo to afford the title compound as a dark red 
solid (90 mg, 97%); m.p. 115-118 °C (dec); [ ]20Dα  -39.58 (c 2.010, CH2Cl2); vmax 
(film)/cm-1 1657 (C=N); δH (300 MHz; CDCl3) 7.83 (1H, s, CHN), 7.82 (1H, s, CHN), 
7.53-7.44 (10H, m, ArH), 7.42 (2H, d, J 1.9, CHC(C=N)), 6.24 (2H, d, J 1.9, CHC(O)), 
5.35-5.28 (2H, m, CH(Ph)(N)), 4.57-4.45 (4H, m, CHAHB(O)); δC (75 MHz; CDCl3) 
158.3 (C=N), 144.9, 136.6, 131.4, 129.8, 129.6, 129.5(9), 129.5(5), 129.5(0), 124.6, 
110.3, 71.3 and 70.4; δB (100 MHz; CDCl3) 5.4; m/z LRMS (ESI+) 465 [(M+H)+, 75%], 








3-Formylfuran-2-boronic acid 177 (56 mg, 0.4 mmol) was stirred with (R)-2-amino-1-
phenylethanol (R)-170 (55 mg, 0.4 mmol) were stirred in CDCl3 (5 mL) for 5 minutes 
in the presence of 4 Å molecular sieves. The sieves were removed using gravity 
filtration and the solvent removed in vacuo to afford the title compound as a dark 
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brown solid (85 mg, 92%); m.p. 124-126 °C (dec); [ ]20Dα  +18.51 (c 1.155, CH2Cl2); 
vmax (film)/cm-1 1662 (C=N); δH (300 MHz; CDCl3) 8.26 (2H, br s, CHN), 7.56 (4H, br 
d, ArH), 7.45 (2H, d, J 1.9, CHC(C=N)), 7.39-7.26 (6H, m, ArH), 6.34 (2H, d, J 1.9, 
CHC(O)), 5.56-5.51 (2H, m, CHAHB(N)) and 4.11-4.08 (4H, m, CHAHB(N), 
CH(Ph)(O)); δC (75 MHz; CDCl3) 157.7 (C=N), 145.1, 142.1, 129.7, 129.0, 128.8, 
128.6, 128.1, 126.7, 124.5, 110.4, 76.2 and 63.7; δB (100 MHz; CDCl3) 5.0; m/z LRMS 
(ESI+) 465 [(M+H)+, 65%], 415.2 (100), 323.2 (83); HRMS (ESI+) found 465.1793 
([M+H]+ C26H22B2N2O5 requires 465.1793). 





4.1 1H NMR Spectra from the Derivatisation of Racemic Samples  
of Chiral Diols  
 
4.1.1 (S)-(-)- α-methylbenzylamine 
 
(α-S,R)-102a and (α-S,S)-102b (spectrum in acetone-d6)..……………………….... A3 
(α-S,R)-103a and (α-S,S)-103b…………………………………………………….. A4 
(α-S,R)-104a and (α-S,S)-104b (spectrum in acetone-d6)....……………………….. A5 
(α-S,R)-105a and (α-S,S)-105b…………………………………………………….. A6 
(α-S,4S,5R)-106a and (α-S,4R,5S)-106b…………………………………………… A7 
(α-S,3aR,7aR,10R,11S)-107a and (α-S,3aS,7aS,10S,11R)-107b…………………… A8 
(α-S,4R,5R)-108a and (α-S,4S,5S)-108b…………………………………………… A9 
(α-S,R)-109a and (α-S,S)-109b (spectrum in acetone-d6)...……………………… A10 
(α-S,R)-110a and (α-S,S)-110b…………………………………………………… A11 
(α-S,4S,5S)-111a, (α-S,4R,5R)-111b and (α-S,4S,5R)-111c..…………………….. A12 




(α-S,R)-113a and (α-S,S)-113b…………………………………………………… A14 
(α-S,R)-114a and (α-S,S)-114b…………………………………………………… A15 
(α-S,R)-115a and (α-S,S)-115b…………………………………………………… A16 
(α-S,R)-116a and (α-S,S)-116b…………………………………………………… A17 
(α-S,4S,5R)-117a and (α-S,4R,5S)-117b…………………………………………. A18 
(α-S,3aS,7aS,10S,11R)-118a and (α-S,3aR,7aR,10R,11S)-118b…………………. A19 
(α-S,4R,5R)-119a and (α-S,4S,5S)-119b…………………………………………. A20 
(α-S,R)-120a and (α-S,S)-120b………………………………………………..….. A21 
(α-S,R)-121a and (α-S,S)-121b………………………………………………….... A22 
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5.2 1H NMR Spectra from the Derivatisation of Racemic Samples  
of Chiral Diamines  
 
(R,2S,4S,5S)-126a and (R,2S,4R,5R)-126b…………………………………….… .A23 
(2S,3aR,4′S,5′S,7aR)-134a and (2S,3aS,4′S,5′S,7aS)-134b .....…………………... .A24 
(4′S,4S,5S,5’S)-135a and (4′S,4R,5R,5’S)-135b…………………………………. ..A25 
(S,1R,2R)-138a and (S,1S,2S)-138b...……………………………………………...A26 
 
 
5.3 1H NMR Spectrum for the Derivatisation of Racemic  
O-Protected Amino Alcohol 2-phenylglycinol 
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Table 1.  Crystal data and structure refinement for (S,2R,4S)-154. 
  
  
      Identification code                (S,2R,4S)-154 
  
      Empirical formula                C33 H30 B N O3 
  
      Formula weight                     499.39 
  
      Temperature                        150(2) K 
  
      Wavelength                         0.71073 A 
  
      Crystal system                     monoclinic 
 
      Space group                        P 21  
  
      Unit cell dimensions               a = 8.1770(2) A   alpha = 90 deg. 
                                          b = 14.8410(5) A    beta = 94.8390(10) deg. 
                                          c = 10.5950(3) A   gamma = 90 deg. 
  
      Volume                              1281.17(6) A^3 
  
      Z, Calculated density              2,  1.295 Mg/m^3 
  
      Absorption coefficient             0.081 mm^-1 
  
      F(000)                              528 
  
      Crystal size                        0.35 x 0.35 x 0.25 mm 
  
      Theta range for data collection    6.27 to 27.51 deg. 
  
      Limiting indices                   -10<=h<=10, -19<=k<=18, -13<=l<=13 
  
      Reflections collected / unique     15517 / 5671 [R(int) = 0.0875] 
  
      Completeness to theta =   27.51      97.7 % 
  
      Max. and min. transmission         0.9799 and 0.9720 
  
      Refinement method                  Full-matrix least-squares on F^2 
  
      Data / restraints / parameters     5671 / 1 / 347 
  
      Goodness-of-fit on F^2             1.031 
  
      Final R indices [I>2sigma(I)]      R1 = 0.0514, wR2 = 0.1221 
  
      R indices (all data)               R1 = 0.0681, wR2 = 0.1329 
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       Absolute structure parameter       -0.3(11) 
  
      Largest diff. peak and hole        0.230 and -0.232 e.A^-3 
  
 
Table 2.   
Atomic coordinates ( x 10^4) and equivalent isotropic displacement parameters (A^2 x 
10^3) for (S,2R,4S)-154. 
 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
  
          
  
               x             y             z           U(eq) 
          
  
           
B            4797(3)       1032(2)       7371(2)       28(1) 
N            2785(2)        886(1)       7426(2)       28(1) 
O(1)         5551(2)       1500(1)       8471(1)       29(1) 
O(2)         4851(2)       1552(1)       6193(1)       28(1) 
O(3)         1058(2)       -364(1)       7335(2)       37(1) 
C(1)         5442(2)       2421(2)       8530(2)       27(1) 
C(2)         4685(3)       2787(2)       9566(2)       32(1) 
C(3)         4490(3)       3690(2)       9678(2)       33(1) 
C(4)         5018(3)       4282(2)       8746(2)       29(1) 
C(5)         4691(3)       5220(2)       8785(2)       35(1) 
C(6)         5125(3)       5780(2)       7846(2)       36(1) 
C(7)         5911(3)       5429(2)       6818(2)       34(1) 
C(8)         6245(3)       4526(2)       6756(2)       30(1) 
C(9)         5823(2)       3920(2)       7718(2)       26(1) 
C(10)        6115(2)       2975(2)       7654(2)       25(1) 
C(11)        7089(2)       2550(2)       6681(2)       26(1) 
C(12)        8740(3)       2815(2)       6498(2)       28(1) 
C(13)        9574(3)       3515(2)       7204(2)       32(1) 
C(14)       11161(3)       3744(2)       7003(2)       36(1) 
C(15)       12004(3)       3290(2)       6081(2)       39(1) 
C(16)       11248(3)       2600(2)       5415(2)       35(1) 
C(17)        9611(2)       2349(2)       5592(2)       29(1) 
C(18)        8838(3)       1609(2)       4914(2)       33(1) 
C(19)        7291(3)       1350(2)       5124(2)       30(1) 
C(20)        6413(2)       1824(1)       6006(2)       26(1) 
C(21)        5313(2)          8(2)       7247(2)       29(1) 
C(22)        6860(3)       -400(2)       7341(2)       32(1) 
C(23)        7006(3)      -1312(2)       7064(2)       37(1) 
C(24)        5620(3)      -1819(2)       6687(2)       40(1) 
C(25)        4074(3)      -1432(2)       6587(2)       37(1) 
C(26)        3951(3)       -519(2)       6864(2)       30(1) 
C(27)        2371(3)          8(2)       6732(2)       31(1) 
C(28)        1474(3)       -207(2)       8653(2)       35(1) 
C(29)        2162(3)        761(2)       8731(2)       29(1) 
C(30)         921(3)       1491(2)       8991(2)       33(1) 
C(31)         683(3)       1646(2)      10397(2)       37(1) 
C(32)         101(4)        813(3)      11070(3)       58(1) 
C(33)        -452(4)       2440(3)      10535(3)       61(1) 
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             Table 3.  Bond lengths [A] for (S,2R,4S)-154. 
            
  
            B-O(1)                        1.448(3) 
            B-O(2)                        1.471(3) 
            B-C(21)                       1.586(3) 
            B-N                           1.665(3) 
            N-C(27)                       1.521(3) 
            N-C(29)                       1.525(3) 
            N-H                           0.90(3) 
            O(1)-C(1)                     1.372(3) 
            O(2)-C(20)                    1.370(2) 
            O(3)-C(27)                    1.408(3) 
            O(3)-C(28)                    1.428(3) 
            C(1)-C(10)                    1.388(3) 
            C(1)-C(2)                     1.413(3) 
            C(2)-C(3)                     1.355(3) 
            C(3)-C(4)                     1.416(3) 
            C(4)-C(5)                     1.418(4) 
            C(4)-C(9)                     1.425(3) 
            C(5)-C(6)                     1.366(4) 
            C(6)-C(7)                     1.411(3) 
            C(7)-C(8)                     1.372(3) 
            C(8)-C(9)                     1.424(3) 
            C(9)-C(10)                    1.425(3) 
            C(10)-C(11)                   1.495(3) 
            C(11)-C(20)                   1.383(3) 
            C(11)-C(12)                   1.435(3) 
            C(12)-C(13)                   1.421(3) 
            C(12)-C(17)                   1.422(3) 
            C(13)-C(14)                   1.375(3) 
            C(14)-C(15)                   1.413(4) 
            C(15)-C(16)                   1.362(4) 
            C(16)-C(17)                   1.418(3) 
            C(17)-C(18)                   1.430(3) 
            C(18)-C(19)                   1.358(3) 
            C(19)-C(20)                   1.412(3) 
            C(21)-C(26)                   1.393(3) 
            C(21)-C(22)                   1.399(3) 
            C(22)-C(23)                   1.391(4) 
            C(23)-C(24)                   1.391(4) 
            C(24)-C(25)                   1.384(4) 
            C(25)-C(26)                   1.391(3) 
            C(26)-C(27)                   1.507(3) 
            C(28)-C(29)                   1.543(3) 
            C(29)-C(30)                   1.525(3) 
            C(30)-C(31)                   1.536(3) 
            C(31)-C(33)                   1.515(4) 
            C(31)-C(32)                   1.523(4) 
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           Table 4.  Bond lengths [A] and angles [deg] for (S,2R,4S)-154. 
 
            
  
 
            O(1)-B-O(2)                 112.99(18) 
            O(1)-B-C(21)                115.30(18) 
            O(2)-B-C(21)                113.87(18) 
            O(1)-B-N                    112.90(17) 
            O(2)-B-N                    101.44(16) 
            C(21)-B-N                    98.55(16) 
            C(27)-N-C(29)               104.85(16) 
            C(27)-N-B                   105.97(16) 
            C(29)-N-B                   117.00(16) 
            C(27)-N-H                   109.8(19) 
            C(29)-N-H                   104.7(17) 
            B-N-H                       114.1(18) 
            C(1)-O(1)-B                 119.24(16) 
            C(20)-O(2)-B                111.88(15) 
            C(27)-O(3)-C(28)            104.63(17) 
            O(1)-C(1)-C(10)             121.94(18) 
            O(1)-C(1)-C(2)              116.89(19) 
            C(10)-C(1)-C(2)             121.1(2) 
            C(3)-C(2)-C(1)              120.6(2) 
            C(2)-C(3)-C(4)              120.6(2) 
            C(3)-C(4)-C(5)              121.3(2) 
            C(3)-C(4)-C(9)              119.1(2) 
            C(5)-C(4)-C(9)              119.5(2) 
            C(6)-C(5)-C(4)              121.0(2) 
            C(5)-C(6)-C(7)              120.0(2) 
            C(8)-C(7)-C(6)              120.3(2) 
            C(7)-C(8)-C(9)              121.5(2) 
            C(8)-C(9)-C(4)              117.7(2) 
            C(8)-C(9)-C(10)             122.37(19) 
            C(4)-C(9)-C(10)             119.87(19) 
            C(1)-C(10)-C(9)             118.24(18) 
            C(1)-C(10)-C(11)            118.41(19) 
            C(9)-C(10)-C(11)            123.34(18) 
            C(20)-C(11)-C(12)           118.93(19) 
            C(20)-C(11)-C(10)           118.24(18) 
            C(12)-C(11)-C(10)           122.62(18) 
            C(13)-C(12)-C(17)           117.73(18) 
            C(13)-C(12)-C(11)           123.04(19) 
            C(17)-C(12)-C(11)           119.21(19) 
            C(14)-C(13)-C(12)           121.1(2) 
            C(13)-C(14)-C(15)           120.7(2) 
            C(16)-C(15)-C(14)           119.4(2) 
            C(15)-C(16)-C(17)           121.4(2) 
            C(16)-C(17)-C(12)           119.6(2) 
            C(16)-C(17)-C(18)           121.2(2) 
            C(12)-C(17)-C(18)           119.17(18) 
            C(19)-C(18)-C(17)           120.84(19) 
            C(18)-C(19)-C(20)           120.0(2) 
            O(2)-C(20)-C(11)            119.42(18) 
            O(2)-C(20)-C(19)            118.81(19) 
            C(11)-C(20)-C(19)           121.77(19) 
            C(26)-C(21)-C(22)           118.2(2) 
            C(26)-C(21)-B               110.54(18) 
            C(22)-C(21)-B               130.9(2) 
            C(23)-C(22)-C(21)           120.0(2) 
            C(24)-C(23)-C(22)           120.3(2) 
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            C(25)-C(24)-C(23)           120.9(2) 
            C(24)-C(25)-C(26)           118.0(2) 
            C(25)-C(26)-C(21)           122.6(2) 
            C(25)-C(26)-C(27)           124.2(2) 
            C(21)-C(26)-C(27)           113.2(2) 
            O(3)-C(27)-C(26)            115.8(2) 
            O(3)-C(27)-N                105.30(17) 
            C(26)-C(27)-N               104.23(17) 
            O(3)-C(28)-C(29)            105.06(18) 
            N-C(29)-C(30)               110.82(17) 
            N-C(29)-C(28)               102.29(17) 
            C(30)-C(29)-C(28)           115.19(18) 
            C(29)-C(30)-C(31)           114.96(18) 
            C(33)-C(31)-C(32)           111.6(2) 
            C(33)-C(31)-C(30)           109.8(2) 
            C(32)-C(31)-C(30)           113.7(2) 
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Table 5.   
Anisotropic displacement parameters (A^2 x 10^3) for (S,2R,4S)-154. 
The anisotropic displacement factor exponent takes the form: 
    
 -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
     
______________________________________________________________________ 
  
          U11        U22        U33        U23        U13        U12 
    
______________________________________________________________________ 
  
B        28(1)      26(1)      29(1)       2(1)       4(1)      -2(1) 
N        28(1)      26(1)      30(1)       3(1)       3(1)       0(1) 
O(1)     34(1)      24(1)      29(1)       2(1)       2(1)      -4(1) 
O(2)     29(1)      27(1)      28(1)       2(1)       3(1)      -3(1) 
O(3)     32(1)      34(1)      46(1)      -2(1)       7(1)      -7(1) 
C(1)     29(1)      23(1)      29(1)       1(1)       0(1)      -4(1) 
C(2)     33(1)      35(1)      28(1)       1(1)       5(1)      -6(1) 
C(3)     32(1)      36(1)      31(1)      -8(1)       6(1)      -3(1) 
C(4)     27(1)      31(1)      30(1)      -6(1)       1(1)      -2(1) 
C(5)     34(1)      32(1)      37(1)      -8(1)       0(1)       2(1) 
C(6)     42(1)      24(1)      42(1)      -3(1)      -4(1)       3(1) 
C(7)     39(1)      27(1)      36(1)       3(1)       0(1)      -1(1) 
C(8)     30(1)      30(1)      30(1)      -1(1)       1(1)       0(1) 
C(9)     27(1)      25(1)      27(1)      -2(1)       0(1)      -2(1) 
C(10)    26(1)      26(1)      25(1)      -1(1)       1(1)      -2(1) 
C(11)    28(1)      24(1)      25(1)       1(1)       3(1)      -1(1) 
C(12)    31(1)      27(1)      27(1)       5(1)       2(1)       1(1) 
C(13)    32(1)      30(1)      33(1)       2(1)       0(1)      -2(1) 
C(14)    31(1)      36(1)      41(1)       1(1)      -3(1)      -7(1) 
C(15)    27(1)      47(2)      41(1)       7(1)       5(1)      -4(1) 
C(16)    31(1)      40(1)      36(1)       6(1)       9(1)       2(1) 
C(17)    28(1)      30(1)      28(1)       4(1)       4(1)       2(1) 
C(18)    35(1)      35(1)      29(1)       0(1)       7(1)       3(1) 
C(19)    35(1)      28(1)      28(1)      -3(1)       4(1)      -1(1) 
C(20)    29(1)      24(1)      26(1)       3(1)       4(1)       1(1) 
C(21)    31(1)      27(1)      28(1)       1(1)       5(1)      -2(1) 
C(22)    30(1)      34(1)      32(1)       2(1)       5(1)       3(1) 
C(23)    40(1)      35(1)      37(1)       2(1)      12(1)       7(1) 
C(24)    53(1)      28(1)      40(1)      -2(1)      16(1)       3(1) 
C(25)    44(1)      30(1)      37(1)      -5(1)      10(1)      -9(1) 
C(26)    32(1)      29(1)      30(1)      -1(1)       6(1)      -3(1) 
C(27)    32(1)      28(1)      34(1)      -1(1)       3(1)      -6(1) 
C(28)    34(1)      31(1)      42(1)       5(1)       8(1)      -1(1) 
C(29)    27(1)      30(1)      30(1)       3(1)       5(1)       0(1) 
C(30)    32(1)      30(1)      36(1)       3(1)       4(1)       4(1) 
C(31)    36(1)      40(1)      36(1)       0(1)       5(1)       4(1) 
C(32)    74(2)      57(2)      46(2)       2(1)      23(1)     -12(2) 
C(33)    66(2)      70(2)      47(2)     -11(2)      10(1)      26(2) 
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Table 6.   
Hydrogen coordinates ( x 10^4) and isotropic displacement parameters (A^2 x 10^3) 
for (S,2R,4S)-154. 
  
           
                    x             y             z           U(eq) 
          
  
   
      H(2)         4310          2396         10191          38 
      H(3)         3996          3927         10386          39 
      H(5)         4164          5462          9475          41 
      H(6)         4896          6407          7886          44 
      H(7)         6210          5820          6166          41 
      H(8)         6769          4299          6055          36 
      H(13)        9027          3830          7826          38 
      H(14)       11696          4213          7488          43 
      H(15)       13087          3464          5928          46 
      H(16)       11831          2280          4819          42 
      H(18)        9414          1294          4309          39 
      H(19)        6799           851          4678          36 
      H(22)        7811           -55          7593          38 
      H(23)        8057         -1588          7133          44 
      H(24)        5735         -2440          6496          48 
      H(25)        3126         -1779          6336          44 
      H(27)        2031           128          5818          37 
      H(28A)       2309          -645          8998          42 
      H(28B)        491          -260          9134          42 
      H(29)        3109           788          9393          35 
      H(30A)       -152          1328          8547          39 
      H(30B)       1276          2065          8624          39 
      H(31)        1777          1814         10824          44 
      H(32A)        863           314         10965          87 
      H(32B)       -997           645         10704          87 
      H(32C)         63           944         11974          87 
      H(33A)        -42          2964         10094          91 
      H(33B)       -493          2583         11435          91 
      H(33C)      -1557          2288         10165          91 
      H            2170(30)      1330(20)      7070(30)      35(7) 
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Table 1.  Crystal data and structure refinement for (R,R)-149. 
  
  
      Identification code                (R,R)-149 
  
      Empirical formula                  C26 H32 B2 Cl6 N2 O3 
  
      Formula weight                     654.86 
  
      Temperature                        150(2) K 
  
      Wavelength                         0.71073 A 
  
      Crystal system                     monoclinic 
 
      Space group                        P 21 
  
      Unit cell dimensions               a = 12.8270(2) A   alpha = 90 deg. 
                                          b = 9.1150(2) A    beta = 90.4400(10) deg. 
                                          c = 13.5150(3) A   gamma = 90 deg. 
  
      Volume                              1580.10(6) A^3 
  
      Z, Calculated density              2,  1.376 Mg/m^3 
  
      Absorption coefficient             0.574 mm^-1 
  
      F(000)                              676 
  
      Crystal size                        0.50 x 0.40 x 0.25 mm 
  
      Theta range for data collection    4.16 to 27.48 deg. 
  
      Limiting indices                   -16<=h<=16, -11<=k<=11, -17<=l<=17 
  
      Reflections collected / unique     17416 / 6826 [R(int) = 0.0302] 
  
      Completeness to theta =   27.48      99.4 % 
  
      Max. and min. transmission         0.8697 and 0.7622 
  
      Refinement method                  Full-matrix least-squares on F^2 
  
      Data / restraints / parameters     6826 / 1 / 372 
  
      Goodness-of-fit on F^2             1.038 
  
      Final R indices [I>2sigma(I)]      R1 = 0.0437, wR2 = 0.1027 
  
      R indices (all data)               R1 = 0.0475, wR2 = 0.1059 
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       Absolute structure parameter       0.45(5) 
  
      Largest diff. peak and hole        0.613 and -0.649 e.A^-3 
   
Table 2.   
Atomic coordinates ( x 10^4) and equivalent isotropic displacement parameters (A^2 x 
10^3) for (R,R)-149. 
 
U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
           
  
                 x             y             z           U(eq) 
          
  
 
  B(1)          773(2)       4849(3)       1701(2)       26(1) 
  B(2)         2107(2)       5704(3)       2905(2)       27(1) 
  N(1)         1083(2)       5931(2)        737(1)       29(1) 
  N(2)         2439(2)       4122(2)       3424(1)       29(1) 
  O(1)         1309(1)       3463(2)       1549(1)       29(1) 
  O(2)         2883(1)       5933(2)       2133(1)       30(1) 
  O(3)         1048(1)       5632(2)       2578(1)       26(1) 
  C(1)         -476(2)       4841(3)       1470(2)       28(1) 
  C(2)        -1313(2)       4109(3)       1899(2)       31(1) 
  C(3)        -2326(2)       4339(3)       1540(2)       37(1) 
  C(4)        -2516(2)       5292(4)        755(2)       40(1) 
  C(5)        -1700(2)       6026(3)        308(2)       37(1) 
  C(6)         -703(2)       5766(3)        670(2)       32(1) 
  C(7)          261(2)       6405(3)        294(2)       33(1) 
  C(8)         2139(2)       6470(3)        495(2)       32(1) 
  C(9)         2749(2)       5252(3)        -32(2)       39(1) 
  C(10)        2243(3)       4864(4)      -1024(2)       50(1) 
  C(11)        3881(3)       5705(5)       -187(2)       57(1) 
  C(12)        2644(2)       7055(3)       1442(2)       33(1) 
  C(13)        2270(2)       6715(3)       3886(2)       31(1) 
  C(14)        2186(2)       8218(3)       4061(2)       39(1) 
  C(15)        2383(2)       8782(4)       5004(2)       50(1) 
  C(16)        2680(2)       7856(4)       5771(2)       55(1) 
  C(17)        2778(2)       6346(4)       5625(2)       49(1) 
  C(18)        2581(2)       5817(3)       4677(2)       35(1) 
  C(19)        2639(2)       4291(3)       4349(2)       34(1) 
  C(20)        2408(2)       2677(3)       2951(2)       32(1) 
  C(21)        3367(2)       2436(3)       2288(2)       37(1) 
  C(22)        3389(2)        849(3)       1916(2)       44(1) 
  C(23)        4386(2)       2769(4)       2844(3)       54(1) 
  C(24)        1372(2)       2526(3)       2386(2)       31(1) 
  C(30)        -560(2)       7703(3)       3613(2)       38(1) 
  Cl(1)       -1860(1)       7260(1)       3292(1)       44(1) 
  Cl(2)        -252(3)       9444(4)       3101(2)       68(1) 
  Cl(3)        -371(3)       7745(9)       4883(3)       65(1) 
  Cl(2A)       -357(6)       9521(8)       3520(20)     124(5) 
  Cl(3A)       -396(7)       7080(20)      4882(6)       70(3) 
  C(40)        4977(2)       7163(3)       3308(2)       34(1) 
  Cl(4)        5537(1)       5944(1)       4139(1)       86(1) 
  Cl(5)        5599(1)       7114(2)       2190(1)      104(1) 
  Cl(6)        5045(1)       8908(1)       3833(1)      103(1) 
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           Table 3. Bond lengths [A] for (R,R)-149. 
            
  
            B(1)-O(3)                     1.425(3) 
            B(1)-O(1)                     1.454(3) 
            B(1)-C(1)                     1.629(4) 
            B(1)-N(1)                     1.684(3) 
            B(2)-O(3)                     1.427(3) 
            B(2)-O(2)                     1.463(3) 
            B(2)-C(13)                    1.627(3) 
            B(2)-N(2)                     1.658(3) 
            N(1)-C(7)                     1.282(3) 
            N(1)-C(8)                     1.480(3) 
            N(2)-C(19)                    1.283(3) 
            N(2)-C(20)                    1.465(3) 
            O(1)-C(24)                    1.419(3) 
            O(2)-C(12)                    1.417(3) 
            C(1)-C(2)                     1.394(3) 
            C(1)-C(6)                     1.401(3) 
            C(2)-C(3)                     1.400(4) 
            C(3)-C(4)                     1.391(4) 
            C(4)-C(5)                     1.385(4) 
            C(5)-C(6)                     1.385(4) 
            C(6)-C(7)                     1.462(4) 
            C(8)-C(12)                    1.527(3) 
            C(8)-C(9)                     1.536(4) 
            C(9)-C(11)                    1.525(4) 
            C(9)-C(10)                    1.527(4) 
            C(13)-C(14)                   1.395(4) 
            C(13)-C(18)                   1.401(4) 
            C(14)-C(15)                   1.395(4) 
            C(15)-C(16)                   1.389(5) 
            C(16)-C(17)                   1.396(5) 
            C(17)-C(18)                   1.391(4) 
            C(18)-C(19)                   1.462(4) 
            C(20)-C(24)                   1.534(3) 
            C(20)-C(21)                   1.543(3) 
            C(21)-C(22)                   1.531(4) 
            C(21)-C(23)                   1.533(4) 
            C(30)-Cl(2A)                  1.681(8) 
            C(30)-Cl(3)                   1.732(5) 
            C(30)-Cl(1)                   1.766(3) 
            C(30)-Cl(2)                   1.777(4) 
            C(30)-Cl(3A)                  1.815(10) 
            C(40)-Cl(5)                   1.716(3) 
            C(40)-Cl(4)                   1.732(3) 
            C(40)-Cl(6)                   1.743(3)  
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           Table 4.  Bond angles [deg] for (R,R)-149. 
            
   
            O(3)-B(1)-O(1)              116.0(2) 
            O(3)-B(1)-C(1)              113.44(19) 
            O(1)-B(1)-C(1)              115.72(19) 
            O(3)-B(1)-N(1)              106.95(18) 
            O(1)-B(1)-N(1)              106.58(18) 
            C(1)-B(1)-N(1)               95.28(18) 
            O(3)-B(2)-O(2)              115.94(19) 
            O(3)-B(2)-C(13)             113.28(19) 
            O(2)-B(2)-C(13)             114.6(2) 
            O(3)-B(2)-N(2)              109.42(19) 
            O(2)-B(2)-N(2)              104.57(18) 
            C(13)-B(2)-N(2)              96.69(18) 
            C(7)-N(1)-C(8)              122.3(2) 
            C(7)-N(1)-B(1)              111.13(19) 
            C(8)-N(1)-B(1)              125.97(19) 
            C(19)-N(2)-C(20)            122.6(2) 
            C(19)-N(2)-B(2)             110.9(2) 
            C(20)-N(2)-B(2)             126.25(18) 
            C(24)-O(1)-B(1)             115.76(17) 
            C(12)-O(2)-B(2)             115.30(18) 
            B(1)-O(3)-B(2)              120.63(18) 
            C(2)-C(1)-C(6)              116.9(2) 
            C(2)-C(1)-B(1)              133.0(2) 
            C(6)-C(1)-B(1)              110.1(2) 
            C(1)-C(2)-C(3)              120.0(2) 
            C(4)-C(3)-C(2)              121.0(3) 
            C(5)-C(4)-C(3)              120.3(3) 
            C(4)-C(5)-C(6)              117.5(2) 
            C(5)-C(6)-C(1)              124.2(2) 
            C(5)-C(6)-C(7)              126.2(2) 
            C(1)-C(6)-C(7)              109.6(2) 
            N(1)-C(7)-C(6)              113.5(2) 
            N(1)-C(8)-C(12)             108.26(19) 
            N(1)-C(8)-C(9)              109.5(2) 
            C(12)-C(8)-C(9)             115.3(2) 
            C(11)-C(9)-C(10)            109.9(2) 
            C(11)-C(9)-C(8)             110.9(2) 
            C(10)-C(9)-C(8)             111.1(3) 
            O(2)-C(12)-C(8)             112.9(2) 
            C(14)-C(13)-C(18)           117.8(2) 
            C(14)-C(13)-B(2)            133.2(3) 
            C(18)-C(13)-B(2)            109.0(2) 
            C(15)-C(14)-C(13)           120.2(3) 
            C(16)-C(15)-C(14)           120.3(3) 
            C(15)-C(16)-C(17)           121.2(3) 
            C(18)-C(17)-C(16)           117.2(3) 
            C(17)-C(18)-C(13)           123.3(3) 
            C(17)-C(18)-C(19)           126.9(3) 
            C(13)-C(18)-C(19)           109.8(2) 
            N(2)-C(19)-C(18)            113.5(2) 
            N(2)-C(20)-C(24)            108.6(2) 
            N(2)-C(20)-C(21)            111.3(2) 
            C(24)-C(20)-C(21)           112.9(2) 
            C(22)-C(21)-C(23)           109.3(2) 
            C(22)-C(21)-C(20)           110.0(2) 
            C(23)-C(21)-C(20)           111.5(2) 
            O(1)-C(24)-C(20)            112.79(19) 
            Cl(2A)-C(30)-Cl(3)           91.6(8) 
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            Cl(2A)-C(30)-Cl(1)          110.7(4) 
            Cl(3)-C(30)-Cl(1)           111.9(2) 
            Cl(2A)-C(30)-Cl(2)           19.5(10) 
            Cl(3)-C(30)-Cl(2)           109.7(3) 
            Cl(1)-C(30)-Cl(2)           108.73(17) 
            Cl(2A)-C(30)-Cl(3A)         110.9(6) 
            Cl(3)-C(30)-Cl(3A)           19.4(4) 
            Cl(1)-C(30)-Cl(3A)          105.3(3) 
            Cl(2)-C(30)-Cl(3A)          128.4(5) 
            Cl(5)-C(40)-Cl(4)           111.15(16) 
            Cl(5)-C(40)-Cl(6)           111.08(17) 
            Cl(4)-C(40)-Cl(6)           107.63(14) 
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Table 5.   
Anisotropic displacement parameters (A^2 x 10^3) for (R,R)-149. 
The anisotropic displacement factor exponent takes the form: 
 
    -2 pi^2 [ h^2 a*^2 U11 + ... + 2 h k a* b* U12 ] 
    
______________________________________________________________________ 
  
          U11        U22        U33        U23        U13        U12 
    
______________________________________________________________________ 
  
B(1)     33(1)      26(1)      20(1)      -1(1)       5(1)      -5(1) 
B(2)     28(1)      30(1)      22(1)      -4(1)       5(1)      -2(1) 
N(1)     39(1)      26(1)      22(1)      -2(1)       5(1)      -6(1) 
N(2)     28(1)      34(1)      26(1)       2(1)       4(1)      -3(1) 
O(1)     37(1)      27(1)      23(1)      -2(1)       5(1)      -2(1) 
O(2)     30(1)      31(1)      28(1)      -3(1)       8(1)      -4(1) 
O(3)     31(1)      29(1)      20(1)      -5(1)       3(1)      -2(1) 
C(1)     34(1)      30(1)      22(1)      -5(1)       0(1)      -2(1) 
C(2)     34(1)      34(1)      23(1)      -3(1)       1(1)      -5(1) 
C(3)     34(1)      50(2)      26(1)      -7(1)       0(1)      -7(1) 
C(4)     35(1)      53(2)      32(1)      -7(1)      -4(1)       1(1) 
C(5)     44(1)      40(1)      27(1)       1(1)      -3(1)       4(1) 
C(6)     40(1)      29(1)      26(1)      -2(1)       0(1)      -1(1) 
C(7)     44(1)      32(1)      23(1)       1(1)       2(1)      -1(1) 
C(8)     39(1)      31(1)      27(1)       2(1)       8(1)      -9(1) 
C(9)     45(2)      43(2)      28(1)      -3(1)      13(1)      -6(1) 
C(10)    64(2)      55(2)      31(1)      -9(1)       7(1)      -5(2) 
C(11)    50(2)      71(2)      50(2)     -16(2)      22(1)     -13(2) 
C(12)    36(1)      28(1)      33(1)      -3(1)       7(1)     -10(1) 
C(13)    23(1)      43(1)      29(1)     -11(1)       4(1)      -3(1) 
C(14)    29(1)      43(2)      46(2)     -20(1)       3(1)      -4(1) 
C(15)    38(1)      61(2)      51(2)     -32(2)       3(1)      -1(1) 
C(16)    39(1)      85(3)      40(2)     -37(2)       5(1)      -8(2) 
C(17)    41(2)      79(2)      26(1)     -15(1)       2(1)      -6(2) 
C(18)    27(1)      51(2)      28(1)      -9(1)       5(1)      -7(1) 
C(19)    29(1)      46(2)      28(1)       0(1)       2(1)      -4(1) 
C(20)    36(1)      29(1)      31(1)       4(1)       2(1)      -1(1) 
C(21)    39(1)      33(1)      39(1)       2(1)       8(1)       6(1) 
C(22)    45(2)      43(2)      44(2)     -14(1)      -5(1)       9(1) 
C(23)    37(1)      45(2)      81(2)     -20(2)       9(1)      -5(1) 
C(24)    38(1)      26(1)      29(1)       1(1)       4(1)      -5(1) 
C(30)    33(1)      41(2)      38(1)       0(1)       2(1)       4(1) 
Cl(1)    39(1)      49(1)      44(1)      -7(1)      -1(1)      -3(1) 
Cl(2)    47(1)      59(1)      98(2)      30(1)     -22(1)     -15(1) 
Cl(3)    37(1)     125(3)      34(1)      -8(2)       3(1)       5(2) 
Cl(2A)   49(2)      32(2)     293(15)      2(5)      14(6)       0(2) 
Cl(3A)   41(2)     135(7)      33(2)      -3(4)      -3(1)      -6(4) 
C(40)    26(1)      39(1)      38(1)       1(1)      -3(1)      -2(1) 
Cl(4)    84(1)      65(1)     108(1)      44(1)     -52(1)     -25(1) 
Cl(5)    51(1)     217(2)      44(1)     -18(1)      14(1)     -37(1) 
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Table 6.  Hydrogen coordinates ( x 10^4) and isotropic displacement parameters (A^2 x 
10^3) for (R,R)-149. 
  
         
______________________________________________________________________ 
  
                    x             y             z           U(eq) 
         
______________________________________________________________________ 
  
     H(2)        -1195          3453          2435          37 
     H(3)        -2892          3837          1836          44 
     H(4)        -3210          5441           524          48 
     H(5)        -1819          6682          -227          44 
     H(7)          278          7103          -227          40 
     H(8)         2060          7309            23          39 
     H(9)         2742          4358           396          46 
     H(10A)       1519          4563          -918          75 
     H(10B)       2628          4057         -1331          75 
     H(10C)       2257          5723         -1460          75 
     H(11A)       4255          4911          -520          85 
     H(11B)       4210          5904           455          85 
     H(11C)       3903          6592          -597          85 
     H(12A)       3292          7582          1271          39 
     H(12B)       2165          7768          1754          39 
     H(14)        1994          8860          3537          47 
     H(15)        2314          9805          5121          60 
     H(16)        2820          8257          6408          66 
     H(17)        2970          5707          6151          58 
     H(19)        2808          3501          4779          41 
     H(20)        2423          1916          3484          38 
     H(21)        3313          3106          1704          45 
     H(22A)       3998           707          1493          65 
     H(22B)       2752           646          1536          65 
     H(22C)       3432           180          2483          65 
     H(23A)       4373          3783          3084          82 
     H(23B)       4976          2639          2396          82 
     H(23C)       4459          2098          3407          82 
     H(24A)       1288          1497          2166          37 
     H(24B)        792          2757          2838          37 
     H(30)         -85          6950          3323          45 
     H(40)        4228          6894          3206          41 
      
 
 
